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Abstract
Membrane proteins continue to represent a major challenge for most analytical techniques.
Using bacteriorhodopsin (BR) as model system, this work aims to develop mass
spectrometry (MS)-based approaches for exploring the structure, dynamics and folding of
membrane proteins.

As the first step, BR in its native lipid environment was exposed to hydroxyl radicals,
which were produced by laser photolysis of hydrogen peroxide. It was found that the
resulting methionine (Met) labeling pattern was consistent with the known BR structure.
This finding demonstrates that laser-induced oxidative Met labeling can provide structural
information on membrane proteins. In subsequent experiments, the effects of different
denaturing agents (heat, acid, and SDS) on the BR conformation were investigated. It was
demonstrated that each of these non-native conditions results in unique structural features
that give rise to characteristic Met labeling patterns. These results highlight the ability of
laser-induced oxidative labeling to detect conformational changes of membrane proteins.

Obtaining better insights into the structural properties of SDS-denatured BR is particularly
important because this form of protein is widely used as starting point for folding studies.
Combining oxidative labeling with site-directed mutagenesis and fluorescence
measurements, this work yielded a detailed structural model of SDS-denatured BR.
Subsequently, pulsed oxidative labeling coupled with rapid mixing and MS was used to
characterize short-lived intermediates that become populated during BR refolding. The
combination of pulsed oxidative labeling and stopped-flow spectroscopy provided key
iii
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structural insights into the kinetic mechanism by which the SDS-denatured protein inserts
and folds into the lipid bilayer.

Complementary to oxidative labeling, hydrogen/deuterium exchange (HDX) MS was
employed to examine the structure and dynamics of BR under various physiochemical
conditions. Structural features of different detergent/lipid-bound BR samples were
characterized by their HDX kinetics. Comparative HDX experiments of BR were carried
out in the dark (resting state) and under illumination where the induced retinal
isomerization mediates proton transport (functioning state). Isotope exchange was found to
be much faster during light exposure than in the dark. This observation reveals that
structural dynamics of the protein scaffold are "accelerated" by motions of the retinal,
reflecting a direct coupling between protein dynamics and function.

Keywords:

membrane protein, bacteriorhodopsin, mass spectrometry, oxidative

labeling, hydroxyl radical, hydrogen/deuterium exchange, protein dynamics, membrane
protein folding.
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Chapter-1 Introduction
1.1 Membrane Proteins
1.1.1 General Background
Simply speaking, proteins do almost everything in living cells. All functions of living
organisms, such as metabolism, energy conversion, communication, regulation,
reproduction and structural support, are related to proteins. Proteins are linear biopolymers
composed of 20 different amino acids, which are linked to each other by peptide bonds.
Most proteins can perform their specific biological functions only after folding into unique
three-dimensional structures.1 The architecture of proteins can be divided into four
hierarchical levels: (1) Primary structure: the amino acid sequence. DNA (or RNA in
some viruses) encodes the primary protein structure. (2) Secondary structure: the local
arrangement of the peptide backbone into α-helices, β-sheets, turns, and coiled regions.
Different secondary structure elements can be present in the same protein molecule. (3)
Tertiary structure: the overall shape of a single polypeptide chain. Tertiary structure
completely defines the structure of a protein molecule. (4) Quaternary structure: the shape
or structure that results from the interaction of more than one polypeptide chain, usually
called subunits, which function as parts of a protein complex. Proteins can be divided into
three main classes: globular proteins, fibrous proteins, and membrane proteins. Almost all
globular proteins are water-soluble, and many are enzymes. Fibrous proteins often provide
structural support. Membrane proteins often serve as receptors for cell signaling or
transporters to provide channels for polar or charged molecules to pass through the cell
membrane.
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Each living cell is surrounded by a biological membrane that is an organized assembly of
lipids and associated membrane proteins. The lipids are arranged as a bilayer. The
associated membrane proteins can be classified into two groups: integral (intrinsic) and
peripheral (extrinsic) membrane proteins based on the nature of the lipid bilayer-protein
interactions as shown in Figure 1-1. Most biological membranes contain both types of
membrane proteins. Integral membrane proteins are permanently attached to the
membrane and have one or more segments that are embedded in the lipid bilayer. They
associate tightly with the membrane through hydrophobic interactions and can be separated

Integral membrane proteins

lipid
membrane

A

B
Peripheral membrane protein

Figure 1-1. Schematic of a lipid bilayer and associated membrane proteins.
A: α-helical membrane protein; B: β-barrel membrane protein.
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from the membrane only by treatment with agents that disrupt membranes. These proteins
are generally free to diffuse laterally in the lipid matrix. Most peripheral membrane
proteins are loosely attached to protruding portions of integral membrane proteins, or
interact with lipid head groups.

The presence of a membrane is essential for living systems as it provides a physical barrier
between the cell and its environment. Many functions of the membrane are mediated by
integral membrane proteins. These proteins are key players in a variety of important cellular
processes including ion and solute transport (ion channels and transporters), energy
conversion (respiration, ATP synthesis), and cell signaling (G-protein coupled receptors
and growth factor receptors). Based on their secondary structure, integral membrane
proteins are divided into two classes: 1) α-helical and 2) β-barrel membrane proteins.

1.1.2 α-Helical Membrane Proteins
The vast majority of integral membrane proteins are α-helical. They represent an estimated
20%~25% of all open reading frames (ORFs) in fully sequenced genomes.2 This type of
protein possesses one or more transmembrane helices that are connected by extramembrane
loops (Figure 1-1). A conspicuous characteristic in the amino acid sequence is the presence
of hydrophobic stretches of approximately 20 nonpolar residues, which are just enough to
span the hydrophobic core of a typical bilayer in an α-helical conformation.3 Loops that
protrude into the aqueous phase on both sides are usually hydrophilic. A few polar groups
can be included in the helical sequence, provided that the helix remains hydrophobic on
average or that group polarity is diminished, such as in ion pairs or protonated state. Also,
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the interior of transmembrane regions is often lined with hydrophilic residues, giving rise to
amphipathic helices. The net hydrophobicity favors the association of these helices into
membrane interior relative to the aqueous milieu. As a result, hydrophobic effects drive the
formation of transmembrane helices.4, 5

Statistical analyses of transmembrane helices show that large hydrophobic amino acids
such as leucine, isoleucine, valine and phenylalanine prefer the lipid-exposed surface to the
protein interior. It is remarkable that glycine and proline are abundant in transmembrane
helices although they tend to be helix breakers. About 60% of transmembrane helices
contain significant bends or other distortions.5 These occurrences emphasize the important
contribution of the hydrophobic environment to the stabilization of hydrogen bonding and
helix formation. Aromatic side chains, particular tryptophan and tyrosine, are often located
near the termini of helices. Additionally, even though cysteine is abundant, no disulfides
have been found in transmembrane regions.4

Unlike soluble proteins whose structure is stabilized mostly by the hydrophobic effect, the
importance of hydrophobic interactions is minimal for transmembrane helices that are
dominated by non-polar residues in a bilayer milieu. Inter-helix side chain hydrogen bonds
have been identified in a number of membrane proteins, but their impacts on overall
stability and folding were found to be modest.5, 6 In contrast, extensive van der Waals
interactions play a major role in stabilizing the helical packing in the bilayer.4, 5 These
helices exhibit a narrow distribution of packing angles with a strong preference at ~20o that
favors inter-helix side chain interdigitation. Small residues such as glycine, alanine and
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serine, preferably appear at the helix-helix interface where they are often involved in
specific interactions. Setting aside prosthetic groups and lipid interactions, helix packing is
the dominant factor to provide specific helix-helix recognition and stabilization.4, 5

1.1.3 β-Barrel Membrane Proteins
β-Barrel membrane proteins occur in the outer membrane of Gram-negative bacteria.7, 8
The outer membrane protects the bacteria from hostile environments, while these proteins
serve as channels to permit the entry of small solutes such as nutrients. β-Barrel proteins
also occur in eukaryotes in the outer membrane of mitochondria and chloroplasts. β-Barrel
membrane proteins account for 2 ~ 3 % of all ORFs.2 All these species share a common
architecture (Figure 1-1), composed of an antiparallel β-barrel, with loops protruding
outside the membrane. Transmembrane β-barrels of known structure consist of 8 to 22
β-strands that roll up, forming a solvent accessible channel with a minimum diameter of 7
Å. The number of strands must be even to permit the β-sheet to close up on itself. The N and
C termini are at the periplasmic barrel end. All strands are antiparallel and tilted by 30 ~ 60o
relative to the membrane normal. The side chains at the solvent-exposed surface are often
polar.7 In contrast, the outer surface of the barrel exposed to the membrane consists of
hydrophobic side chains with two girdles of aromatic residues in the lipid head group
regions. Since the transmembrane segments are β-strands, every second residue is facing
the lipids and hence needs to be hydrophobic. Compared to helical membrane proteins, the
sequences of β-barrel proteins tend to be relatively hydrophilic, usually containing
alternating hydrophobic and hydrophilic residues.7, 8
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1.2 Membrane Protein Structure and Dynamics
1.2.1 Non-Mass Spectrometry Techniques
Membrane proteins comprise ~30% of the human genome.9 More than half of all known
drug targets are membrane proteins.10 Despite their biomedical importance, relatively little
is known about the structure and function of these species, when compared to their globular
counterparts. For example, among the more than 60,000 coordinate files currently available
in the protein data bank (PDB) (http://www.pdb.org/) there are only ca. 200 unique
membrane protein structures (http://blanco.biomol.uci.edu/).11

X-ray crystallography and NMR are classical techniques for determining the structure of
soluble proteins. X-ray crystallography has long been the “gold standard” to obtain protein
structure at atomic resolution. Since the first three-dimensional structure of myoglobin was
solved,12, 13 over 39000 X-ray crystal structures of proteins and other biological molecules
have been determined. Around 85% of the protein structures available in the PDB were
determined by X-ray crystallography. X-ray crystallography can solve the structures of
very large molecules. However, the target protein must be available in large amounts
(milligrams) and very high purity, in order to initiate successful crystallization. Moreover,
this technique is limited to native proteins, because partially unfolded species do not
crystallize. NMR spectroscopy is another indispensable technique for examining protein
structure and dynamics.14 NMR investigations can yield three-dimensional structures of
proteins with a high resolution, similar to what is achievable by X-ray crystallography.
Roughly 15% of the protein structures in the PDB were obtained by NMR. NMR
spectroscopy is often the only way to obtain high resolution information on partially or
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wholly unstructured proteins. However, NMR is typically limited to relatively small
proteins.15

As noted earlier, the native fold of globular proteins is characterized by a hydrophobic core,
and an exterior that is dominated by polar and charged side chains. This architecture results
in high water solubility and a low tendency to aggregate. In contrast, membrane proteins
exhibit a large hydrophobic surface area that is in contact with alkyl chains of the lipid
bilayer. Hydrophilic regions are usually limited to segments that interact with polar lipid
head groups and/or that protrude out of the membrane plane, e.g., cytoplasmic or
extracellular loops. A number of charged and polar residues may also be found in the
interior, particularly for systems that act as pores or transporters, and that contain internal
water molecules.16 Once removed from the lipid bilayer, membrane proteins tend to
undergo rapid denaturation and/or aggregation caused by the exposure of hydrophobic
surface elements to the aqueous solvent. The most common strategy for stabilizing isolated
membrane proteins is the solubilization in detergent micelles. However, the micellar
environment represents a less-than-perfect mimic of the membrane bilayer. As a result, the
occurrence of structural changes and aggregation can often not be completely eliminated.17
The use of bicelles (bilayered micelles)18 or liposomes (lipid vesicles)19 can sometimes
represent a useful alternative.

Membrane proteins are amenable to the same structure determination methods as globular
proteins, albeit with a much lower success rate. The first X-ray crystal structures of
myoglobin appeared in 1950s,12, 13 but it took almost thirty additional years until the first

8

membrane protein structure was published.20 In many cases, a key prerequisite for
successful X-ray studies on membrane proteins is the proper choice of detergent molecules
that co-crystallize with the protein, while at the same time preventing precipitation.17
Bicelle-mediated crystallization has been reported as well.18 Detergent-solubilized
membrane protein complexes tend to be quite large, and the resulting slow rotational
diffusion causes peak broadening in solution NMR experiments which complicates the
acquisition of high quality spectra.21 Nonetheless, structural information on a few
membrane proteins has been obtained using this approach.22 Although still in its infancy,
the application of solid-state NMR methods to liposome-reconstituted systems represents
a promising novel strategy.23 In addition, the use of magic-angle spinning NMR
spectroscopy to systems with very long rotational correlation times has been
demonstrated.24

As a result of the difficulties associated with the application of X-ray and NMR techniques
to membrane proteins, there is a considerable interest in low resolution methods capable of
providing at least some structural information.25 Probably the simplest of these strategies
are Kyte-Doolittle hydropathy analyses which yield secondary structure predictions (e.g.
transmembrane helices vs. loops) on the basis of the amino acid sequence.26 While the
reliability of these prediction schemes is limited, they allow hypotheses regarding structure
and topology to be developed which can then be tested experimentally, e.g., by protease
protection assays.27 Cysteine (Cys) scanning mutagenesis represents a more informative but
very labor intensive approach.28 This method requires the availability of a genetically
engineered Cys free background construct. Individual Cys residues are then incorporated in
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specific locations. Subsequently the protein is exposed to a thiol specific coupling reagent,
and the extent of reaction is monitored using a fluorescence-based readout or other
detection methods. Only those Cys residues that are accessible to the labeling reagent will
react readily. In this way it is possible to obtain fairly accurate information on the locations
of loops and transmembrane regions, as well as some insights into packing interactions.
Additional topological information can be obtained by using a combination of membrane
permeable and impermeable reagents.28 In a Herculean effort, Kaback and coworkers29
subjected over 400 positions of the 417 amino acids of the protein lac permease to this Cys
substitution technique, resulting in a three-dimensional model that was later found to be
largely consistent with a X-ray crystal structure.30

Low resolution spectroscopic methods have also been widely used to probe the global
conformation of membrane proteins. For instance, in the far-UV region (190-250nm),
different forms of secondary structure result in characteristics CD patterns. Hence, CD
spectroscopy is commonly used to estimate the secondary structure of membrane
proteins.31 The fluorescence of tryptophans is sensitive to environment. Most membrane
proteins contain tryptophan residues. Fluorescence spectroscopy is thus often employed for
detecting global or local structural changes in response to alterations in the solvent
environment. For membrane proteins that contain additional chromophores, UV-Vis
spectroscopy can be used to monitor the structural changes.

A well defined protein structure usually represents a prerequisite for function, but it has
been widely accepted that protein structure is not static. Proteins are in constant motion,
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sampling different conformational substates around the average structure.32-34 The relative
probabilities of these conformational substates are governed by the Boltzmann distribution.
The kinetics of inter-conversion among these substates are defined by free energy barriers.
These structural fluctuations are thought to be essential for protein functions such as
enzyme catalysis, ligand binding, signaling, and transport. Native proteins represent a
fine-tuned balance between a highly ordered and stable conformation that ensures
specificity, and a state that remains dynamic enough to maintain functionality.
Characterizing protein dynamics is thus important for understanding the function and
stability.32

Several experimental and computational methods are available for probing the dynamic
properties of proteins. Classical crystallography can provide limited information about
protein dynamics by theoretical estimates of uncertainty in atomic positions using
B-factors. Recent developments such as time-resolved X-ray techniques have permitted
more detailed dynamic information to be gained.35 NMR spectroscopy is a powerful
technique for providing insights into protein dynamics at different time scales. Relaxation
measurements yield time-dependent correlation functions that can be interpreted in terms
of internal dynamics.36 Molecular dynamics simulations have emerged as one of the most
important tools for examining protein conformational dynamics over the past decade.37, 38
The main advantage of such computer simulations is that they can provide unbeatable
details about individual molecular motions as a function of time. To validate the simulation
methodology, however, experimental data are required.
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1.2.2 Mass Spectrometry-Based Approaches
With the advent of electrospray ionization (ESI)39 and matrix-assisted laser desorption/
ionization (MALDI),40 mass spectrometry (MS) has become an indispensable tool, not only
for studying protein sequences and post-translational modifications,41 but also for
examining their conformation, folding and dynamics.42 Experiments on membrane proteins
mostly employ liquid chromatography (LC)/ESI-MS, but the application of MALDI-MS
has been demonstrated as well.43 Similar to other analytical techniques, however, the
application of MS to membrane proteins continues to be challenging.44 Nonetheless,
following pioneering work in the late 1990s,45-47 this area is now experiencing continuous
growth48-51 and even large-scale projects in membrane proteomics have become feasible.9,
52-54

Other interesting applications include the use of nanoESI-MS for the analysis of intact

membrane protein assemblies. This approach provides information on subunit
stoichiometries and lipid-protein interactions.55,

56

The applicability of cross-linking to

membrane proteins has been demonstrated as well.57

MS is an analytical technique that measures the mass-to-charge ratio of ions in the gas
phase. For non-experts it may not be straightforward to see how these measurements can be
used for probing the structure and dynamics of proteins in solution. Key to MS-based
structural methods is the use of labeling strategies.58 These approaches rely on the principle
that factors such as polypeptide conformation, solvent exposure and structural dynamics
modulate the labeling behavior of specific sites on the protein. Labeling causes mass
changes that leads to peak shifts in the spectrum. Structural information can be obtained by
analyzing the mass changes of protein fragments in a spatially-resolved manner.

12

1.2.2.1 Hydrogen/Deuterium Exchange Mass Spectrometry
Amide hydrogen/deuterium exchange (HDX) is one of the most popular labeling methods
for studying the structure and dynamics of soluble proteins, and the technique has also been
applied to a few membrane proteins.6, 59-63 HDX experiments rely on the fact that exposure
of a protein to D2O induces N-H  N-D conversion at backbone amide linkages.
Solvent-exposed protein regions that are not involved in hydrogen bonding undergo rapid
exchange, with rate constants approaching the "chemical" HDX rate constant kch of
completely unprotected amides.64 kch is primarily dependent on the nature of amino acids
and neighboring residues at given pH and temperature. Because both acid and base can
catalyze HDX, there is a minimum value of kch at ~ pH 2.5. Importantly, HDX at
hydrogen-bonded N-H groups can be slowed down by as much as eight orders of
magnitude. Exchange at these protected sites is mediated by protein structural fluctuations
that involve the transient disruption of H-bonds and provide temporary solvent access.65, 66
These fluctuations may be interpreted as opening/closing events that are associated with
rate constants kop and kcl, respectively. The HDX mechanism can be described as follows:

Hclose

kop
Hopen

kch

D

D2O

kcl

The overall exchange rate constant kHDX is given by

k HDX =

kop kch
kcl + kch + kop

(1-1)
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The assumption of the exchangeable site being predominantly in its closed state implies
that kop << kcl, such that equation (1-1) becomes:

k HDX =

kop kch
(1-2)

kcl + kch

This expression leads to the two distinct EX2 and EX1 regimes. In the commonly
encountered EX2 limit, characterized by kcl >> kch, the overall exchange-rate constant kHDX
is given by

k HDX =

kop kch
kcl

= K op kch

(1-3)

where Kop is the equilibrium constant of the unfolding reaction of a protein. Kop depends on
the structure and dynamics of proteins. Under these conditions the probability of HDX
occurring during a single opening event is very small, such that numerous opening/closing
cycles are required before isotope exchange takes place. EX2 measurements offer an
avenue toward the thermodynamic characterization of proteins, because the free energy
difference (∆G0) of the open event is given by

∆G 0 = − RT ln K op = − RT ln

k HDX
kch

(1-4)

where the value of kch are known from the literature.64 Spreadsheets for calculating kch at
individual side chains can be downloaded from Dr. Walter Englander’s web site
(http://hx2.med.upenn.edu/).
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In the EX1 limit (kch >> kcl) multiple amide hydrogens in an open region become
simultaneously deuterated during a single unfolding event.66, 67 In this case, equation (1-2)
becomes

k HDX = kop

(1-5)

such that the HDX behavior of the protein reflects the kinetics of the opening event. HDX
of native proteins usually occurs in the EX2 regime. Semi-denaturing conditions sometimes
favor the EX1 regime. EX1 behavior can also be promoted by using basic pH which
increases kch.64

HDX events affect two fundamental parameters, nuclear spin and mass. The former can be
detected by NMR. The later can be identified by MS. In addition, the change in mass also
leads to alterations of vibrational frequencies, which enable the use of FTIR-based HDX
measurements. Traditionally, two-dimensional NMR spectroscopy has been the primary
detection method of choice for HDX experiments,65, 68 but in recent years LC/ESI-MS has
taken over as the more popular technique. Advantages of MS include its superior
sensitivity, tolerance to paramagnetic ligands or co-factors, no strict limitations to
molecular weight, and the possibility to readily distinguish between EX1 and EX2 modes
of exchange.69, 70 The EX2 regime is characterized by a unimodal peak that progressively
shifts to higher mass over time. In the case of EX1, a bimodal mass distribution is observed,
in which the low mass peak represents the protected/folded conformer and the high mass
peak represents the globally unfolded conformer. EX1 measurement provides a unique
opportunity to detect and characterize the transient globally unfolded conformer.
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For globular proteins, the degree of solvent exposure in the native state is not a primary
determinant of HDX rates. In other words, even N-H····O=C groups that are located at the
protein surface can be highly resilient to exchange, as long as the fraction of time spent in
the dissociated (N-H O=C) form is small.71 Hence, HDX experiments on globular proteins
do not necessarily provide structural information per se, but rather insights into protein
conformational dynamics. In the case of membrane proteins the situation might be
somewhat different, because solvent (D2O) access to membrane-embedded or micelleprotected regions could well become a limiting factor for the HDX rate. At present, there
does not appear to be an adequate knowledge base to resolve this interesting issue.

The standard or bottom-up HDX/MS protocol starts with exposure of a native unlabeled
protein to D2O-based buffer.72 Aliquots are removed from the reaction mixture at selected
labeling times. These samples are then exposed to pH 2.5 where the intrinsic HDX rates are
at a minimum, and the protein is digested by pepsin or other acidic proteases.72 LC
separation followed by ESI-MS allows the mass shifts of individual protein fragments to be
measured, such that a spatially-resolved picture of the deuterium incorporation is obtained
for each time point. The occurrence of isotope back exchange necessitates that all of the
steps following acid quenching have to be carried out in a very short amount of time,
typically 10 to 20 minutes, and at a temperature close to 0 °C. Several groups have
subjected isotopically labeled peptides or proteins to gas-phase fragmentation methods
with the goal of enhancing spatial resolution and preventing back-exchange. This approach
is called top-down HDX/MS.73-75
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While there have been a few MS-based HDX studies on short transmembrane peptides

76

and membrane-associated proteins,77 the application of the bottom-up HDX/MS protocol
to integral membrane proteins remains challenging. Along with solubility issues, a general
problem is the difficulty of generating peptic fragments in sufficiently high yield during the
short time interval available, and under low temperature conditions.78 Despite these
challenges, Busenlehner et al. succeeded in generating spatially-resolved HDX profiles for
two detergent solubilized membrane proteins, microsomal glutathione transferase 159 and
cytochrome c oxidase.60 Pepsinolysis of these two proteins may be favored by the presence
of relatively large extra-membrane regions. Rey et al. revealed the conformational
dynamics of the bovine mitochondrial ADP/ATP carrier by developing a separation method
for detergent removal.62,

79

The application of bottom-up HDX/MS to SDS-denatured

bacteriorhodopsin and γ-glutamyl carboxylase yielded spatially-resolved structural
information with ~50% protein sequence.6, 61 In recent work, Griffin et al.63 were able to
study the conformational dynamics of the β2-adrenergic G-protein coupled receptor by the
HDX/MS. Pepsin efficiency in that study was promoted by conducting the digestion step at
22 °C instead of using the customary 0 °C. It was reported that this elevated temperature did
not significantly enhance back exchange, which is surprising considering the results of
earlier studies.70,

72

A possible alternative to the bottom-up HDX/MS protocol for

membrane proteins could be the use of top-down experiments employing ECD or ETD.
Thus far top-down HDX MS have only been reported for water-soluble species.75, 80

1.2.2.2 Covalent Labeling Versus Hydrogen/Deuterium Exchange
In addition to HDX, a large number of MS-based methods for probing protein structures
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rely on the use of hydrophilic covalent probes that irreversibly modify solvent-accessible
side chains. The data obtained in this way reflect the dominant protein structure(s) present
in solution. This is quite different from HDX, where the overall isotope exchange behavior
can be governed by weakly populated non-native conformers.81 Compared to a "labile"
modification technique such as HDX, the stable nature of most covalent modifications
facilitates certain aspects of the analysis. For example, in addition to digestion and LC
separation it is possible to incorporate purification and concentration steps. Scrambling of
covalently attached moieties during MS/MS is generally of no concern. Peptide mapping in
covalent labeling experiments typically involves tryptic digestion which leads to specific
peptide bond cleavage on the C-terminal side of arginine and lysine, unless these residues
are followed by proline.82 In contrast, pepsin and other acidic proteases used for HDX
approaches provide cleavage patterns that are largely unpredictable.72

It is a convenient feature of the HDX approach that an isotopically labeled peptide will
show almost the same elution behavior as the unlabeled peptide under given LC conditions.
In contrast, covalent labeling will alter retention times on a reverse-phase (RP) column,
such that differentially modified peptides of a given sequence will not co-elute. For
example, the introduction of hydrophilic modifications (such as oxidation events) will
shorten retention times under RPLC conditions. Despite the use of a specific protease the
resulting chromatograms can be quite complicated. It may take some efforts to ensure that
all possible modifications for a given peptide have been accounted for. In addition, the
introduction of covalent modifications may alter peptide ionization efficiencies,83 such that
a quantitative determination of the labeling level is not always straightforward.
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Another point to consider is the possible occurrence of structural changes following the
labeling event. HDX is generally considered to be "benign" in this regard, meaning that
changes in protein structure and stability as a result of deuterium incorporation are not very
dramatic.67, 84 In contrast, the introduction of covalent modifications can result in marked
structural changes. Thus, it has to be ensured that the experiments are conducted under
carefully controlled conditions where the measured covalent labeling pattern reflects the
protein conformation of interest, and not an artificially altered structure. Approaches that
have been used to monitor the extent of these potential artifacts include optical
measurements,85 as well as first-order,86 and second-order87 kinetic analyses. Some
covalent probes react with the protein so quickly that the labeling process goes to
completion before major structural changes can occur. When used under single-exposure
conditions, these techniques are therefore believed to provide an artifact-free reflection of
the protein structure. An example of such approaches is the laser-induced oxidative
labeling,88 which will be discussed in the following Chapters.

1.2.2.3 Site-Specific Covalent Labeling
A host of hydrophilic reagents have been developed to covalently label proteins. Some of
those compounds react only with a specific type of side chains, whereas others are more
non-specific. The acetylation of Lys represents an example of a specific labeling strategy,89
but numerous reagents targeting other residues (e.g., Cys, Met, Arg, Glu, Asp, His, Trp and
Tyr) have been developed as well.90 Many of these specific labeling agents have been
applied to the structural studies of membrane proteins. The general workflow of these
experiments starts with labeling membrane proteins, followed by limited proteolysis of the
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protein and analyzing the resulting peptides by LC/MS. Tandem mass spectrometry
(MS/MS) is then used to identify the labeling sites (Figure 1-2). As an alternative to this
"bottom-up" approach, the experiments may be conducted in a "top-down" fashion.48, 91

The hydrophilic oxidizing agent chloramine T has been employed for mapping methionine
accessibility of human erythrocyte membrane band 3 protein.92 For the native protein,
Met oxidation was found to occur at solvent-accessible sites, but not in membrane
protected regions. Enhanced oxidation was found for several Met residues after detergent
exposure, indicating the occurrence of structural changes in a transmembrane segment.

Tetra-nitromethane can specifically induce nitrosylation at tyrosine residues and was used
to probe the topology of vesicle-reconstituted glycine receptor.93 Several modifications
were identified by proteolysis of the SDS solubilized protein followed by LC-MS/MS.
Interestingly, two of these sites (Tyr223 and Tyr228) were found to be located in a putative
transmembrane helix, but based on the labeling data it was concluded that the
corresponding segment likely forms an extramembrane loop.

A variety of hydrophobic photoreactive probes were used for monitoring conformational
switching events of the nicotinic acetylcholine receptor in response to changes in
transmembrane potential.94 Oocytes expressing the protein were manipulated using a
voltage-clamp setup in the presence of the labeling agent. Voltage changes and labeling
on/off conditions were coordinated by a shutter that controlled exposure of the protein to a
UV light source. Differences in the labeling pattern measured under different voltage
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Figure 1-2. General workflow for covalent labeling of membrane proteins with subsequent
MS analysis.
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conditions provided insights into the voltage-induced conformational changes.

Acetylation of lysine residues was employed to monitor interactions between rhodopsin
and a transducin-derived short peptide.89 It was demonstrated that light exposure of
membrane samples alters the solvent accessibility of several acetylation sites, and that
binding of the light-activated protein to the peptide modifies the solvent exposure of some
cytoplasmic loops. Protein-protein interactions were also explored by Wen et al.95 who
applied 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride for labeling Asp
and Glu in the membrane-associated FMO protein of a photosynthetic bacterium. In this
way information was obtained about the way this protein interacts with the transmembrane
reaction center complex. Those studies,89, 95 as well as related experiments,96 demonstrate
that covalent modification techniques not only provide information regarding membrane
protein structures and conformational switching events, but also about noncovalent binding
to other molecules. The term "footprinting" is often used in this context, referring to
experiments where access of a labeling agent to a protein surface is blocked by the presence
of a binding partner. Note, however, that some researchers employ this term in a somewhat
broader context, more or less synonymous with "covalent labeling".97

1.2.2.4 Hydroxyl Radical Labeling
Of the numerous covalent labeling agents, hydroxyl radical (⋅OH) represents the most
widely used non-specific covalent probe because of its small size and high reactivity.67, 86,
88, 98

This species can be generated in a number of ways, e.g., by using electrochemical,99

photochemical,88,

100

radiolytic,86 and corona discharge101 methods, as well as Fenton
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chemistry.102 ⋅OH has been shown to generate oxidative modifications for at least 14 out
of the 20 amino acid side chains, whereas backbone cleavage is uncommon if the
conditions are chosen properly.86 Oxidative labeling of proteins with known structures
generally results in spatial oxidation patterns that are consistent with the solvent exposure
of individual residues.

The overall degree to which any given target site undergoes labeling is determined by a
combination of solvent accessibility and intrinsic reactivity.86, 103 The sulfur-containing
residues Cys and Met are the most reactive, followed by the aromatic side chains Trp, Tyr,
and Phe. Also His, Leu, Ile, Arg, Lys, Val, Pro, Gln, and Glu represent potential
modification sites.104 The remaining 4 residues Gly, Ala, Asp and Asn are not useful as
probes because of their very low reactivity. Although radical reactions can proceed through
complex mechanisms which is not always well understood, the most frequently observed
products are amino acids with an oxygen atom incorporated shown as follows:105

1) Oxidation of sulfur-containing residues: the reactions of ⋅OH radical with Met and
Cys residues take place at the sulfur atom. For Met, the formation of methionene sulfoxide
results in +16 Da mass shift.

CH3

CH3

S

S O

CH2

CH2

CH2

CH2

R

R
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2) Oxidation of aromatic unsaturated residues: ⋅OH usually attacks aromatic rings by
addition reactions. Subsequently, the resulting radical species react with O2 yielding +16
Da or higher integer multiple increase in mass.

R

R

CH2

CH2

OH

3) Oxidation of aliphatic residues: carbon-centered radicals that form by hydrogen
abstraction often react with O2 to generate unstable peroxide radical, which eventually
convert to hydroxyl or ketone groups, resulting in +16 Da or +14 Da mass shifts.

CH3
CH2

CH3

CH3

HO-CH

CH2

CH2

R

R

C=O
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CH2
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Overall, despite the highly complex reaction mechanisms, exposure of a protein to ⋅OH
typically culminates in the incorporation of oxygen atoms into amino acid side chains,
resulting in easily recognizable +16 Da or multiple shifts in the mass spectrum.86 Less
abundant products associated with other mass shifts may be formed as well.67, 86

For interpreting the combined effects of conformational and chemical factors on the
reactivity of a given side chain i, it has been proposed that the second order rate constant 103
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ki for the reaction with ⋅OH can be modeled as

k i = α i × k iint

(1-6)

where k iint represents the "intrinsic" rate constant that applies in case of a completely
unprotected side chain. Each of the 20 residues is characterized by a specific k iint value.86
The dimensionless parameters αi depend on the protein conformation. Complete protection
corresponds to αi = 0 (no labeling), whereas for a fully solvent accessible side chain αi = 1.

Oxidative labeling has been used for structural studies on water soluble proteins since that
late 1990s.106 Surprisingly, it was not until quite recently that this approach has been
adopted for experiments on membrane proteins. For example, Fenton chemistry was
applied for oxidative labeling of membrane protein in vivo using a large scale
proteomics-type approach.107 In this way it was possible to monitor structural transitions
of the outer membrane protein OmpF in living Escherichia coli cells. Oxidation was found
at Met and aromatic residues, but also for Asp, Leu, Val, and Ser side chains. Oxidation
sites were mapped predominantly to regions of the protein that are known to be solvent
accessible on the basis of X-ray structural data. An extension of this approach to in vivo
studies on mammalian membrane proteins could provide researchers with new avenues for
deciphering the mechanisms of membrane-coupled biochemical processes.

Irradiation of water with γ-rays generates ⋅OH and other radiolytic species that induce
protein oxidation.85 Such a radiolysis method was applied to study the prepore to pore
transition of the Bacillus anthracis protective antigen.108

LC/MS/MS revealed that
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oxidation occurred at various types of residues, including Met, Tyr, Trp, and Ile/Val. The
differential labeling patterns seen in the two switching states were in partial agreement with
a computational model of the pore, for which no X-ray structure is available. The data
obtained provide valuable input for future refinements of the proposed pore structure.

Radiolytic oxidative labeling can also be performed by exposure of a protein solution to
pulsed X-ray radiation from a synchrotron. This method was applied to monitor
photo-induced structural transitions of rhodopsin, which is a member of the G-protein
coupled receptor family.109 Surprisingly, considerable oxidative labeling was observed not
only in solvent-exposed regions, but also in transmembrane segments that would be
expected to be protected based on existing X-ray data. The authors of that study attributed
this behavior to the presence of functionally important ordered water molecules which are
known to be present in the protein center.109

As noted in previously, covalent modifications may induce structural changes that can lead
to experimental artifacts.87 ⋅OH labeling is no exception in that oxidative modifications
may induce altered protein conformations.110 However, structural changes caused by ⋅OH
labeling are often quite small.100,

111

One contributing factor for the lack of drastic

structural changes after oxidation is the small size of the attached oxygen atoms, when
compared to other labeling and/or crosslinking agents.112 Moreover, oxidative
modifications predominantly affect residues on the protein surface, which usually have a
considerable degree of conformational freedom. Despite the relatively small magnitude of
oxidation-induced conformational changes, the possible occurrence of structural damage is
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an aspect that has to be carefully considered when analyzing ⋅OH labeling experiments.

Hambly and Gross were the first to point out that the extent of possible artifacts due to
oxidation-induced conformational changes is related to the time scale of ⋅OH exposure.
Conformational changes in response to covalent modifications can occur within fractions
of a millisecond.113 Labeling times for the techniques discussed so far (radiolysis or Fenton
chemistry induced radical labeling) are considerably longer, ranging from tens of
milliseconds to several minutes.106, 114 Radical attacks during such a relatively extended
labeling period may lead to the exposure of previously buried side chains, and ⋅OH labeling
of these newly exposed sites would then result in oxidation events that do not reflect the
original protein structure.103

Artifacts of this type can be avoided by using a strategy where the protein experiences a
single ⋅OH labeling pulse that is shorter than the fastest possible conformational changes.
Such an approach was realized by using a nanosecond-pulsed KrF excimer laser (248 nm)
for the photolysis of H2O2. Quasi-single exposure conditions can be implemented by
directing a train of laser pulses at an optical window in a protein flow tube.88, 100, 115 With
the addition of an appropriate radical scavenger, the duration of the resulting ⋅OH labeling
pulses can be reduced down to the microsecond time range. This rapid laser-induced radical
labeling may be preferable over other radical labeling approaches, but thus far this
technique has been applied only to some soluble proteins.
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1.3 Membrane Protein Folding
1.3.1 Protein Folding Mechanism
Most proteins adopt highly ordered structures under physiological conditions. The native
conformation represents the biologically active state of a protein. Protein folding in vivo
often starts when the nascent polypeptide chain emerges from the ribosome.116 The
conformational space accessible to a polypeptide chain is astronomically large. How can
proteins fold into a specific structure on a biologically relevant timescale? This puzzle,
called “Levinthal’s paradox”, has attracted immense scientific interest.117 The area of
protein folding is, however, more than just an intellectual challenge. Insight into protein
folding mechanisms is critical for understanding a wide range of diseases that are linked to
misfolding and aggregates, such as Alzheimer’s, Parkinson’s, mad cow disease and
others.118 In the long term, the knowledge of protein folding will help us predict structure
from sequence, and finally guide us to design new proteins or biomolecules for desired
applications.119

Exposure of a native protein to chemical denaturants or extremes of pH and temperature
can induce the transition to a largely disordered state. In 1960s Anfinsen discovered that
unfolded soluble proteins can spontaneously refold to their native conformation once the
denaturant is removed.120 This discovery implies that, at least for globular proteins, the
unique three-dimensional structure of a protein must be encoded by its linear amino acid
sequence. The native state of a protein corresponds to the conformation with the lowest
overall free energy. Spontaneous refolding in vitro often goes to completion within
milliseconds to seconds.1 How do proteins find the native states so quickly? Folding
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through a random research can not occur, because it would take infinite time. It was thus
assumed that there must be defined pathways to simplify the choices in folding. Two
models prevailed in the 1980s. One is the “framework model”, which postulates that
proteins fold through a stable secondary structure that forms before the tertiary structure is
locked in place.121 In contrast, the “hydrophobic collapse model” suggests that a protein
would rapidly collapse around its hydrophobic side chains such that folding can take place
in a confined volume.122 The secondary structure would be directed by native-like tertiary
interactions.

Conventionally, stopped-flow spectroscopy (CD, fluorescence, or UV-Vis) has been the
primary tool for exploring folding kinetics.123 However, structural information obtained
from spectroscopic probes is typically limited to global structure features. The search for
folding mechanism has driven significant advances in experimental techniques for
monitoring folding events. For example, FRET (Förster resonance energy transfer) and
EPR (electron paramagnetic resonance) were developed to detect site-specific contacts.124
Ф-value analysis can characterize transition states during protein folding.125 HDX coupled
with NMR is able to provide residue-specific structural information on folding
intermediates.65,126 Mass spectrometry in conjunction with pulsed HDX or covalent
labeling was also demonstrated to be an attractive approach to explore folding kinetics and
folding intermediates.127, 128

These new experimental techniques uncovered much new information on folding kinetics.
Important findings include that chymotrypsin inhibitor II was shown to fold in a
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cooperative two-state model without detectable kinetic intermediates.129 Ф-value analysis
of the transition state showed that secondary and tertiary structure are formed in parallel as
chymotrypsin inhibitor II undergoes a general collapse.130 These studies challenged both
the framework and hydrophobic collapse model. A new view involving “folding funnels”
has recently emerged.131, 132 In this view, protein folding is seen as biased conformational
diffusion on a funnel-like energy landscape. The denatured state of a protein populates a
large ensemble of structures. Folding is the inevitable consequence of the requirement to
lower the free energy. Folding processes are microscopically heterogeneous and may
proceed by numerous pathways instead of a single pathway. In general, folding energy
landscapes are rugged that are suboptimal for folding through which the polypeptide chain
has to navigate to the native state. Local minima can give rise to the formation of folding
intermediates. The overall folding kinetics are determined by the shape of the energy
landscape. The energy landscape picture provides a conceptual framework for
understanding both two-state and multi-state folding kinetics. Folding funnels can explain
many experimental observations that are otherwise paradoxical, and thus this model has
now been generally accepted.

1.3.2 Membrane Protein Folding Mechanism
The investigation of membrane protein folding has greatly lagged, compared to the
considerable progress with soluble proteins. In vivo, α-helical membrane proteins are
folded and inserted co-translationally into biological membranes with the assistance of
translocons.2 In 1980, Khorana et al. demonstrated that functional bacteriorhodopsin (BR)
could be regenerated from a fully denatured state.133, 134 The regeneration of BR in vitro
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provides the first evidence that Anfinsen’s hypothesis holds true for integral membrane
proteins: membrane proteins exist at a free energy minimum. The amino acid sequence
contains all information needed to define the tertiary structure of membrane proteins. This
pioneering work initiated in vitro folding studies of membrane proteins. However, the
folding experiments of α-helical membrane proteins were found to be notoriously difficult.
After considerable efforts, five additional α-helical membrane proteins (LHCII, DGK,
DsbB, KcsA, 5-HT receptor) have so far been denatured and then refolded into model
membranes.135, 136

The “Two-stage model” was first proposed by Popot and Engelman to explain the folding
mechanism of α-helical membrane proteins.3 It divides the folding processes into two
stages: (1) insertion and (2) helix association. The first stage comprises spontaneous
insertion of a polypeptide chain into a lipid bilayer and simultaneous secondary structure
formation. For an integral membrane protein, the hydrophobic effect drives the
spontaneous membrane insertion. However, even the most hydrophobic polypeptides can
not insert into the lipid bilayer without concomitant secondary structure formation. Huge
free-energy increases would incur with the loss of hydrogen bonds between the polypeptide
backbone and water molecules. The energetic penalty occurring upon desolvation of the
polypeptide backbone forces it to assume regular secondary structure as long as it is
embedded in a hydrophobic environment.137 In this model, individual transmembrane
helices are considered to be independently stable structures. Experimental studies on
different membrane proteins show that many helices are independently stable, but some are
stabilized by tertiary contacts.138 During stage 2, transmembrane helices interact with one
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another to give rise to the final native tertiary structure.

Membrane protein folding is intimately linked to the interactions between the protein and
the bilayer. A lipid bilayer has two chemically distinct regions. The hydrophobic core in the
center is roughly 30 Å thick and dominated by hydrocarbon chains. Each interface region is
ca. 15 Å thick, and consists of lipid head groups as well as layers of water molecules.
Considering that partitioning an exposed peptide backbone to the hydrophobic core entails
very large energetic penalties, and that the thickness of the interfaces is sufficient to
accommodate a helix lying parallel to the membrane plane, Jacobs and White expanded the
two-stage model into “Four-stage model”: partitioning, folding, insertion and
association.139 Hydrophobic peptide segments are thought to first bind to the interface, then
partition into the interface and simultaneous helix formation occurs, finally the individual
helices insert the lipid bilayer followed by helix association.140 Recent simulation studies
on a model transmembrane peptide support this model.141, 142

The biogenesis of β-barrel membrane proteins is very different form that of helical proteins.
In vivo, outer membrane proteins are secreted into the periplasm. Periplasmic chaperones

bind these proteins to prevent their aggregation and ferry them to the outer membrane.7
Most outer membrane proteins are though to insert and fold spontaneously into the outer
membrane in vivo. In 1990, functional porin was refolded in vitro from a random coil
conformation for the first time.143 Since then, 17 β-barrel proteins have been refolded in
vitro. Because of the modest hydrophobicity of individual β-strands, many β-barrel

membrane proteins can be extracted from the membrane in a fully unfolded form when
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treated with urea or guanidinium chloride. Unlike individual helices, individual β-strands
are not stable in the hydrocarbon core of the bilayer. The simplest way to satisfy all the
hydrogen bonding requirements in a sheet is to wrap it up into a barrel. Therefore, the
folding of β-barrel proteins can not follow the two-stage model as helical membrane
proteins do. In contrast, the insertion and folding should be highly coupled process.
Extensive folding studies on OmpA and recent folding studies on PagP by Ф-value analysis
support such a concerted insertion-folding mechanism.144, 145

1.3.3 Folding Kinetics of Membrane Proteins
Experimental protein folding studies can be divided into two categories. In equilibrium
experiments, the conformation of the protein is studies as a function of denaturant
concentration. Measurements are taken only after a thermodynamic equilibrium has been
established. In kinetic studies, conformational changes are monitored as a function of time,
following rapid alteration of solvent conditions. Equilibrium studies sometimes yield
structural information of partially folded species that may resemble short-lived
intermediates.146 Kinetic experiments remain the most direct approach for gaining insights
into time-dependent structural changes.147 To study the folding kinetics of a membrane
protein, suitable folding conditions have to be identified, under which the unfolded protein
can refold efficiently into model membranes.

Temperature, pH and chemical denaturants have been used to unfold membrane proteins.
Both extreme pH (acid or base) and temperature are incapable of reversibly unfolding
α-helical membrane proteins for folding studies.136 Urea and guanidine hydrochloride
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(GdnHCl) are unable to denature most α-helical membrane proteins. For example, neither
8 M urea or 6 M GdnHCl perturbed the tertiary structure of BR.148 However, many β-barrel
proteins such as OmpA, OmpF, OmpG and OmpT, can be unfolded by 8 M urea or 6 M
GdnHCl, and then refolded.136 An efficient and widely used denaturant for membrane
proteins is SDS. SDS exposure can often lead to the denaturation of α-helical membrane
proteins. It thus plays an essential role in studying α-helical membrane protein folding. BR,
LHCII, DAGK and DsbB have been denatured by SDS and refolded successfully in vitro.136
Although SDS has shown a strong ability to disrupt the tertiary structure of α-helical
membrane proteins, SDS denatured states often retain residual structures. These species
seem more like membrane-bound intermediates with pre-formed core structures. SDS is
not an excellent denaturant in the view of understanding the folding from an entirely
unfolded polypeptide chain to a folded native structure. However, SDS denaturation is so
far the most successful approach to provide a reference state for exploring α-helical
membrane protein folding. Interesting, SDS does not appear to be very effective in
denaturing β-barrel membrane proteins.143

Once denatured membrane proteins are available, the second challenge is to identify
optimal refolding conditions. In sharp contrast to the folding of soluble proteins that is
entirely defined within the sequence, membrane protein folding is defined by both the
polypeptide sequence and the model membrane (typically micelles or lipid bilayers).
Lipid/detergent composition, organization, and lipid-protein interactions can be important
for shaping the folding energy landscape of membrane proteins. According to refolding
conditions identified,136 there is a bias against anionic detergents for folding. Small
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sonicated vesicles and thinner bilayers provide a kinetic advantage for the folding of
β-barrel proteins.145 Besides specific protein-lipid interactions, the most important bilayer
properties include curvature elastic energy and hydrophobic match.5 In addition, buffering
pH, ionic strength and temperature can be important factors. For example, pH 6 is the
optimal condition for BR folding. The folding efficiency decreases notably at pH 8.149 In
short, favorable refolding conditions involve in the right combination of lipid/detergent
composition, lipid vesicle size, buffer, pH and temperature.

Kinetic folding experiments involve the availability of a trigger as well as techniques for
measuring folding events in a time-resolved and spatially-resolved manner. The methods
employed for membrane protein folding are similar to those for soluble proteins.
Stopped-flow mixing is the predominant method to trigger a membrane protein folding on
the time scale of milliseconds to minutes. Classical optical spectroscopy (CD, Fluorescence,
and UV-Vis) plays the predominant role in detecting structural changes in these folding
experiments.149-151 Recently some new methods have been developed with improved spatial
resolutions. Site-specific fluorescence was used to detect the membrane insertion events of
individual helices of BR.152 EPR was applied to monitor the solvent accessibility and the
position of particular residues during LHCII folding.25 Ф-value analysis has been used to
characterize the transition state during PagP and BR folding.144, 153 NMR and MS which
have proven to be powerful tools for probing folding kinetics of soluble proteins,126-128
however, remain untapped for studying the folding kinetics of membrane proteins.

There are only few kinetic folding studies on membrane proteins, because it is hard to find
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appropriate refolding conditions. So far, the studies of folding kinetics in vitro have focused
on three α-helical membrane proteins, BR,149, 150, 154, 155 LHCII,156 DGK,157 and a β-barrel
protein OmpA.144 BR, as the first integral membrane protein to be refolded in vitro, has
been a paradigm for membrane protein folding. BR functions as a light-driven proton pump
in archaebacterium Halobacterium salinarum. Each BR monomer consists of bacterioopsin
(BO) and a retinal. The BO polypeptide chain folds into seven transmembrane helices
(A-G) which are connected by short extra-membrane loops.158, 159 The retinal is bound to
the protein (helix G) via a protonated Schiff base. BR represents an excellent system for
folding studies. It is stable, easy to be expressed and purified, folds reversibly in micelles
or lipid bilayers, contains trypophan residues and a bound retinal chromophore that can
serve as optical probes.

The in vitro BR refolding is typically conducted by diluting SDS-denatured proteins into
bicelles or lipid vesicles in the presence of retinal. The folding kinetics of BR have been
extensively investigated using stopped-flow spectroscopy.149-151, 154 It was proposed that
the folding process involves at least one partially folded apoprotein, followed by the
noncovalent binding of retinal to the apoprotein, and finally covalent Schiff base formation
that represents the acquisition of native structure. Some studies indicated that the folding
kinetics of BR are both sequence-dependent and lipid-dependent.149,160,161 These pioneering
studies had a major impact on the general understanding of α-helical membrane protein
folding. However, structural information on folding intermediates and even the starting
point SDS-denatured state is quite limited. A comprehensive characterization of these
important conformers is required for deciphering the BR folding mechanism.
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1.4 Electrospray Ionization Mass Spectrometry (ESI-MS)
1.4.1 The ESI Process
The principle of all mass spectrometric techniques is to analyze the mass-to-charge ratio
(m/z) of ions in the gas phase. Ions can be produced in many ways. Electrospray ionization
(ESI) is a soft ionization technique. The advent of ESI-MS in the 1980s provided a means
to observe spectra of intact proteins,42 a discovery honored with the Chemistry Nobel Prize
(to John Fenn in 2002). Matrix-assisted laser desorption/ionization (MALDI) 162 is another
soft ionization technique for protein studies. Yet, the direct coupling of solution phase
chemistry and gas phase detection tends to make ESI-MS a more natural choice for many
protein experiments.

The ESI source has undergone continued development, but the general arrangement has
remained the same (Figure 1-3). The analyte is introduced to the source in solution either
from a syringe pump or as the eluent flow from liquid chromatography. The analyte
solution flow passes through the electrospray capillary to which a high potential is applied
(typically 2.5 to 5 kV). Under the influence of this potential, the analyte solution exiting
from the capillary tip forms a mist of small droplets. A carrier gas such as nitrogen is often
used to help nebulize the liquid and help evaporate the solvent. As the droplets traverse the
space between the needle tip and the cone, solvent evaporation occurs. Then, each droplet
shrinks until it reaches the point at which the surface tension can no longer sustain the
charge (the Rayleigh limit), and the droplets break up. This produces smaller droplets that
can repeat the same process until the analyte transformed into a full gas phase ion. The
analyte can be singly or multiply charged. Not all ions pick up the same number of charges,
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therefore a number of peaks (charge state distribution) are commonly observed in the ESI
mass spectrum of a protein.163

Spray
capillary

Taylor
cone

Droplet shrinkage

MS

Electrons
anode

cathode

Figure 1-3. Schematic representation of the mechanism of ion formation in ESI.

1.4.2 Mass Analyzers
Mass analysis of the analyte ions is undertaken by mass analyzer. There are various types
of mass analyzer, including quadrupole, time-of-flight (TOF), ion trap, and Fourier
transform ion cyclotron resonance (FT-ICR) mass analyzers. Many mass spectrometers use
two or more mass analyzers for tandem mass spectrometry (MS/MS), such as triple
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quadrupoles and quadrupole-TOF (Q-TOF) instruments. The latter type of mass
spectrometer was used in this thesis. The principle of quadrupole and TOF analyzers will
be briefly discussed.

1.4.2.1 Quadrupole Mass Analyzer
A quadrupole mass analyzer is composed of four parallel rods. Each opposing rod pair is
connected together electrically, and a radio frequency (RF) voltage is applied between one
pair of rods and the other. A direct current voltage is then superimposed on the RF voltage.
Ions produced in the source of the instrument are then focused and travel down the
quadrupole between the rods. Their motion will depend on the oscillating electric fields and
their mass-to-charge ratio. Only ions with a certain m/z will reach the detector for a given
ratio of voltages. Other ions have unstable trajectories and will collide with the rods. This
permits selection of ions with a particular m/z or allows the operator to scan for a range of
m/z values by continuously varying the applied voltage.

Quadrupole mass spectrometers usually have low resolution (<4000), low mass range
(<4000) and slow scan rates. But this mass analyzer excels at applications where particular
ions of interest are studied because they can stay tuned on a selected ion for extended
periods of time. Quadrupoles are thus generally placed in tandem to enable them to perform
fragmentation studies in modern mass spectrometers. The most common type is the triple
quadrupole mass spectrometer that has three consecutive quadrupoles arranged in series to
incoming ions. The first quadrupole (Q1) acts as a mass filter to select ions of interest. The
second quadrupole (Q2) serves as a collision cell where only RF are applied (non-mass
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filtering) and selected ions from the Q1 are fragmented. The resulting fragment ions are
analyzed by the third quadrupole (Q3). Replacing the Q3 with a TOF mass analyzer results
in another popular hybrid Q-TOF mass spectrometer.

1.4.2.2 Time of Flight (TOF) Mass Analyzer
TOF mass analyzers use an electric field to accelerate ions. When an ion with charge z is
accelerated into the flight tube by the voltage U, its potential energy is converted to kinetic
energy. The resulting velocity (v) of the ion after acceleration is determined by equation 1-7.
The velocity of ions flying along the field-free time-of-flight tube will not change.
Therefore the time (t) required for the ion to reach the detector is obtained by equation 1-8:

v=

t=

2 zU
m

L
m 1
=L
v
z 2U

(1-7)

(1-8)

where m is the mass of the ion and L is the length of the flight tube. Ions with different m/z
have different drift times and hence are separated in the flight tube. Lighter ions will reach
the detector first. From this time and the known instrument parameters a mass spectrum can
be obtained after converting the measured time (t) to m/z.

If ions with same m/z entering the flight tube have energy dispersion, the resolution of TOF
will be decreased dramatically. One efficient method to correct the kinetic energy
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dispersion in the direction of ion flight is using a reflectron. The reflectron uses a constant
electrostatic field to reverse the ion beam toward the detector. The more energetic ions
penetrate deeper into the reflectron, and take a slightly longer path to the detector. Less
energetic ions of the same charge-to-mass ratio penetrate a shorter distance into the
reflectron and, correspondingly, take a shorter path to the detector. Ions with same m/z but
slightly different in kinetic energy can reach the detector at the same time after the
reflection. Without a reflectron, the TOF resolution is no more than 4000. A
reflectron-TOF can achieve much higher resolution (~ 20,000 in some models) and high
accuracy (< 5 ppm). The other advantages of TOF mass spectrometers are fast analyzing
ions simultaneously and extremely high mass range (over 10,000).

1.5 Scope of this Thesis
Using bacteriorhodopsin (BR) as model system, this work aims at developing novel
MS-based approaches for exploring the structure, dynamics and folding of integral
membrane proteins.

Compared to other covalent labeling strategies, laser-induced hydroxyl radical (⋅OH)
labeling has obvious advantages: the microsecond ⋅OH lifetime implies that this technique
can be free of oxidation-induced structural artifacts under controlled conditions. Even more
important is that the technique is potentially suitable for detecting temporal structural
changes of proteins during folding/unfolding processes. However, so far, the method has
not been applied to membrane proteins. In the first step, native BR in its natural lipid
environment was exposed to laser-induced hydroxyl radicals with the aim to validate the
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method. The resulting labeling patterns agree well with the X-ray structure of native BR
(Chapter-2). In subsequent studies, the labeling approach was applied to probe the structure
of semi-denatured BR samples induced by heat, acid or SDS. Mapping the structure of SDS
denatured BR is particularly important because this form of protein is widely used as
starting point for folding studies. Combining site-directed mutagenesis with oxidative
labeling and spectroscopic studies, a detailed structure model of SDS-denatured BR was
developed (Chapter-3). Taking advantage of the very rapid radical bursts induced by laser
photolysis, the pulsed radical labeling in conjunction with rapid mixing and MS was used
for characterizing short-lived BR folding intermediates. For the first time, the MS-based
oxidative labeling approach provided key structural insights into the folding mechanism of
a membrane protein (Chapter-4).

Complementary to covalent labeling, hydrogen/deuterium exchange (HDX) with MS is
another powerful tool for protein studies. HDX experiments were carried out for
charactering the structural features of various BR samples (Chapter-5). To explore and
correlate membrane protein dynamics and function, comparative HDX experiments of BR
were carried out in the dark (resting state) and under illumination where the light-induced
retinal isomerization mediates the vectorial proton transport (functioning state). Our results
suggest that structural fluctuations/dynamics of the protein scaffold are "accelerated" by
motions of the retinal, reflecting a direct coupling between protein dynamics and function
(Chapter-6).
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Chapter-2 Structural Characterization of Bacteriorhodopsin in
Its Natural Lipid Environment by Oxidative Methionine
Labeling and Mass Spectrometry

2.1 Introduction
Mass spectrometry (MS) has become an indispensable tool for studying protein structure,
dynamics, interactions, and function.1, 2 Due to its high sensitivity and high-throughput
capabilities, MS provides structural biologists with an arsenal of methods that are
complementary to traditional techniques such as NMR spectroscopy and X-ray
crystallography. Many MS-based approaches employ labeling steps in bulk solution,
making use of the fact that target site reactivities are modulated by the protein
conformation. Tightly folded regions can provide significant protection, whereas amino
acids located in partially unfolded or highly dynamic areas are modified more readily.
Spatially-resolved information can be obtained through the analysis of protein fragments
after labeling. This can be achieved using traditional "bottom-up" approaches, where
proteolytic peptides are analyzed by LC-MS/MS, or by "top-down" strategies that involve
the dissociation of intact proteins in the gas phase.3, 4 HDX is one of the most popular
labeling methods.5-8 In addition, there is a host of covalent modification approaches, many
of which target specific reactive side chains such as Lys or Cys.9-11

Hydroxyl radicals (⋅OH) represent a probe that is being widely used for the oxidative
labeling of proteins.12-19 In contrast to many other covalent labeling agents, ⋅OH normally
exhibits a low specificity that allows it to react with a wide range of target sites. A number
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of different methods are available for hydroxyl radical production, all of which have their
unique advantages and limitations (see refs.12, 13, 15). Despite the highly complex reaction
mechanisms, exposure of a protein to ⋅OH usually culminates in the incorporation of
oxygen atoms into amino acid side chains, resulting in easily recognizable +16 Da shifts in
the mass spectrum.12 The overall degree to which any given target site undergoes labeling
is determined by a combination of solvent accessibility and intrinsic reactivity.12, 20 The
presence of sulfur atoms in Met and Cys makes these two residues most reactive, followed
by the aromatic side chains of Trp, Tyr, and Phe. Also His, Leu, Ile, Arg, Lys, Val, Pro, Gln,
and Glu represent possible modification sites.21, 22 ⋅OH labeling of proteins with known
structures generally results in spatial oxidation patterns that are highly consistent with the
solvent exposure of individual residues. Met side chains, however, represent a special case
because formation of the corresponding sulfoxide (MetO)

23

can take place even for

residues that are deeply buried.24-27 The basis of this unusual behavior has not been
uncovered yet. Proposals have been made that the effect might be due to processes
involving solvated electrons28 or intramolecular radical transfer,29 rather than direct contact
with ⋅OH. Based on the results of those previous reports,24-26, 28, 29 the validity of using Met
oxidation levels as a structural probe remains unclear. Interestingly, protein stability
measurements based on MetO levels have been shown to be feasible,17 highlighting that
much remains to be learned about the behavior of Met under oxidative labeling conditions.

Every living cell is surrounded by a lipid bilayer that contains integral membrane proteins.
The overall character of these proteins is amphipathic, i.e., they possess a large
hydrophobic surface area that interacts with the membrane alkyl chains, whereas loops
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extending into the aqueous phase on both sides are mostly hydrophilic. Membrane proteins
are involved in essential processes such as energy conversion, transport, signal
transduction, and cell-cell interactions. Up to 30% of all proteins encoded by the human
genome are estimated to be membrane proteins30, and many of them represent potential
drug targets.31 Unfortunately, the fact that membrane proteins are water insoluble makes
them notoriously difficult to work with. Their hydrophobic exterior tends to result in
aggregation and precipitation; it also interferes with the growth of crystals that are
amenable to X-ray structure determination. Because in situ studies are often not feasible,
experimentalists commonly resort to surfactant-solubilized species. However, removal of
the lipid bilayer often interferes with the structural integrity of the protein, and does not
offer long-term protection against aggregation.32 As a result of these difficulties, membrane
proteins are vastly underrepresented in databases, representing only 1% of all known
protein structures.30

Similar to other analytical techniques, the application of MS to membrane proteins
continues to be much less common than studies on their water soluble counterparts.33
Nonetheless, following pioneering work in the late 1990s,34-36 this area is experiencing
continuous growth, and even large-scale proteomics projects are gradually becoming
practicable.37, 38 Experiments on membrane proteins mostly employ LC/ESI-MS, but the
application of MALDI-MS has been demonstrated as well.39 Notable progress is also being
made in MS-based structural studies on membrane proteins, e.g., by using protease
protection assays for the determination of topological features.40 The successful application
of HDX/MS to surfactant-solubilized species has been demonstrated,41, 42 and it was even
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shown that HDX patterns of short transmembrane peptides can be analyzed by direct
infusion of liposome solutions.43 In addition, various covalent labeling techniques have
been used, e.g., for structural mapping,44 monitoring protein-ligand interactions,45, 46 and
for detecting conformational changes.47

For reasons unknown, ⋅OH labeling has been largely overlooked as an approach for
structural studies on membrane proteins. This is surprising, considering the popularity of
this technique for investigations on water-soluble species. One potential issue is the fact
that many membrane proteins are methionine rich,48, 49 keeping in mind that the reactivity
of this amino acid has been found to be problematic in previous oxidative labeling
experiments (see above).

Using bacteriorhodopsin (BR) as a model system, this study reports the first application of
laser-induced ⋅OH labeling19 for the structural characterization of a membrane protein in its
natural lipid bilayer environment. BR is the main component of the Halobacterium
salinarum purple membrane, and it probably represents the best characterized membrane

protein.50-53 The purple color is due to the presence of a retinal chromophore which is
bound to Lys216 via a protonated Schiff base. Trans/cis isomerization of this chromophore
allows the protein to act as a light-driven proton pump.54 The BR polypeptide chain
comprises 248 amino acids that fold into seven transmembrane helices which are connected
by short extra-membrane loops. The helices are oriented roughly perpendicular to the
membrane plane (Figure 2-1).55, 56

53

M163

M32

M20
M209
M145
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lipid
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M60
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M68

Figure 2-1. X-ray structure of bacteriorhodopsin (pdb code: 1XJI) with its seven
transmembrane helices. The nine methionines are shown in red, and the retinal
chromophore is depicted in green. Also shown is the approximate location of the lipid
bilayer relative to the protein.
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T7
T6-7

F
161

ESMRPEVAST FKVLRNVTVV LWSAYPVVWL IGSEGAGIVP
T10

T8
G
201

LNIETLLFMV LDVSAKVGFG LILLRSRAIF GEAEAPEPSA
T11

T13

T10-11
241

GDGAAATS

Figure 2-2. Amino acid sequence of BR (pdb code 1XJI). Transmembrane helices (A-G)
are represented as black boxes. Tryptic peptides (T1, T2, ...) used in this study are indicated
as double-headed lines. T3-4, T6-7 and T10-11 represent peptides resulting from missed
cleavages. Methionines are highlighted. The N-terminal "X" represents pyroglutamate.36
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BR contains nine methionines, six of which are located in transmembrane helices, and three
in connecting loops (Figures 2-1, 2-2). In the purple membrane BR molecules are packed in
clusters of three, forming a two-dimensional hexagonal lattice.57, 58 The protein accounts
for 75% (by weight) of the membrane, the remainder consists of a variety of neutral and
acidic diether lipids.59, 60 These lipids fill the space between BR trimers, and they also
occupy the center of the trimeric rings.

Peptide mapping and tandem MS experiments in this study reveal an unexpected oxidative
labeling behavior for BR, with methionine oxidation as the only observable covalent
modification. It is demonstrated that the extent of MetO formation is highly correlated with
the protein structure, allowing the differentiation between buried and solvent exposed
regions. Based on these findings we propose that Met oxidation studies could become a
valuable tool for monitoring the structure, folding, and dynamics of membrane proteins.

2.2 Experimental
2.2.1 Materials
Purple membranes were isolated from Halobacterium salinarum, strain L33, transformed
with a plasmid encoding the protein (bop) and resistance to novobiocin.61 Cell growth,
harvesting, disruption, and purple membrane purification by sucrose gradient
centrifugation were performed according to standard procedures.62 The final aqueous stock
solutions obtained by this method had a protein concentration of ca. 170 µM, contained
40% sucrose, and were stored at -80 °C prior to analysis. Protein concentrations were
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determined by UV-Vis spectroscopy using a Cary 100 spectrophotometer (Varian,
Mississauga, ON, Canada) based on a molar absorption coefficient of ε280 = 65,000 M-1
cm-1 for purple membrane/SDS solutions.50 Sequencing-grade modified trypsin was
purchased from Promega (Madison, WI). RapiGest SF was obtained from Waters
Corporation (Milford, MA). SDS, ammonium bicarbonate, and formic acid were from
Sigma (St. Louis, MO). All chemicals were used without further purification.

2.2.2 Laser-Induced Oxidative Labeling
Covalent labeling of the protein was performed following a procedure similar to that
previously described by Hambly and Gross.19, 63 A KrF excimer laser (GAM EX 100/125,
Orlando, FL) producing 18 ns pulses at 248 nm, 16 Hz and 62.5 mJ per pulse was used to
generate hydroxyl radicals through photolysis of H2O2 within a 100 µm i.d. flow capillary
made of fused silica (TSP100170 Polymicro Technologies, Phoenix, AZ). The laser beam
was focused onto this capillary by a 500 mm lens, with a capillary-lens distance of 26 cm.
A UV transparent window was created by removing the polyimide coating from the
capillary using a butane torch. The width of the laser spot at the capillary was determined to
be ca. 2 mm, corresponding to a volume of about 16 nL being irradiated during each laser
pulse. 200 µL of purple membrane suspension (protein concentration 10 µM with 15 µM
glutamine, 3% sucrose), and different concentrations of H2O2 (up to 0.2%, corresponding
to ca. 60 mM, at pH 6.8) were loaded into a glass syringe and flushed through the flow
capillary at 40 µL min-1 using a syringe pump (Harvard Apparatus, Boston, MA).
Glutamine and other organic species in the solution (membrane lipids and the protein itself)
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act as radical scavengers and limit the duration of the labeling pulse to ca. 1 µs.63 Under
these conditions every protein molecule is exposed only to a single labeling pulse. This
characteristic, along with the extremely short pulse duration eliminates possible
oxidation-induced structural artifacts19,
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which are of potential concern for covalent

labeling strategies involving longer exposure times.11 Control experiments (not shown)
carried out on purple membranes in the absence of sucrose resulted in data virtually
identical to those discussed below. The capillary outflow was collected in a
microcentrifuge tube that contained 10 µL 1 µM catalase at pH 6.8 for removal of residual
H2O2, thereby avoiding secondary oxidation reactions.26 Previous work has demonstrated
that the mere presence of H2O2 in the concentration range used here does not affect the
structure and stability of proteins, as long as no oxidation reactions take place.17

2.2.3 Intact Protein Analysis.
A phase extraction method was used to recover oxidatively labeled BR from the purple
membrane suspension.64 Following oxidative labeling, 100 µL of purple membrane
suspension was mixed on a vortex for 10 s with 400 µL chloroform /methanol/water
(22:56:22 v/v/v). The mixture was centrifuged at 13000 g for 5 minutes which resulted in
a layer of precipitated protein at the interface. After carefully removing the upper aqueous
and the lower chloroform phase, the precipitate was dissolved in 100 µL formic acid.

2.2.4 Peptide Mapping and HPLC/MS analysis
200 µL aliquots of the oxidatively labeled sample at pH 6.8 were lyophilized. Subsequently,

58

the dry powder was dissolved in 65 µL of 50 mM aqueous ammonium bicarbonate buffer
(pH 8) containing 0.1% (w/v) RapiGest SF. Protein solubilization by this acid-labile
surfactant enhances the susceptibility to enzymatic cleavage without inhibiting
endopeptidase activity, and without interfering with LC-MS analyses.48, 65 The resulting
sample solution was boiled at 100 0C for 3 min and then cooled to room temperature,
followed by digestion with sequencing-grade trypsin overnight at 37 °C using a 1:20 (w/w)
enzyme: protein ratio. The digests were flash-frozen in liquid nitrogen and stored at -80 °C.

All experiments were performed on a Q-TOF Ultima API mass spectrometer (Waters,
Milford, MA) equipped with a Z-spray electrospray ionization (ESI) source. Spectra were
acquired in positive ion mode at a sprayer voltage of 3 kV and a desolvation temperature of
200 °C. For intact protein analysis, the formic acid solution was infused directly into the
ion source at a flow rate of 10 µL min-1. Experimental spectra were converted to mass
distributions using the MaxEnt 1 routine provided by the instrument manufacturer. For
peptide analysis, the mass spectrometer was coupled to a Waters 1525µ HPLC system
employing a C18 2.1 mm × 100 mm (Symmetry 300) column (Waters). For each injection
25 µL of digested sample were loaded onto the LC column without prior RapiGest removal.
Solvent A was 0.1% aqueous formic acid, and solvent B consisted of 50:50 (v/v)
acetonitrile/isopropanol with 0.065% formic acid. Elution was carried out at a flow rate of
50 µL min-1. A linear gradient was run from 0 to 45% B in 45 min, then from 45% to 58%
B in 5 min, from 58% to 80% B in 45 min, finally from 80% to 100% B in 5 min. Most
peptides eluted in a range between 15 and 80 min. Confirmation of peptide identities and
localization of oxidation sites was performed by tandem MS in data-dependent acquisition
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mode, employing collision-induced dissociation in an Ar-filled hexapole cell.

Oxidation levels are reported by plotting the fraction of unmodified peptide, Fu, vs. the
hydrogen peroxide percentage. Fu is defined as Au/Atot, where Au is the integrated area under
the isotope distribution of the unmodified species, and Atot is the total area of the
unmodified peptide plus that of the oxidatively modified form(s). This procedure is widely
used in the ⋅OH labeling literature.12, 16, 20, 25, 66-68 It has been argued that Fu values measured
in this way should only be interpreted in a semi-quantitative way, because unmodified and
labeled peptides may exhibit different ionization efficiencies.67, 69 However, the first-order
kinetics commonly observed during peptide and protein ⋅OH labeling suggest that these
differences are not very pronounced.12 Also, it will be seen that most tryptic peptides
studied here are large, such that slight modifications (MetO formation, in particular) will
not affect their ionization efficiencies too much. No evidence for differences in ionization
efficiency were found upon carbodiimide labeling of peptides, which represents a much
more severe modification than MetO formation.45, 70

2.3 Results and Discussion
2.3.1 Intact Protein Analysis
Aqueous purple membrane suspensions containing native BR were oxidatively labeled,
employing the photochemical cleavage of H2O2 by a nanosecond laser pulse as ⋅OH source.
ESI-MS analysis of the unlabeled protein reveals a mass of (26783 ± 1) Da, in close
agreement with the value expected from the amino acid sequence (26783.6 Da).36 Control
experiments carried out in the absence of H2O2 and laser exposure reveal a small +16 Da
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satellite peak, indicating a low level of background oxidation (Figure 2-3A). This finding is
not surprising, given that BR contains nine Met residues which are prone to spontaneous
oxidation during protein isolation and/or storage.71 BR does not contain any cysteines.
Other small peaks in the mass distribution of Figure 3A are attributed to trace contaminants
such as metal cations. Oxidative labeling of the protein by laser exposure in 0.05% H2O2
results in major peaks shifted by +16, +32, and +48 Da (Figure 2-3C). Higher oxidation
states are likely present, but obscured by noise in the data. Experiments carried out in the
presence of H2O2, but without laser irradiation (Figure 2-3B), resulted in a mass
distribution very similar to that in Figure 2-3A. This control experiment confirms that
covalent labeling in our experiments is indeed caused by photochemically produced
radicals, and that the extent of undesired secondary oxidation processes is insignificant.26

2.3.2 Peptide Mapping
Several different methods have been reported for the mapping of BR.38, 39, 48, 72 Here, the
covalently labeled protein was solubilized using an acid-labile surfactant65 prior to
digestion and LC/ESI-MS analysis, as described in the Experimental section. The data
analysis in this work was based on the 11 most intense tryptic peptides, yielding a protein
sequence coverage of 97% (Figure 2-2). The spectral quality for these fragments (Figure
2-4) is considerably higher than for the intact protein (Figure 2-3). Oxidative labeling of
intact purple membrane suspensions was carried out on solutions containing 0% (control),
0.02%, 0.1%. The resulting tryptic peptides reveal drastically different oxidation
characteristics. For example, T8 represents the protein segment that is most readily labeled.
In 0.02% H2O2 both the unmodified form and a +16 Da species are observed at comparable
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signal intensities (Figure 2-4B). After labeling in 0.1% H2O2 (Figure 2-4C) the signal of the
unmodified peptide is close to 0.2. A totally different behavior is seen for T7, where the
unmodified form remains dominant under all conditions (Figure 2-4E-G).

The labeling data can be visualized by plotting the fraction of unmodified peptide, Fu, vs.
the hydrogen peroxide percentage (Figure 2-5). The ten peptides can be grouped into three
categories based on their oxidation behavior. (i) No labeling is detectable for T11 and T13,
corresponding to Fu ≈ 1. (ii) T1, T5, T6-7, T7, and T10 exhibit moderate labeling, with Fu
values that remain in the range of 0.8 even for the highest peroxide concentration used. (iii)
T2, T8, and T3-4 represent protein regions that are most susceptible to oxidation with Fu
values as low as 0.2.

2.3.3 Tandem Mass Spectrometry
MS/MS experiments confirm that all observed covalent modifications are due to sulfoxide
(MetO) formation. Labeling at non-methionyl residues was not detectable, although very
small amounts of other products cannot be ruled out. As an example, Figure 2-6 compares
MS/MS data of unlabeled and singly oxidized T8. Fragmentation yields unmodified y''9
ions in both cases. In contrast, the signals for y''10 (and y''11) are shifted by 16 Da, thus
confirming that the oxygen atom is located on Met163 (Figure 2-6). Analogous data (not
shown) were obtained for the other single-Met peptides. Of particular interest is T3-4 with
its three Met residues. Fragmentation of the singly labeled peptide (Figure 2-7) reveals that
oxidation is restricted to Met68, as seen from the +16 Da shifts for y''15 - y''17 (Figure
2-7B-D, F-H), along with unmodified y''14 fragments in both cases (Figure 2-7A, E).
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Figure 2-3. Deconvoluted ESI mass distributions of intact BR under different oxidative
labeling conditions. (A) no laser irradiation, no H2O2 (control); (B) no laser irradiation,
0.1% H2O2 (control); (C) after laser irradiation, 0.05% H2O2. Note that the retinal
chromophore is lost during sample preparation, but was present during labeling. Peaks
designated as +16, +32, and +48 represent the incorporation of one, two, and three oxygen
atoms, respectively
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Figure 2-4. ESI mass spectra of selected tryptic peptides obtained under different oxidative
labeling conditions: T8 (A-C, doubly charged,), T7 (E-G, triply charged), and T3-4 (I-K,
quadruply charged). First row of panels (A, E, I), unlabeled controls; second row (B, F, J),
0.02% H2O2; third row (C, G, K), 0.1% H2O2.

Fraction unmodified, Fu

64

1.0

T11
T13

0.8

T1
T5
T6-7
T7
T10

0.6

0.4

0.2

T2
T8
T3-4

0.0
0.00

0.05

0.10

0.15

0.20

0.25

% H 2O 2

Figure 2-5. Oxidation levels of various tryptic peptides, expressed as fraction unmodified
(Fu) and plotted as a function of H2O2 percentage.
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Figure 2-6. Partial MS/MS product ion spectra obtained after fragmentation of [T8 + 2H]2+
(unlabeled peptide, panels A-C), and of the singly oxidized species [T8OX + 2H]2+ (panels
D-F). Shown at the top of the Figure is the sequence of T8.
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Figure 2-7. Partial MS/MS product ion spectra obtained after fragmentation of [T3-4 +
4H]4+ (unlabeled peptide, panels A-D), and of the singly oxidized species [T3-4OX + 4H]4+
(panels E-H). For further explanations, see the caption of Figure 2-6.

No modifications were found for the other two methionines (see e.g. the b16 signals in
Figure 2-7, B and F), confirming that Met56 and Met60 remain unlabeled. The observation
of exclusive Met oxidation reveals a remarkable chemical selectivity. This finding contrasts
earlier studies on various water-soluble proteins by laser-induced oxidation19, 27, 63 (and
other ⋅OH labeling strategies), which always found a host of additional oxidation sites,
besides methionine.
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2.3.4 Structural Interpretation
The peptide data of Figure 2-5, along with the MS/MS analyses discussed in the preceding
section reveal that the Met residues 20, 56, 60, 118, 145, and 209 are labeled to a much
lesser extent than Met32, Met68, and Met163. This dramatic difference is most pronounced
in 0.2% H2O2 where the two groups exhibit Fu values around 0.8 and below 0.2,
respectively. Comparison with the crystal structure of BR (Figure 2-1) reveals that the
former group of methionines is part of the tightly packed protein core that is embedded in
the lipid membrane. In contrast, the easily oxidized residues Met32, Met68, and Met163 are
located in surface loops that are exposed to the aqueous environment. Thus, spatially
resolved MS measurements of Met oxidation provide structural information that is fully
consistent with the known BR structure.55, 73

2.4 Conclusions
Many previous oxidative labeling studies have taken advantage of the fact that hydroxyl
radicals can react with a wide variety of amino acid side chains, leading to modifications at
multiple different sites. The extent of oxidative labeling is generally found to be well
correlated with the solvent exposure of the corresponding residues. However, inclusion of
Met oxidation levels in these data sets has been problematic due to extensive MetO
formation even at deeply buried methionyl side chains.24-29 As a result, Met oxidation could
not thus far be used as a reliable probe of protein structure. We note, however, that the
unusual reactivity of methionyl side chains only leads to difficulties with data interpretation
when considering Met oxidation within the context of labeling levels seen for other
residues. The results of this work demonstrate that unambiguous structural information can
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be obtained by comparing the oxidation levels of various methionines among each other. In
this way it is possible to differentiate residues located in solvent exposed loops from those
that are shielded within the protein core.

The oxidative labeling data presented in this study are unusual in that MetO formation is
the only detectable type of covalent modification occurring in the entire protein. This
behavior is quite different from that observed for water-soluble proteins in previous studies,
where oxidative labeling of at least 14 out of the 20 naturally occurring amino acids is
normally observed.12 Without doubt, one contributing factor for the remarkable chemical
selectivity seen here is the presence of nine methionines in BR, which is a much higher
number than for previously studied proteins. Competition of these extremely rapidly
reacting sites (having rate constants close to the diffusion limit)74 with less reactive side
chains will automatically result in significant protection against oxidation for other residues.
An additional factor could be the presence of bilayer lipids. Just like virtually all other
bio-organic compounds, these species are expected to act as radical scavengers.68,
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Extensive radical absorption by scavengers will tend to protect the protein from covalent
labeling, except for Met residues which represent the most reactive "oxidation hot spots".

It might be argued that the specific oxidation of Met is not as structurally informative as the
largely non-selective labeling observed in previous ⋅OH footprinting studies on
water-soluble proteins. However, non-selective labeling tends to result in overwhelmingly
complex spectra, unpredictable MS/MS fragmentation patterns, and considerable
difficulties in quantifying oxidation data in a spatially-resolved manner. Selective labeling
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of only one type of residue, on the other hand, greatly facilitates the data analysis and
interpretation. This has been demonstrated in the current work, where six Met residues in
the protein core could be readily distinguished from three that are located in solvent
exposed loops. The fact that many membrane proteins are methionine rich48, 49 makes the
application of Met labeling all the more useful for this type of system. Membrane protein
function, folding, and dynamics continue to be most challenging research topics,51 and the
application of Met oxidative labeling could become a valuable experimental tool in these
areas. Protein engineering methods75 can be used for inserting further methionines in
various positions of interest. Based on the medium size and mildly hydrophobic character
of Met (Kyte-Doolittle score 1.9)76 many of these substitutions would be expected to leave
the structure and dynamics of membrane proteins unaltered, thereby providing valuable
additional probes for ⋅OH labeling.

Overall, the proof-of-principle experiments in this work demonstrate that oxidative
labeling with MS detection allows structural information to be gained for membrane
proteins in their natural lipid bilayer environment. The use of artificial surfactant micelle
systems that can interfere with the native protein structure is not required for this approach.
The technique will be most valuable for the many membrane proteins that so far have not
been amenable to X-ray crystallography or electron diffraction.
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Chapter-3 Mapping the Structure of Bacteriorhodopsin under
Semi-Denaturing Conditions by Laser-Induced Oxidative
Labeling and Mass Spectrometry
3.1 Introduction
Experimental studies on the structure and folding of membrane proteins represent
considerable challenges. X-ray crystallography, NMR spectroscopy and other techniques
have provided a wealth of information on water-soluble species, whereas the general
understanding of membrane proteins continues to lag behind. This situation represents a
critical bottleneck because of the central role that membrane proteins play in cellular
transport, energy conversion, signaling, and as drug targets.1 Fortunately, the past few
years have witnessed encouraging progress in the biophysical characterization of
membrane proteins.2-7 For example, novel insights into the molecular interactions that
stabilize membrane protein structures have recently emerged.8, 9

Most structural studies on both water-soluble and membrane proteins focus on the native
conformation. Yet, partially disordered conformers can play biologically important roles as
well, for example as folding intermediates,10-12 during amyloidogenesis,13 for
ligand-binding,14, 15 and for membrane translocation.16 The native state of every protein is
in equilibrium with various semi-unfolded species.17 In a physiological environment the
concentrations of these excited states are usually very low (as dictated by the Boltzmann
distribution). However, their formation can be promoted in a mildly denaturing solvent
environment.10, 17 Non-native proteins usually do not crystallize, but NMR spin relaxation
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measurements18 and hydrogen/deuterium exchange (HDX) approaches19 have been
successfully applied in a number of cases. Once again, however, the overwhelming
majority of these studies have been conducted on water-soluble proteins.

Electrospray ionization mass spectrometry (ESI-MS) is becoming an increasingly
important tool for the characterization of membrane proteins, e.g., for determining
molecular weights,20 for probing covalent modifications,21 and for large-scale proteomics
projects.22 Intact multiprotein/surfactant complexes have been successfully analyzed by
ESI-MS, a development that might pave the way towards measurements on the subunit
composition of membrane protein assemblies.23 Membrane protein conformations and
dynamics have been explored in HDX experiments with ESI-MS detection.8, 24, 25 Another
particularly promising approach is the use of ESI-MS-based covalent labeling techniques
for structural studies. Numerous labeling reagents with different specificities are available
that induce covalent modifications on amino acid side chains.26 The utility of these
compounds is based on the principle that solvent-exposed sites exhibit a higher reactivity
than those in inaccessible locations. The exact positions of covalently labeled sites can be
determined by peptide mapping and MS/MS. Solvent exposure data generated in this way
provide insights into protein tertiary structures.27-31

Hydroxyl radical (⋅OH) represents a particularly interesting covalent labeling probe. This
species can be generated by electrochemical, photochemical, radiolytic or redox-based
methods, and it can react with at least 14 out of the 20 amino acid side chains.32, 33 Most of
the oxidative modifications generated in this way are easily recognizable as +16 Da
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modifications in the resulting mass distributions, but less abundant products associated
with other mass shifts may also be formed.33-36 Oxidative labeling has been used for the
structural mapping of numerous water-soluble biomolecular systems,33, 35, 37-39 as well as a
few membrane proteins.40, 41

In Chapter-2, we applied ⋅OH labeling to native purple membranes. It was found that
oxidative modifications on BR exclusively occurred at Met residues under the conditions
used. BR contains a total of nine methionines (Figure 3-1a), whereas cysteines are absent.
MetO formation is known to be a preferred oxidative process,33 but the complete lack of
oxidation at other residues in BR is nonetheless somewhat surprising. Most importantly,
however, it was demonstrated that Met labeling provides structural information. Extensive
MetO formation occurred at M32, M68, and M163 which are solvent exposed in loop
regions. The labeling levels at the remaining six Met residues were several fold lower,
consistent with their locations in solvent-inaccessible regions of the purple membrane.
Many membrane proteins are rich in methionine, and hence the mapping of Met oxidation
represents a promising approach for obtaining structural information on these species in
situ, i.e., in their natural lipid environment. This simple method could become a useful

complement to the current practice of generating numerous cysteine mutants for tagging
experiments aimed at exploring membrane protein structures and topologies.42, 43

The aim of the present work is to characterize the structure of a membrane protein under
semi-denaturing conditions, using bacteriorhodopsin (BR) as a model system. This work
employs a combination of optical spectroscopy and oxidative labeling for characterizing
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the structure of BR under partially denaturing conditions. Data obtained for the native
protein are compared to measurements carried out in the presence of acid, SDS, and after
exposing the protein to heat. Previous studies have shown that all three conditions modify
the properties of BR to a certain extent. The exact nature of these changes, however,
remains a matter of debate. Much of the ongoing controversy regarding the structure of BR
in the presence of denaturants stems from complications with the interpretation of CD
spectra for proteins within membrane sheets.44,

45

Additionally, in the case of

SDS-containing solutions detergent binding to peptide carbonyl groups affects differences
in the absorption of left and right circular polarized light.46 The oxidative labeling
technique used here represents an alternative structural approach. We demonstrate that each
of the tested conditions results in structural features that give rise to characteristic Met
oxidation patterns and spectroscopic signatures. Oxidative labeling experiments on BR
variants that contain additional Met residues make it possible to probe the solvent
accessibility of the protein with an even better coverage. This work demonstrates how the
combination of oxidative labeling with protein engineering and optic measurements can
provide insights into structural aspects of membrane proteins.

3.2 Experimental
3.2.1 Sample Preparation
Purple membranes from H. salinarum were harvested and purified by sucrose gradient
centrifugation as described in Chapter-2. Cell lines expressing the L93M and V179M
variants were a generous gift from Janos K. Lanyi (University of California at Irvine).
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Purification of these mutant proteins was performed in the same way as for wt BR. The
expected masses of intact wt BR, L93M BR, and V179M BR based on the amino acid
sequences (including retinal) were calculated as 27050 Da,47 27068 Da, and 27082 Da,
respectively. Intact mass measurement of all three BR samples confirmed these theoretical
mass values to within ± 1 Da. The amino acid substitutions of the two mutated proteins
were further verified by tryptic peptide mapping and ESI-MS/MS (data not shown). All
protein samples were stored at -80 °C prior to analysis. Sequencing-grade modified trypsin
was purchased from Promega (Madison, WI). The acid-labile surfactant RapiGest SF was
obtained from Waters (Milford, MA). SDS, ammonium bicarbonate, sodium phosphate,
potassium phosphate, formic acid and NATA were from Sigma (St. Louis, MO). All
chemicals were used as received.

Structural studies on BR were carried out by exposing purple membranes to four different
solvent conditions. For experiments on the native protein, native purple membranes or
mutants were suspended in 10 mM sodium phosphate buffer at pH 7. Acidic samples were
generated by addition of HCl to pH 2.5. Lower pH values induced excessive aggregation
and hence were not used in this work. SDS samples were exposed to 0.2% (w/v) (7 mM)
sodium dodecyl sulphate in 10 mM sodium phosphate buffer (pH 7). The critical micelle
concentration of SDS under these conditions is 5 mM.48 SDS samples containing higher
detergent concentrations (up to 2%) yielded experimental results very similar to those
discussed above for 0.2% (data not shown). Heat-exposed BR was obtained by incubating
samples containing 10 mM sodium phosphate buffer (pH 7) in a water bath at 100 0C for 8
minutes, followed by cooling to room temperature (22 ± 1 0C). After these procedures all
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samples were sonicated in a water bath (Fisher Scientific, FS60, Ottawa, Ontario, Canada)
for 15 minutes, followed by equilibration at room temperature for six hours.

3.2.2 Optical Spectroscopy and Oxidative Labeling
UV-Vis absorption data were recorded on a Varian Cary 100 spectrophotometer (Varian,
Mississauga, Ontario, Canada). Fluorescence emission spectra were acquired on a
Fluorolog-3 instrument (Horiba Jobin Yvon, Edison, NJ) with an excitation wavelength of
280 nm. All optical measurements were performed at a protein concentration of 15 µM at
room temperature. Protein-free solutions were used as blanks.

Covalent labeling of BR was performed as described in Chapter-2. Briefly, solutions with
a total protein concentration of 12 µM were pumped through a 100 µm i.d. flow capillary
made of fused silica (TSP100170 Polymicro Technologies, Phoenix, AZ) at 40 µL min-1.
The sample solution also contained 0.05% (15 mM) H2O2, 3% sucrose, and 15 mM
glutamine as radical scavenger.39 A KrF excimer laser (GAM EX 100/125, Orlando, FL)
producing 18 ns pulses at 248 nm and 16 Hz was used to generate hydroxyl radicals by
peroxide photolysis. Each laser pulse induces labeling of a 16 nL portion of sample. The
resulting single-exposure flow segments are separated by 24 nL portions of non-labeled
solution, estimated on the basis of a plug flow approximation.49 These conditions were
chosen in order to eliminate oxidation-induced structural artifacts, as discussed in detail
elsewhere.39 Capillary outflow aliquots of 100 µL were collected in microcentrifuge tubes
containing 10 µL of 1 µM catalase (pH 7) for removal of residual H2O2. To ensure catalase
activity the collection tube also contained 10 µL of 200 mM phosphate buffer (pH 7) for
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acidic samples, and 300 µL water in the case of SDS experiments. Control experiments
carried out with and without H2O2 revealed the occurrence of secondary oxidation reactions
at a low level,50 corresponding to an average difference in oxidation background of less
than 2%.

3.2.3 Peptide Mapping and UPLC/MS Analysis
100 µL aliquots of unlabeled control samples or labeled BR samples were lyophilized.
Subsequently, the dry powder was dissolved in 40 µL of 50 mM ammonium bicarbonate
buffer (pH 8) containing 0.1% (w/v) RapiGest. Dissolution was achieved by extensive
vortex mixing followed by 15 minutes of sonication in a water bath. For native, heated, and
acidic BR the resulting solutions were digested directly with trypsin for 24 h at 37 °C using
a 1:20 (w/w) enzyme: protein ratio. SDS interferes with digestion and had to be removed
by K+ precipitation. For this purpose 8 µL 1.0 M potassium phosphate buffer (pH 8) was
added to the SDS sample solutions. The resulting precipitate was removed by
centrifugation at 13,000 g for 5 minutes. The supernatant was digested as described above.
All digests were flash-frozen in liquid nitrogen and stored at -80 °C.

Protein digests were analyzed on a Q-TOF Ultima API mass spectrometer (Waters)
equipped with a Z-spray ESI source. Spectra were acquired in positive ion mode at a
sprayer voltage of 3 kV and a desolvation temperature of 250 °C. The mass spectrometer
was coupled to an Acquity UPLC system (Waters) employing a 1.7 µm C18 BEH 130
column (2.1 mm × 100 mm). For each injection 5 µL of digested sample were loaded onto
the UPLC column without prior lipid or RapiGest removal. Solvent A was 0.1% aqueous
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formic acid, and solvent B consisted of 50:50 (v/v) acetonitrile/isopropanol with 0.065%
formic acid. Chromatographic separations were carried out at 40oC with a flow rate of 100
µL min-1. A linear gradient was run from 3 to 5% B in 4 minutes, then from 15% to 40%
B in 7 minutes, from 40% to 70% B in 2 minutes, from 70% to 85% B in 10 minutes, and
finally from 85% to 100% B in 6 minutes. Most peptides eluted in a range between 7 and
24 min. Peptide identities were confirmed by MS/MS in data-dependent acquisition mode,
employing collision-induced dissociation (CID) in an Ar-filled hexapole cell. Oxidation
labeling sites were determined in offline MS/MS experiments, by collecting the UPLC
eluent in a 96-well plate. These samples were then injected into the mass spectrometer
using a TriVersa NanoMate (Advion, Ithaca, NY) chip-based ion source.

3.2.4 Data Analysis
The degree of methionine oxidation for each peptide is reported as the "fraction
unmodified", Fu, which is calculated from the ESI-MS data as
Fu =

Au
Au + Aox

(3-1)

where Au and Aox are the integrated peak areas of the unmodified species and its oxidation
product(s), respectively. Eq. 3-1 is based on the commonly made assumption that
differences in the ionization efficiency between unmodified peptides and the oxidation
products are negligible.33, 51 Some peptides and their oxidation products gave rise to the
formation of sodium adducts, which were also included for calculating Au and Aox. No
particular considerations are required for tryptic peptides that contain a single methionine,
but T3-4 with its three Met residues (M56, M60, and M68) requires special treatment. The
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Fu of M68 can be calculated from the T3-4 labeling data using a modified version of Eq. 3-1

Fu ( M 68) =

Au
Au + Aox ( +16) + Aox ( +32) + Aox ( +48)

(3-2)

and the combined oxidation levels of M56 and M60 are reflected in the expression

Fu ( M 56 / M 60) =

Au + Aox ( +16)
Au + Aox ( +16) + Aox ( +32) + Aox ( +48)

(3-3)

where +16, +32, and +48 refer to signals arising from singly, doubly, and triply oxidized
T3-4. The validity of Eqs. 3-2 and 3-3 is based on the MS/MS results of Figure 3-5.

Not all of the observed protein oxidation is attributable to laser-induced labeling.
Significant oxidation can occur prior to H2O2/laser exposure during pre-treatment of the
samples (especially for heated BR, see Results and Discussion). As noted above, a low
basal level of oxidation (< 2%) is also caused by the presence of H2O2 in the solution. To
take into account these background effects we have to distinguish three different
parameters: (i) Fuapp is the apparent Fu obtained by applying Eq. 3-1 directly to data
obtained after labeling. (ii) Fubgr represents the Fu of BR that has undergone oxidation as a
result of various background processes. The corresponding samples were treated in exactly
the same way as those in the oxidative labeling experiments, except that the
H2O2-containing solutions were not exposed to laser irradiation. (iii) Fucorr reflects the
actual extent of laser-induced labeling, corrected for background oxidation. Let Ru be the
relative peak area of an unmodified peptide in the mass spectrum, and Rox the relative area
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of the corresponding oxidation product(s) with Ru + Rox = 1. Using the superscript notation
defined above, it can stated that
app

Fu

corr

=

Ru

app

Ru
app
bgr
+ Rox − Rox

(3-4)

After considering that (1 - Roxbgr) = Rubgr = Fubgr, and Ruapp = Fuapp we obtain the relationship
app

Fu

corr

=

Fu
bgr
Fu

(3-5)

which provides a simple tool for quantifying the actual amount of laser-induced oxidative
labeling in the presence of background oxidation. All Fu values calculated in this work
represent an average of at least three independent measurements. Error bars reflect the
maximum deviation from each average value.

3.3 Results and Discussion
3.3.1 Optical Spectroscopy
BR in its native purple membrane environment displays an absorption band with a
maximum at 568 nm, attributable to the retinal chromophore (Figure 3-2A).52, 53 Although
the protein contains eight tryptophans (Figure 3-1B), it is only weakly UV fluorescent in its
native state (Fig. 3-2B). The Trp fluorescence properties of BR may be modulated by
several factors.54 However, the low emission intensity observed here for the native protein
is largely due to the fact that most Trp residues (in particular W86, W138, W182, and
W189, Figure 3-1B) are in close spatial proximity to the retinal chromophore, such that
their emission is quenched by FRET.55
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Exposure of BR to pH 2.5 results in a shift of the retinal absorption maximum to around
602 nm (Figure 3-2A). Protonation of D85 has been shown to be chiefly responsible for this
spectroscopic change.56 An elevated background in the absorption spectrum is attributed to
light scattering, suggesting partial aggregation.57 The level of Trp fluorescence quenching
remains virtually unchanged under acidic conditions (Figure 3-2B). Consistent with recent
X-ray data,56 these observations indicate that the retinal remains attached to the protein at
low pH, and that its orientation relative to the Trp residues is similar as in the native state.

BR in SDS exhibits a prominent absorption peak at 392 nm, whereas the 568 nm signal has
disappeared (Figure 3-2A). The 392 nm band is commonly attributed to free retinal.53, 58, 59
Indeed, control experiments carried out on the isolated chromophore in protein-free SDS
solution resulted in an absorption band very similar to that in Figure 3-2A, with a maximum
at 394 nm (data not shown). This finding confirms that residual interactions between the
retinal and the protein (and/or the membrane lipids) are absent or extremely weak. A
fourfold increase in the Trp fluorescence intensity (Figure 3-2B) is consistent with a
disruption of the Trp to retinal FRET, a result that also points to removal of the
chromophore from its binding pocket.55

Previous calorimetry studies have shown that BR exhibits a reversible premelting transition
at ~78 °C, which is followed by a main transition at ~96 °C that is irreversible.53, 60
Irreversibly denatured protein was produced in this study by heating to 100 °C, followed by
cooling to room temperature. The retinal absorption spectrum measured after this heat
treatment is weak, with faint bands around 570 and 390 nm (Figure 3-2A). We attribute this
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Figure 3-1. Side view (a) of BR (pdb code: 1XJI) and top view (b) from the extracellular.
Transmembrane helices (A-G) are shown in gray cylinders; methionines are in red spheres.
Also shown are leucine 93 and valine 179 (blue spheres) which were converted to
methionines for some experiments. Tryptophan side chains that are in close proximity to
the retinal (shown in green) are highlighted in purple sticks. Other tryptophans are shown in
orange.
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Figure 3-2. (A) UV-Vis absorption spectra and (B) fluorescence emission spectra of BR
under different conditions. Dotted lines, pH 7 (native protein); dashed line, pH 2.5; solid
line, pH 7 in 0.2% SDS; dash-dotted line, pH 7 after heating to 100 0C. Also shown in panel
B are fluorescence data for 20 µM NATA in 0.2% SDS, normalized to account for the
different concentration and the number of chromophores per molecule.
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behavior to partial dissociation of the retinal from the protein, followed by aggregation of
the chromophore in the solvent. Evidence for partial retinal release from its binding pocket
also comes from the fluorescence data in Figure 3-2B, which show an almost threefold
increase in emission intensity as the result of a reduced Trp-retinal energy transfer
efficiency. In addition, thermal decomposition of retinal could occur under these conditions
as well.

In summary, the data in Figure 3-2A report the retinal binding state under the various
experimental conditions. The retinal remains attached to the protein at acidic pH. Heat
treatment of the protein induces partial retinal release, whereas a complete disruption of the
retinal-protein interactions occurs in SDS. These findings are in agreement with the results
of previous work.45,

53, 56, 58, 61

Fluorescence data of Figure 3-2B also provide some

information on the degree of protein unfolding in response to the three denaturing agents.
In particular, the fluorescence emission maximum reflects the degree of Trp solvent
exposure. Native and acidic BR in Figure 3-2B both have their emission maxima at 333 nm.
A slight shift to 336 nm is observed for the heated and SDS samples. Transferring a Trp
residue from a nonpolar environment to the aqueous phase generally results in a red shifted
emission.62, 63 However, the 3 nm change observed here for SDS and heat denaturation has
to be considered very minor. For comparison, Figure 3-2B also contains data for NATA in
SDS, which mimics the properties of an exposed Trp side chain in a detergent-containing
solvent environment. The NATA emission maximum is dramatically red shifted to 360 nm.
Taken together, these data imply that all the Trp residues in BR remain almost completely
shielded from the aqueous environment under all conditions used. This conclusion will be
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complemented with the results of oxidative labeling (see below).

3.3.2 Oxidative Methionine Labeling
Laser-induced oxidative labeling, tryptic peptide mapping, and MS/MS were employed for
studying the solvent accessibility of individual regions in native BR, as well as for
acidified, SDS containing, and heated samples. The resulting tryptic peptides of these
different BR samples are the same as shown in Figure 2-2, yielding a sequence coverage of
97%. As an example, Figure 3-3 illustrates the behavior for fragment T7. The extent of
oxidative labeling for this peptide is minimal for all solvent conditions used. In contrast, T1
shows a low oxidation level only for native and acidic BR, whereas labeling of the SDS and
heated samples results in pronounced +16 Da signals (Figure 3-3, E-H).

MS/MS data of tryptic peptides were employed for identifying the location of oxidation
sites. Consistent with our earlier results on native BR in Chapter-2, it was found that the
oxidation of Met residues to sulfoxide (MetO) is the only identifiable covalent modification,
regardless of the solvent conditions used. Exploring the basis of this remarkable Met
selectivity is beyond the scope of the current work. Selected MS/MS data are depicted in
Figure 3-4, where results for peptide T1 from unlabeled BR (panels A-C) are shown
together with those for oxidized T1 after laser-induced labeling (panels D-F). It is seen that
yn-ions with n > 10 are shifted by 16 Da, identifying M20 as the oxidative labeling site.
MS/MS data for oxidized T3-4 obtained under different conditions (data not shown)
confirm that the single oxidation of T3-4 reflects MetO formation at M68 for all BR
samples studies here, as shown in Figure 2-4.
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Figure 3-3. ESI mass spectra of selected BR tryptic peptides T7 (A-D) and T1 (E-H) after
oxidative labeling under different conditions: First row of panels (A, E), native BR; second
row (B, F), pH 2.5; third row (C, G), in 0.2% SDS; fourth row (D, H), after heat exposure.
Both peptides shown in this figure are triply charged.
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Figure 3-4. Partial MS/MS spectra of the tryptic peptide T1 from unlabeled BR (m/z
1110.60, A-C), and for the peptide (T1 + 16) after laser-induced oxidative labeling of BR in
SDS (m/z 1115.93, D-F). The precursor ion is triply charged.
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Figure 3-5. Laser-induced oxidative labeling of methionine residues in BR. Shown is the
fraction unmodified, Fu, obtained in three different ways: (A-D), uncorrected values Fuapp;
(E-H), background oxidation levels Fubgr; (I-L), values obtained after background
correction (Fucorr). The first row of panels refers to native purple membrane samples; row
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represent data for M32, M68, and M163. Also shown along the bottom are the locations of
individual Met residues in helices A, B, D, E, or G.
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For discussing the oxidative labeling behavior of individual methionines it is convenient to
consider "fraction unmodified" (Fu) values, calculated as outlined in the Experimental
section. Met side chains that are completely shielded are characterized by Fu ≈ 1, whereas
exposure to the solvent leads to Fu < 1. Application of Equation 3-1 directly to the
uncorrected oxidative labeling data yields the Fuapp progressions depicted in Figure
3-5A-D. For assessing the level of background oxidation, experiments were carried out on
all four types of samples in the presence of H2O2 but without laser irradiation (Figure 3-5,
E-H). The Fubgr patterns obtained in this way reveal that background oxidation is quite
predominant for M32 and M163. Both of these residues are positioned in solvent exposed
loops on the cytoplasmic side of native BR (Figure 3-1). Background oxidation of M32 and
M163 is most pronounced after heating (Figure 3-5H), consistent with earlier studies on
other proteins that have demonstrated spontaneous MetO formation at elevated
temperature.57, 64 As a side aspect, we note that these covalent modifications may contribute
to the irreversible nature of BR thermal denaturation.64 Equation 3-5 allows the calculation
of background corrected Fucorr values from the Fuapp and Fubgr measurements. The Fucorr
progressions obtained in this way exclusively reflect oxidation events that are caused by
laser-induced labeling (Figure 3-5, I-L).

Inspection of the corrected oxidation data (Figure 3-5, I-L) reveals that M32, M68, and
M163 exhibit Fucorr values in the range of 0.6 to 0.7 for all solvent conditions studied.
Because only ca. 40% of the solution is being laser irradiated (see Experimental section),
Fucorr ≈ 0.6 corresponds to the maximum possible degree of labeling, reflecting complete
solvent exposure of the affected side chains. The observation of nearly complete oxidative
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labeling for M32, M68, and M163 is consistent with the positioning of these residues in
solvent-exposed loops of native BR (Figure 3-1). The data (Figure 3-5, J-L) demonstrate
that this solvent exposure is retained under partially denaturing conditions. This finding is
particularly noteworthy in the case of SDS (Figure 3-5K), as one might suspect that steric
shielding by detergent binding to solvent exposed methionines 59, 65, 66 could lead to partial
protection from oxidation. Our results imply that any such detergent-mediated shielding at
protruding loops is insignificant.

The results for native BR (Figure 3-5I) show a striking difference in the labeling behavior
of the three solvent accessible methionines (M32, M68, and M163), and the six Met
residues that are buried within the purple membrane. The latter are characterized by Fucorr
values close to unity, which attests to their lack of solvent exposure. This behavior is
consistent with our earlier oxidative labeling data in Chapter-2, as well as with the results
of NMR spectroscopy.67 The dramatic labeling differences of solvent accessible and
inaccessible methionines in Figure 3-5I reaffirms the validity of using MetO formation as
a structural probe in our experiments. This is an non-trivial conclusion, considering that the
high reactivity of methionine can lead to oxidation even for non-exposed residues under
some conditions.51, 68-72 The data of Figure 3-5I demonstrate that such aberrant behavior
does not occur for the experimental settings used here.

3.3.3 Structural Interpretation - Low pH
Of the three denaturants studied here, the effects of low pH on the BR structure are best
understood. Recently it has even been possible to crystallize the protein under acidic
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conditions, revealing that the overall structure of the lipid/protein membranes only
undergoes relatively subtle conformational changes.56 Thus, unlike for many soluble
proteins acid does not induce large-scale unfolding of BR. Consistent with those X-ray
data, the oxidative labeling pattern of acidified BR (Figure 3-5J) is almost indistinguishable
from that measured for the native protein (Figure 3-5I), demonstrating that M20 (helix A),
M56/M60 (helix B), M118 (helix D), M145 (helix E), and M209 (helix G) remain
completely shielded from the solvent at low pH. Also, the optical data of Figure 3-2
confirm that all Trp residues maintain their hydrophobic environment, and that the retinal
remains in its binding pocket under acidic conditions.

3.3.4 Structural Interpretation - SDS Exposure
SDS disrupts the purple membrane and results in BR monomers.58, 61 As noted earlier
(Figure 3-2), SDS exposure also leads to hydrolytic loss of the retinal chromophore.
Obtaining better insights into the protein structure under these conditions is of particular
importance because of the widespread use of SDS-solubilized state as the starting point for
refolding studies.5-8 On the basis of CD measurements it has been suggested that the helical
content of the protein in SDS is reduced from the native state value of 74% down to 42%.45
However, this interpretation has been questioned because of the unique challenges
associated with BR structural studies by CD.44-46 FRET measurements have shown that
SDS exposure leads only to a very small (2 Å) increase in the interhelix distance between
B and F.46 NMR spectroscopy reveals that BR fragments retain a native-like helicity in
SDS,73 but the conformational propensities of these segments may be different in the
context of the full-length protein. Hence, there is no consensus regarding the degree of
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secondary structure loss and unfolding induced by SDS.46

Oxidative labeling of BR in SDS reveals that M20 (helix A) becomes almost completely
solvent accessible with Fucorr = 0.67 (Figure 3-5K). Significant deprotection is also seen for
M118 (helix D, Fucorr = 0.80). In contrast, M56/M60, M145, and M209 retain Fucorr values
close to unity, which means that these residues remain shielded from the solvent. A lack of
water exposure is also evident for the eight Trp residues as seen from the fluorescence data
in Figure 3-2B. These observations imply that a large protein core is preserved upon BR
solubilization in SDS, where a substantial number of residues remain inaccessible to water.
This behavior is different from structural models of other SDS-denatured proteins, where
the detergent is believed to disrupt the majority of all tertiary interactions, as well as unravel
most secondary structure elements.59, 65, 66

In native BR all of M20, M56, M60, M118, M145, and M209 are arranged in close spatial
proximity to the retinal (Figure 3-1). It is remarkable that SDS selectively enhances the
solvent accessibility of M20 and M118, while the four other methionines remain fully
protected. To account for this labeling pattern we will consider two possible scenarios. (i)
It could be envisioned that retinal loss creates a water-filled channel in the protein center,
while leaving the apo-protein structure largely intact. Oxidative labeling of M20 and M118
could then occur after ⋅OH diffusion into this cavity. However, it is difficult reconcile this
proposal with the observation of selective labeling for just two residues. For example,
M118 and M145 are directly adjacent to each other in the native retinal binding pocket
(Figure 3-1), but only the former gets oxidized in SDS. Also, the fact that the Trp residues

94

maintain a nonpolar environment (Figure 3-2B) argues against an SDS-denatured state that
bears an internal water-filled cavity. (ii) An alternative model for BR in SDS represents a
more likely scenario, where hydrolytic retinal loss leads to collapse of the binding pocket
such that water remains largely excluded from the protein core. We propose that the solvent
exposure of M20 and M118 can be accounted for by partial breakdown of helices A and D,
concomitant with exposure of the unraveled regions to the bulk (Figure 3-6). The possible
involvement of such "extrusion phenomena" for partially denatured membrane proteins has
been noted earlier.74 Evidence for partial unfolding of helix D in SDS also comes from
earlier fluorescence tagging experiments.75 The outside faces of the remaining helical
elements will be surrounded by detergent molecules in a micellar fashion, such that a
hydrophobic environment is maintained. Complete extrusion of helix A is unlikely,
because this would imply solvent exposure for W10 and W12. In the fluorescence spectrum
of Figure 3-2B such a scenario would result in a pronounced red-shifted shoulder. The lack
of such a spectral feature implies that the N-terminal residues of helix A remain protected.

Unfortunately, the absence of Met residues in helices C and F does not allow direct
structural information on these helices to be obtained by oxidative labeling. For gaining a
better understanding of the structure of SDS-denature BR, two BR variants (L93M and
V179M) were examined, which provide potential oxidation sites in helix C or F (Figure
3-1a), respectively. In this way, each helix is covered by at least one potential oxidative
labeling site. Trypsinolysis of L93M BR and V179M BR resulted in similar peptides to
wild type BR. The newly introduced methionines in L93M and V179M variants are located
in peptides T5 and T10-11 (Figure 2-2), respectively. Similar to wt BR, after exposing
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these BR variants to ·OH labeling, MetO formation (corresponding to a +16 Da mass shift)
was the only detectable type of covalent modification. Laser-induced oxidative labeling
was conducted for both native BR variants and SDS-denatured variants.

A comprehensive overview of the protein labeling behavior under native conditions and
SDS state is obtained by considering the Fucorr values of individual Met residues (Figure
3-7). As expected, only the three loop-exposed methionines (M32, M68, and M163) were
extensively oxidized in native state. SDS denaturation did not affect the extensive
oxidation of the loop methionines. In contrast, the denatured protein showed obvious
oxidation on peptide T5 and T1 for both variants. MS/MS data of the oxidized T5 from
SDS-denatured L93M BR (Figure 3-8), as well as SDS-denatured V179M BR (not shown),
confirm that M118 is the only oxidative labeling site in these two variants, whereas the
newly introduced M93 remains protected. In addition, Figure 3-7d reveals that SDS
denaturation affects neither the protection of M209, nor that of the substituted M179.

The labeling behavior of the two engineered residues M93 and M179 indicates that helices
C and F remain essentially solvent-inaccessible in the SDS state. Based on these findings
that M56/M60 (helix B), M93 (helix C), M145 (helix E), M179 (helix F) and M209 (G)
keep unlabeled, it is suggested that helices B, C, E, F, and G continue to be largely protected
in SDS micelles, as shown in the structural model (Figure 3-6B).
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BR (b), and of the two protein variants after SDS denaturation (c) and (d). Highlighted in
black are results for the L93M and V179M amino acid substitutions. Data for naturally
occurring Mets are in gray

98

y11

YADWLFTTPLMLLDLALLVDADQGTILALVGADGIMIGTGLVGALTK

Normalized ESI MS Intensity

83

y11

y14

y15

y12

y11

1040

+16 Da

1080

1120

1160

1360

1400

1440

m/z

Figure 3-8. Partial MS/MS product ion spectra obtained after fragmentation of unlabeled
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It is noted that the observed lack of solvent exposure for M56/M60, M93, M145, M179 and
M209 in SDS state does not provide direct proof for the intactness of the corresponding
helices B, C, E, F and G. In principle, protection from solvent access at these residues could
not be ruled out if the micelle-embedded protein segments in Figure 3-6B were to adopt a
more disordered, yet compact conformation. In view of the strong evidence for
considerable helical structure in the SDS-state of BR,45,

46, 73

however, the situation

depicted in Figure 3-6B represents a far more likely scenario.

To test if the structure of BR in SDS is affected by the presence of the retinal in the solution,
oxidative labeling was also carried out on the retinal-free protein (bacterioopsin, BO) in
SDS. The resulting BO labeling pattern (not shown) was found to be indistinguishable from
that of SDS-solubilized BR in Figure 3-5K. In agreement with the optical data of Figure
3-2, this result supports the view that residual protein/retinal interactions are very weak or
absent.

3.3.5 Structural Interpretation - BR after Heat Exposure
Earlier studies on the irreversible thermal denaturation of BR found that cooling of purple
membranes to room temperature after heating to 100 °C leads to limited breakdown of the
trimeric packing.53 In addition, partial loss of retinal takes place (Figure 3-2). Alterations
of the protein's helical structure upon thermal denaturation have been suggested based on
infrared spectroscopy and HDX measurements.76,
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partial disruption of the purple membrane patches.77

Dynamic light scattering indicates

100

Labeling of heated BR leads to significant oxidation of M20 (helix A) and M118 (helix D)
with Fucorr ≈ 0.8, whereas M56, M60, M145, and M209 remain fully protected (Figure
3-5L). This pattern is reminiscent of that observed in SDS (Figure 3-5K). We thus propose
that the structural model of Figure 3-6B with partial unfolding of helices A and D similarly
applies to heated BR as well. The measured Fucorr values imply, however, that the
breakdown of helix A is less pronounced in the latter case. Instead of being surrounded by
a detergent micelle, the heat-denatured protein is expected to be embedded within a
partially intact purple membrane.77

3.4 Conclusions
Characterizing the conformation of semi-denatured membrane proteins remains a
challenging task. The current work demonstrates the application of oxidative methionine
labeling and mass spectrometry for experiments of this kind, complemented by optical
spectroscopy and site-directed mutagenesis. The distinction between solvent accessible and
protected Met residues provides medium-resolution insights into protein structural changes.
The present work confirms the structural resilience of purple-membrane embedded BR
against acidic pH. In contrast, both SDS exposure and thermal denaturation induce marked
conformational changes. Selective solvent exposure of M20 and M118 under these two
conditions reflects partial unfolding of helices A and D.

The introduction of two additional Met residues (M93 and M179) makes it possible to
probe the solvent accessibility of this protein with a better coverage. Out of the eleven
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methionines, eight are located in transmembrane regions, such that every BR helix is
covered by at least one potential labeling site. SDS solubilization makes M20 and M118
significantly more solvent accessible. But M56/M60, M93, M145, M179 and M209 remain
solvent inaccessible. Based on those labeling data and the results of spectrosopy
experiments, we proposed a structural model of SDS-denatured BR: SDS induces
hydrolytic retinal loss and release of the chromophore into the solvent, which is
accompanied by collapse of the retinal binding pocket and partial unfolding/extrusion of
helices A and D. In contrast, helices B, C, E, F, and G remain largely intact and form a
solvent-inaccessible residue core surrounded by SDS micelles, although the cytoplasmic
side is most likely to be disordered (indicated by HDX studies in Chapter-4).

This work uses MetO formation as an easily identifiable covalent modification for
monitoring the solvent accessibility of individual BR segments. This strategy is particularly
suitable for membrane proteins, because many of these species are methionine rich.78, 79
Here we exploit the fact that X  M substitutions in membrane proteins tend to be
structurally benign due to the medium size and mildly hydrophobic character of
methionine.80 In this way it is possible to engineer additional labeling sites into the protein,
thereby enhancing the level of structural detail. In principle, it would be possible to conduct
studies on protein constructs that contain multiple substituted methionines. This work
followed a more cautious strategy that minimizes the possibility of mutation-induced
structural artifacts by studying one substitution at a time. The combination of protein
engineering and oxidative labeling employed here should also be suitable for monitoring
the structure and conformational transitions of other membrane proteins.
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Chapter-4 Kinetic Folding Mechanism of Bateriorhodopsin
Examined

by

Pulsed

Oxidative

Labeling

and

Mass

Spectrometry
4.1 Introduction
Membrane proteins play a key role in numerous biochemical processes. They constitute one
third of the human proteome, and many of them represent important drug targets.
Membrane protein misfolding caused by genetic defects can lead to various diseases.1
Studying the folding mechanisms of membrane proteins is essential for understanding how
altered structures lead to aberrant function. Despite their biological significance, the
general understanding of membrane protein folding mechanisms is quite rudimentary,
compared to the staggering amount of information that has been amassed for soluble
species.2-4 This imbalance is caused largely by the extreme hydrophobicity of membrane
proteins, and their tendency to aggregate once removed from the natural bilayer
environment.5

These difficulties notwithstanding, encouraging recent progress in the general
understanding of membrane protein structure and folding has been made.6-8 In vitro folding
experiments commence by generating a solubilized denatured state, e.g., in SDS or urea.9
Membrane proteins under these non-native conditions often retain significant secondary
and tertiary structure.8, 10 These (semi)denatured species are then refolded by exposure to
micelles, bicelles,11 or lipid vesicles12 which serve as surrogate for the natural membrane.
The number of membrane proteins that have been successfully refolded increases steadily.9,
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13-17

Methods originally developed for soluble proteins, such as thermodynamic

measurements and φ-value analyses,18 are now also being applied to membrane
proteins.19-22 Despite these advances, however, a consensus folding mechanism has not
emerged yet. For α-helix bundles a two-stage model has been proposed, according to which
insertion of independently stable helices into the bilayer is followed by helix association.23
However, it has now become clear that additional steps are usually required for the
formation of native membrane protein structures.5, 24-26

Deciphering the temporal sequence of events during folding requires time-resolved
structural investigations. Similar to studies on soluble proteins,27,

28

the detection and

characterization of short-lived intermediates is a key requirement for piecing together
kinetic folding pathways. An arsenal of techniques has been developed for characterizing
transiently populated conformers,29 but the applicability of these tools to membrane
proteins is limited. Stopped-flow spectroscopy remains the most common technique in this
area. Unfortunately, the data obtained in this way provide only global information, and
details of the structural changes remain hidden. Engineered fluorescence tags30 or spin
labels31-33 can offer additional insights. Nonetheless, there remains a need to establish
robust techniques capable of monitoring the kinetics of membrane protein structural
changes in a spatially resolved fashion.

Covalent labeling of amino acid side chains in combination with mass spectrometry (MS)
provides an interesting approach for examining protein conformations and interactions.
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Exposure to a hydrophilic labeling agent induces modifications at solvent-accessible sites,
whereas buried residues are protected. MS-based peptide mapping can then be used to
determine the locations and the extent of labeling, thereby providing structural
information.34, 35 Hydroxyl radical (⋅OH) is a widely used covalent probe that can induce
oxidative modifications (typically +16 Da)36-38 at accessible side chains. This oxidative
labeling strategy has been applied for monitoring conformational changes and ligand
binding of several membrane proteins under equilibrium conditions.39-42 Hydroxyl radical
may be formed in different ways,36 e.g., by using an excimer laser for the photolysis of
H2O2. This approach makes it possible to generate very brief (~1 µs) "bursts" of ⋅OH.37 The
ensuing labeling pulses are suitable for characterizing short-lived folding intermediates in
rapid-mixing or temperature-jump experiments.43 The feasibility of this approach has been
demonstrated for several water-soluble proteins.44-47 Here we report the first application of
pulsed ⋅OH labeling for millisecond time-resolved folding studies on the membrane protein
Bacteriorhodopsin (BR).

BR represents the main component of the Halobacterium salinarum purple membrane. A
considerable number of studies have focused on the BR photocycle and its associated
proton transfer events.48-50 Even more important in the context of the current work is the
role of BR as a model system for in vitro folding experiments.8, 13, 51-53 BR refolding
typically starts from the SDS-denatured state. SDS solubilizes the protein in monomeric
form, concomitant with hydrolysis of the Schiff base linkage and retinal loss.54, 55 The
retinal-free protein is referred to as Bacterioopsin (BO). Mixing of SDS-denatured BO with
bicelles or vesicles in the presence of free retinal regenerates native BR monomers.13 The
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kinetic mechanism of this process has been explored by stopped-flow fluorescence,56 CD,57
UV-Vis spectroscopy,51, 58 and by mutational analyses.59 Those studies culminated in a
proposed kinetic folding mechanism that may be summarized as 51
<Scheme 1>
retinal
BO in SDS

I1

I2

IR

native BR

where I1 and I2 denote retinal-free intermediates. Interactions with retinal start to take place
once I2 is formed, whereas the earlier conformational changes proceed independently of the
chromophore.51, 56-59 IR represents a noncovalent protein-retinal complex.13, 54, 60 Formation
of the Schiff base linkage ultimately yields native BR.51, 56

Developing a reaction scheme for the BR refolding process has been a big step forward.51,
56-59

Nonetheless, many aspects remain incompletely understood. Most importantly, it has

not been possible yet to conduct an in-depth structural characterization of the various
intermediates. Even the structural feature of the SDS-denatured state is not clear. Also, the
time scale of I1 formation (milliseconds vs. seconds) remains a matter of debate.59, 61, 62
While <Scheme 1> includes only a single noncovalently bound IR species,51 the
involvement of two sequential IR forms has been proposed on the basis of biphasic retinal
binding data.13, 54, 62 More recently, it has been suggested that two spectroscopically distinct
IR intermediates become populated in parallel, rather than sequentially.56

In the previous work (Chapter-3), combining covalent labeling with site-directed
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mutagenesis and spectroscopic measurements, we proposed a detailed structural model of
SDS-denatured state (Figure 3-6B). SDS exposure induces helices A and D largely
unfolded and most likely extruded from the residual core. Met residues in these helices
(M20 and M118) become solvent-accessible in SDS state, whereas they are protected in
native BR. Nonetheless, the SDS-denatured protein retains significant structure, with a
central region that remains inaccessible to water, and with partially intact helices B, C, E,
F, and G. It is consistent with CD measurements that suggest a helical content of 42% for
BO in SDS, down from the native value of 74%.57 After figuring out the structural feature
of the starting point of BR refolding, the aim of the current study is to gain additional
insights into the structural changes that accompany the BR folding. By exposing the protein
to ⋅OH labeling pulses at selected time points during the folding reaction it is possible to
track which of its 9 Met residues undergo time-dependent changes in solvent accessibility.
Comparative measurements with and without retinal reveal which of the structural changes
are associated with cofactor binding. By complementing covalent labeling with
stopped-flow measurements it becomes possible to establish links between time-dependent
changes in Met accessibility, Trp fluorescence, and retinal UV-Vis absorption.

4.2 Experimental
4.2.1 Materials and Sample Preparation
Purple membranes from Halobacterium salinarum were harvested and purified by sucrose
gradient centrifugation as described in Chapter-2. Sequencing-grade modified trypsin was
purchased from Promega (Madison, WI). RapiGest SF was obtained from Waters (Milford,
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MA). SDS, ammonium bicarbonate, sodium phosphate, potassium phosphate, formic acid,
NATA and all-trans-retinal were from Sigma (St. Louis, MO). DMPC was obtained from
Avanti (Alabaster, AL) and CHAPS was from Calbiochem (San Diego, CA). All chemicals
were used as received, and all measurements were conducted at room temperature.

Delipidated BO in SDS was prepared following established procedures with minor
modifications.62, 63 Briefly, 20 µL of purple membrane stock suspension were added to 400
µL chloroform/methanol/triethylamine (100:80:1 v/v/v), followed by sonication and vortex
mixing for 30 minutes to facilitate Schiff base hydrolysis and retinal dissociation. Addition
of buffer (50 mM sodium phosphate at pH 6, unless noted otherwise) in a 1:1 volume ratio
followed by 10 seconds of vortex mixing resulted in phase separation. Delipidated BO was
recovered as a precipitate at the interface after centrifugation at 13,000 g for 5 minutes.
Phase separation and protein recovery were repeated twice. The delipidated BO precipitate
was dissolved in buffer containing 5% w/v SDS using vortex mixing and sonication for 30
minutes. The resulting solution was then diluted to 0.2% SDS with buffer, followed by 30
minutes of vortexing and sonication. After subsequent centrifugation to remove any
insoluble material, the SDS-solubilized BO was dialyzed twice against 3 L buffer
containing 0.2% SDS to remove residual organic solvent. UV absorption measurements
confirmed the absence of retinal after this procedure. The BO concentration in the resulting
samples was on the order of 20 µM, determined based on a molar absorption coefficient of

ε280 = 65,000 M-1 cm-1.13 Refolding buffer was prepared by sonicating 2% DMPC and 2%
CHAPS (w/v) in phosphate buffer (pH 6) for 30 minutes as described previously.62
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4.2.2 Stopped-flow Spectroscopy
Stopped-flow measurements were conducted on a Biologic SFM 300 (Molecular Kinetics,
Indianapolis, IN) system employing 2-syringe mixing in a 1:1 volume ratio. Syringe 1
contained refolding buffer, and syringe 2 contained 6 µM SDS-denatured BO as well as 30
mM glutamine. The latter was added to maintain consistency with the oxidative labeling
conditions (see below). For experiments yielding refolded BR, 1.3 mole equivalents
all-trans-retinal in ethanol were added to syringe 2 prior to mixing with refolding buffer.
The final reaction mixture contained 3 µM protein, 1% DMPC, 1% CHAPS, 0.1% SDS, 15
mM glutamine, and less than 0.2% (v/v) ethanol. For NATA control experiments, the
protein in syringe 2 was replaced by 50 µM NATA. Stopped-flow absorption spectra were
collected using a photodiode array detector, with a diode wavelength separation of 3 nm.
Water was used as baseline reference. Spectra were collected every 60 ms for the first 6 s,
every 0.5 s from 6 s to 56 s, every 1 s from 56 s to 600 s. The integration time was 20 ms in
all cases, and the observation cell had a 1 cm path length. Stopped-flow fluorescence
measurements were performed using a Biologic MOS-250 module, using a 1 ms integration
time per data point for the first 10 ms of the reaction. Longer integration times were used
for later data points. Tryptophan excitation was at 280 nm with 5 nm bandwidth, and
fluorescence was recorded at 340 nm with 20 nm bandwidth.

4.2.3 Continuous-Flow Mixing and Oxidative Labeling
Folding experiments with pulsed oxidative labeling were performed using a custom built
two-syringe continuous-flow device described previously.44 The contents of syringes 1 and
2 were the same as for the stopped-flow measurements above, except that the protein
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concentration in syringe 2 was 20 µM, while maintaining a retinal:protein molar ratio of 1.3.
Also, 0.24% (v/v) H2O2 was added to syringe 1. Both syringes were advanced at 60 µL
min-1 simultaneously by using a syringe pump (Harvard Apparatus, Boston, MA). Folding
was initiated at a custom-built mixer44 that was connected to a reaction capillary with an i.d.
of 100 µm. The average reaction time is proportional to the distance traveled by the solution
downstream of the mixer. A pulsed KrF excimer laser (GAM EX 100/125, Orlando, FL)
operated at 48 Hz and 62 mJ pulse-1 was used to generate ⋅OH by photolysis of H2O2.
Approximately 35% of the total protein in the reaction capillary was irradiated, estimated
on the basis of a laminar flow approximation.64 Glutamine in the reaction mixture acts as
radical scavenger that reduces the duration of the covalent labeling pulse to ~ 1 µs.37 The
condition was chosen to eliminate oxidation-induced structural artifacts.65 Pulsed labeling
was performed at selected folding time points (20 ms to 10 s) by irradiating the protein at
specific positions along the reaction capillary. The mixer performance was verified
optically.28 Mixing efficiency were also confirmed by labeling fully refolded BR at
different capillary positions. Experiments for a reaction time of "zero", corresponding to
SDS-denatured protein prior to initiation of folding, were conducted by omitting
DMPC/CHAPS and retinal from the mixing experiment. Measurements corresponding to
a reaction time of one day were conducted using manual mixing; for this purpose refolded
BR and BO samples were equilibrated for one day in the dark. Two-syringe mixing was
employed for the latter samples similar to the procedure outlined above, ensuring that the
composition of the final mixture was identical to all other time points.
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4.2.4 Peptide Mapping and Quantification of Oxidative Labeling
120 µL aliquots of capillary outflow were collected in microcentrifuge tubes containing 10

µL of 2 µM catalase and 10 µL of 200 mM methionine amide at pH 7 for deactivation of
residual H2O2.66 For t = 0 samples, the collection vials contained 25 µL of 2 µM catalase,
10 µL of 200 mM methionine amide and 350 µL water, to ensure catalase activity even in
the presence of elevated amounts of SDS. Labeled samples and unlabeled controls were
lyophilized. Subsequently, the dry powder was dissolved in 50 µL of 50 mM ammonium
bicarbonate buffer (pH 8) containing 0.2% (w/v) of the acid-labile surfactant RapiGest. The
resulting solutions were digested with trypsin for 24 h at 40 °C using a 1:10 (w/w) enzyme:
protein ratio. Only for t = 0 samples, 10 µL 1.0 M potassium phosphate buffer (pH 8) was
added and the resulting SDS precipitate was removed by centrifugation. The supernatant
was digested as for the other samples. Peptide analyses and oxidation level measurements
by electrospray MS were performed as described previously in Chapter-3, using a Q-TOF
Ultima API mass spectrometer (Waters, Milford, MA) and an Acquity UPLC system
(Waters) with a C18 column. The identity of tryptic peptides, as well as those of MetO
oxidation sites, was confirmed by MS/MS.

The oxidation behavior of Met residues in the their corresponding tryptic peptides is
reported as "fraction unmodified" (Fu). This value was calculated as Fu = Au / (Aox + Au),
where Au and Aox are the integrated peak areas of the unmodified and the oxidized peptide,
respectively. Protonated as well as sodiated ions were considered for this procedure. A
background correction was performed for all data points. In Chapter 3, we used the notation
Fucorr to emphasize the fact that a background correction had been performed. The
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superscript corr is omitted in this study to improve readability of the text.

4.3 Results and Discussion
4.3.1 Stopped-Flow Spectroscopy
BR was refolded by mixing of SDS-denatured BO, free retinal, and DMPC/CHAPS
bicelles. The Trp fluorescence kinetics associated with regeneration of native BR exhibit a
rapid rise with an apparent rate constant kapp of 250 s-1. This is followed by a bi-exponential
decay with kapp values of 0.16 s-1 and 0.027 s-1 (Figure 4-1a). The decrease in emission
intensity can be attributed to retinal binding, which causes FRET quenching.51, 67 Refolding
in the absence of retinal yields "native" BO (Figure 4-2b).51 Similar to the data of Figure
4-1a an initial rapid rise (175 s-1) is seen under these conditions. The emission intensity in
Figure 4-2b continues to grow in a bi-exponential fashion (0.28 s-1, 0.1 s-1), reflecting an
increasingly nonpolar environment for one or more of the eight Trp residues.51

Based on observations very similar to those depicted in Figure 4-1, the presence of two
apoprotein intermediates I1 and I2 on the BR folding pathway has previously been suggested
(Scheme 1).51 It is well established that I2 is generated on a time scale of a few seconds.51,
59

In contrast, the kinetics of the initial step are more controversial. Early work suggested

that I1 forms within ca. 1 s.61, 62 In later studies it was implied that this first intermediate
might be formed on a much faster (millisecond) time scale,59 which is more in line with the
behavior of many water-soluble proteins.68, 69 Notably, the rapid initial rise (kapp ≈ 200 s-1)
observed for both BR and BO can not be taken as direct evidence of a rapid conformational
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Figure 4-1. Stopped-flow Trp fluorescence kinetics acquired during protein folding in
DMPC/CHAPS bicelles, with λex = 280 nm, λem = 340 nm. (a) Folding of BR in the
presence of retinal; (b) folding of BO in the absence of retinal. Insets show data for the
initial 50 ms. Also included in (b) are data for mixing of NATA in SDS with refolding
buffer. Exponential fitting of the protein folding kinetics yields apparent rate constants of
(a) 250 s-1, 0.16 s-1, 0.027 s-1; (b) 175 s-1; 0.28 s-1, 0.1 s-1. For the NATA experiment an
apparent rate constant of 350 s-1 is obtained.
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change, because a similar feature is seen upon mixing bicelles with the Trp derivative
NATA (Figure 4-1b, inset).51 Nonetheless, the fluorescence data of Figure 4-1 do not
exclude the possibility of millisecond conformational changes during BR and BO refolding.
We will return to this point when discussing ⋅OH labeling data (see below).

Additional insights into protein-retinal interactions can be obtained by tracking the UV-Vis
absorption spectrum of the chromophore throughout the folding reaction (Figure 4-2a).
Free retinal in DMPC/CHAPS exhibits an absorption maximum around 385 nm. After 10
s the retinal peak has shifted to ~399 nm, reflecting formation of the noncovalent
protein-retinal complex IR. The appearance of a strongly red-shifted band with λmax around
560 nm commences on a much slower time scale (tens of seconds to minutes), indicative
of Schiff base formation between retinal and K216.70

UV-Vis kinetic traces for three selected wavelengths are depicted in Figure 4-2b. The
disappearance of free retinal is represented by a decreasing absorption at 382 nm. The rise
and subsequent fall at 439 nm reflects the formation and decay of at least one noncovalent
IR intermediate, whereas the slow rise at 559 nm is associated with native BR formation.
The kinetics of these absorbance changes are well described by bi-exponential fits with kapp
values on the order of 0.1 s-1 and 0.006 s-1 (see caption of Figure 4-2 for details). A close-up
view of the spectroscopic traces confirms that the initial ~0.5 s of BR folding occur without
retinal participation (Figure 4-3). Following this initial lag phase, IR formation is evident
from the absorption increase at 439 nm between 0.5 s and 10 s (Figure 4-3b).
Simultaneously, noncovalent protein-retinal interactions lead to quenching of the Trp
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Figure 4-2. (a) Stopped-flow UV-Vis absorption spectra, collected during protein refolding
in the presence of retinal. Also included is the spectrum of free retinal in the same solvent
as the protein after mixing. (b) Kinetic absorption changes at three selected wavelengths.
Exponential fitting yields the following apparent rate constants: 382 nm, 0.09 s-1 and 0.006
s-1; 439 nm, 0.11 s-1 and 0.008 s-1; 559 nm, 0.1 s-1 and 0.005 s-1.
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stopped-flow Trp fluorescence and (b) UV-Vis absorption spectroscopy. Vertical dashed
lines highlight reaction times of 0.5 s and 4 s. Note that the time axis is not linear.
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emission (Figure 4-3a), implying that the retinal moves relatively close to its native position
in the binding pocket.

The spectroscopic data depicted here, as well as the interpretations offered here are
consistent with previous reports.51, 56-59 The primary purpose of including these optical
measurements is to allow a side-by-side comparison with the ⋅OH labeling data discussed
in the following section.

4.3.2 Pulsed Oxidative Labeling
Earlier work (Chapter-2 and Chapter-3) has demonstrated that MetO formation at solvent
accessible methionine side chains represents the dominant oxidation pathway for BR under
⋅OH labeling conditions. The nine methionines can be divided into three groups according
to their oxidation behavior: (i) M32, M68, and M163 are located in solvent accessible
loops. These residues undergo oxidative labeling both in native and in SDS-denatured BR;
(ii) M56/60 (helix B), M145 (E), and M209 (G) are always protected, consistent with
residual structure in the SDS state; (iii) M20 (A) and M118 (D) are solvent accessible in
SDS, but not in native BR. The locations of all nine methionines are highlighted in Figure
3-1. Wild-type BR does not possess Met residues in helices C and F, but site-directed
mutagenesis was employed to probe the behavior of these regions in Chapter-3. It was
found that methionines introduced into helices C and F behaved just as those of group ii,
i.e., they are always protected. These engineered protein variants therefore do not offer any
additional perspective for the kinetic studies conducted here, and wild-type protein was
chosen for the current work.
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Oxidative labeling was performed by exposing BR to a ~1 µs ⋅OH pulse at various time
points during refolding, using a custom built continuous-flow mixing device.44, 45 The short
duration of the labeling event ensures that oxidation-induced structural artifacts are
negligible.37, 65 The labeling behavior of individual Met residues in BR can be tracked by
monitoring proteolytic peptides that are generated by trypsin digestion after ⋅OH exposure.
This procedure yields a total of thirteen tryptic peptides, referred to as T1 to T13 as shown
in Figure 2-2. Examples of unprocessed MS data are depicted in Figure 4-4. Peptide T1
reports on the labeling behavior of M20. A high level of oxidation occurs in the SDS state
(t = 0 ms, Figure 4-4a), evident from the a strong T1+16 signal which reflects MetO
formation at M20. The intensity of T1+16 drops to background levels within 20 ms (Figure
4-4b). A very different behavior is seen for T5 (M118), where pronounced MetO formation
persists for much longer reaction times (Figure 4-4, f-h). The intensity of the corresponding
T5+16 signal decreases to background levels only after several seconds (Figure 4-4i). The
MS signals of several peptides show sodium adduction (such as T5+Na, Figure 4-4, f-j).
These adducts are a common occurrence in electrospray MS, and their inclusion for
quantitative data analyses is straightforward.

It is customary to report the extent of oxidative labeling as "fraction unmodified", Fu.
Protected Met residues do not undergo oxidation, and hence these sites are characterized by
Fu ≈ 1. In contrast, solvent accessible methionines show significantly lower Fu values. For
the conditions used here ca. 35% of the protein molecules in the reaction mixture undergo
·OH exposure.64 This implies that Fu values around 0.65 are expected for Met residues that
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Figure 4-4. ESI mass spectra of tryptic peptides T1 (M20, helix A, panels a-e) and T5
(M118, helix D, panels f-j) obtained after pulsed ⋅OH labeling at different time points
during BR folding. Labeling time points are denoted along the right hand side. Dotted
vertical lines were included to highlight the temporal changes of the T1+16 and T5+16
oxidation products. All peptide ions are triply charged.
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are completely solvent accessible. Temporal Fu profiles were generated for all nine Met
residues. It turns out that the nine Met residues can be grouped into 3 categories: i.) M56/60
(B), M145 (E), and M209 (G) (shown in blue in Figure 4-5I) are completely protected
throughout the entire reaction.

ii.) the loop residues M32, M68, and M163 (shown in red

in Figure 4-5I) remain exposed during the folding. Fu plots M145 and M163 are
exemplified (Figure 4-5II, a). These data provide an important control, confirming that the
⋅OH labeling conditions before and after mixing are not affected by differential radical
scavenging.

iii.) M20 and M118 (shown in orange in Figure 4-5I) undergo changes of

solvent accessibility during the folding reaction. M20 of helix A is fully exposed only at t
= 0, and complete protection is achieved within 20 ms (Figure 4-5II, b). Helix D exhibits a
different behavior as evidenced by the behavior of M118, which only becomes protected
after 4 s (Figure 4-5II, c). The degree of solvent exposure at t = 0 is slightly lower for M118
(Fu = 0.73) than for M20 (Fu = 0.62). This finding is consistent with earlier results obtained
under equilibrium conditions (Chapter-3).

Oxidative labeling experiments analogous to those just described were also conducted in
the absence of retinal. For the most part, the resulting BO folding data are very similar to
those for BR. The only notable difference is the behavior of M118 in helix D (Figure 4-5II,
f)., which retains extensive solvent exposure throughout the entire reaction.

4.3.3 Implications for the BR Folding Mechanisms
The ⋅OH labeling data of this work provide evidence of a rapid conformational change
during BR folding that goes to completion within 20 ms (Figure 4-5II, b). This rapid
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the average of three independent experiments. Error bars indicate standard deviations.
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structural transition leads to complete protection of the initially solvent-exposed M20. The
most likely explanation of this event is folding of helix A from its largely disordered SDS
conformation. This step is consistent with formation of an early intermediate I1 in Scheme
1.59 Observation of virtually the same M20 labeling kinetics with and without retinal
(Figure 4-5II, e) confirms that this initial step is not affected by interactions with the
cofactor. The transition from I1 to I2 is not associated with changes in Met solvent
accessibility. However, the occurrence of this step is evident from a slow fluorescence
increase for BO (Figure 4-1b), reflecting alterations in the Trp surroundings towards a more
nonpolar environment.51

In the presence of retinal, formation of I2 is immediately followed by noncovalent binding
of the cofactor to yield IR, concomitant with emission quenching as well as an absorption
rise at 439 nm. It is evident from Figure 4-3 that this process extends over at least 10 s.
Interaction of retinal with the protein also triggers the transition of M118 from a solvent
accessible to a protected orientation, an event that goes to completion within only 4 s
(Figure 4-5II, c). The transition is attributable to folding of helix D. In the absence of retinal
(BO folding) this transition does not take place. While this step is dependent on the
presence of retinal, it does not require formation of the Schiff base which occurs on a much
slower time scale. Notably, ⋅OH labeling reveals complete protection for M118 after 4 s,
whereas spectroscopic changes are still ongoing at t = 4 s (Figure 3-4). In other words, not
all the events associated with formation of IR occur with the same kinetics, implying that an
additional kinetic intermediate must be involved.18 Thus, our data reveal the existence of an
"early" and a "late" form of IR. These two forms will be referred to as IR* (t ≈ 4s) and IR**
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(t ≈ 10s), respectively. Similar proposals were put forward earlier on the basis of UV-Vis
measurements.13, 54, 62

It is interesting to speculate on the structural features of IR*. In native BR the retinal ionone
ring interacts with. It has been suggested that this interaction represents a key stabilizing
feature of helix D,70, 71 along with contacts between D and C, E.72 M118 is no longer
solvent accessible in IR*, suggesting that interactions between this residue and the ionone
ring have been established. At the same time, the retinal orientation within the binding
pocket remains very much non-native (evident from incomplete Trp quenching, Figure 4-3,
t = 4 s). A scenario that might account for these observations is that in IR* the ionone ring
is in close proximity to M118, while the hydrophilic aldehyde group remains in contact
with solvent water. Such a situation is in line with the expectation that retinal insertion into
the binding pocket should start with the most hydrophobic part (the ionone ring), whereas
the least hydrophobic part (the aldehyde group) will be buried last. Such an arrangement
should be possible if the retinal were placed close to (and roughly parallel to) helix D, with
its aldehyde group protruding into the aqueous environment. The retinal entry point into the
binding pocket remains a matter of debate.73, 74 Considering the linear dimensions of retinal
and its positioning in native BR (Figure 3-1), our proposed IR* structure is compatible with
entry from the extracellular side. Clearly, further evidence is needed to confirm the
suggestions made in the paragraph regarding the retinal orientation in the IR* intermediate.

The transition from IR* to IR** is associated with a further drop in fluorescence intensity
during the 4 s  10 s time interval (Figure 4-3a). This implies that the retinal moves
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towards its native position during this phase. W86, W138, W182, and W189 are in close
spatial contact with the retinal in native BR as shown in Figure 3-1B, and hence quenching
of these four residues will be chiefly responsible for the declining emission level during the
step from IR* to IR**. Ultimately, formation of the Schiff-base linkage on a time scale of
several minutes leads to native BR. As noted earlier, this final step is associated with an
absorption increase at 559 nm (Figure 4-2).

4.4 Conclusions
This work used pulsed ⋅OH labeling with MS detection, in combination with stopped-flow
spectroscopy for probing structural changes during BR folding. The characterization of
short-lived conformers by oxidative labeling has previously been demonstrated for soluble
proteins,44-47 whereas the extension of this approach to membrane proteins in this study is
new. The optical data presented here are in agreement with previous investigations,51, 57-59
while time-resolved information on the solvent accessibility of individual Met residues
provides additional perspectives.

<Scheme 1> remains a useful framework for describing the overall structural changes
associated with BR folding and retinal binding. Similar to earlier work,13, 54, 62 however, our
data present evidence of an "early" and a "late" form of IR. A modified minimal reaction
scheme for the folding of BR can therefore be expressed as follows:
<Scheme 2>
retinal
BO in SDS

I

I

IR*

IR*
*

native BR
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The transition from SDS-denatured BO to an initial intermediate I1 goes to completion
within 20 ms. This process involves formation of helix A, while helix D remains
disordered. It is likely that formation of I1 occurs simultaneously with BO insertion into the
bicelle, as envisioned by some membrane protein folding models.5, 23-25 Formation of I2
occurs more slowly, on the order of several seconds. This transition involves consolidation
of the protein structure, leading to an increasingly hydrophobic environment for several Trp
residues. Noncovalent binding of retinal takes place once I2 is formed, inducing the folding
of helix D. The intermediate generated in this way is indicated as IR* in Scheme 2. The ~4
s time scale of helix D formation observed here is consistent with a 0.33 s-1 phase that has
previously been observed for this step in fluorescence tagging experiments.30 IR* may
represent a state where the retinal has entered its binding pocket "head first" from the
extracellular side, such that the ionone ring interacts with M118 while the aldehyde tail
remains in contact with the aqueous environment. As the retinal then settles further into the
pocket (evident from ongoing UV-Vis spectral changes and enhanced Trp quenching), the
final intermediate IR** is generated. IR** formation goes to completion within ~10 s.
Establishment of the covalent linkage between the retinal aldehyde group and Lys216
occurs on a time scale of minutes, resulting in native BR.

A sequential folding pathway as in <Scheme 2> is consistent with earlier investigations,51,
57-59

and it is also supported by recent time-resolved spin labeling experiments.33

Nonetheless, the occurrence of parallel events as suggested in some studies59, 75 cannot be
ruled out. The retinal binding mechanism observed here may be different from the
processes occurring during BR reconstitution from apomembrane.72 While our in vitro data

128

provide some evidence for retinal entry from the extracellular side, such a scenario is
unlikely to occur in vivo considering that retinal is produced intracellularly.

It is emphasized that <Scheme 2> should still be considered a minimal model. Structural
changes in addition to those discussed here are likely required to bring about the overall
transition from SDS-denatured BO to native BR. Also, slow (tens of minutes) changes may
occur after BR formation as the chromophore equilibrates into the dark-adapted state.59, 75,
76

One point that remains somewhat unclear is whether the earliest intermediate detected in

our experiments is entirely equivalent to the "I1" species proposed by Booth and
coworkers.51, 59

Overall, this study demonstrates how pulsed covalent labeling can provide mechanistic
insights into kinetic folding transitions of membrane proteins. The information obtained in
this way is complementary to data obtained by classical stopped-flow spectroscopy. It is
hoped that this multi-pronged strategy will also be applicable to other membrane protein
systems, thereby narrowing the existing knowledge gap in this area.
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Chapter-5 H/D Exchange Mass Spectrometry and Optical
Spectroscopy as Complementary Tools for Studying the
Structure and Dynamics of Bacteriorhodopsin
5.1 Introduction
Membrane proteins are involved in many essential processes, including oxidative
phosphorylation, photosynthesis, signaling, and transport. Moreover, membrane proteins
represent important drug targets.1 Despite their tremendous importance, the general
understanding of membrane protein structure and function is miniscule when compared to
the amount of information that is available for their water-soluble counterparts. More than
99.6 % of all known protein structures are for water-soluble species,2 although roughly one
third of the sequences encoded by the human genome are believed to be membrane
proteins.3 This imbalance is due to the fact that most membrane proteins are exceedingly
difficult to work with. Once removed from their natural bilayer environment, they tend to
undergo rapid denaturation and aggregation because of their extreme hydrophobicity. Some
degree of stabilization can be achieved by embedding isolated membrane proteins in
detergent micelles, bicelles (bilayered micelles), or lipid vesicles.4 However, precipitation
often still takes place in these surrogate environments. The application of traditional high
resolution structure determination methods such as X-ray crystallography5 and NMR
spectroscopy 6 to membrane proteins has been demonstrated, but the success rate of these
strategies is low. Alternative techniques that are capable of providing low to medium level
structural information are therefore of considerable interest.7
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Following its inception in the early 1990s,8, 9 hydrogen/deuterium exchange (HDX) in
conjunction with electrospray ionization mass spectrometry (ESI-MS) has evolved into one
of the most commonly used tools for probing the structure, dynamics, and folding of
water-soluble proteins.10-13 Prior to that, NMR-based HDX studies had already become a
well established technique.14-16 HDX experiments rely on the fact that exposure of a
protein to D2O induces N-H  N-D conversion at backbone amide linkages. Disordered
protein regions that are not involved in hydrogen bonding undergo rapid exchange, with
rate constants approaching those of isolated dipeptides.17 In contrast, HDX at
hydrogen-bonded N-H groups is slowed down by as much as eight orders of magnitude.
Exchange at these protected sites is mediated by protein structural fluctuations that involve
the transient disruption of H-bonds and provide temporary solvent access.13, 16 HDX/MS is
typically conducted under exchange-in conditions, where an unlabeled protein is exposed
to D2O.9, 18 Aliquots are taken at selected labeling times, followed by acid quenching at pH
2.5. The protein is then digested by pepsin or other acidic proteases at 0 °C,19 and the mass
shifts of individual fragments are determined by LC/MS. In this way the HDX pattern can
be uncovered in a spatially-resolved manner as a function of time.10-13

Various HDX strategies have also been applied to membrane proteins. Instead of using MS
detection, however, past studies in this area have largely relied on vibrational (FTIR)
spectroscopy. 20-22 Upon N-H  N-D conversion the amide II band shifts from 1550 cm-1 to
1450 cm-1, such that global HDX information can be obtained by deconvolution of infrared
spectra. 23, 24 The use of ESI-MS for membrane protein HDX studies remains rare, and only
a handful of studies have reported the successful application of the standard proteolytic
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digestion approach.25-28 Experiments of this kind are hampered not only by solubility
issues, but also by the difficulty of generating proteolytic fragments from membrane
proteins in sufficiently high yield within a short time at low temperature and pH.29

In an attempt to enhance the general applicability of HDX/ESI-MS to membrane proteins,
this work explores the isotope exchange behavior of bacteriorhodopsin (BR) from
Halobacterium salinarum. Electron microscopy30 and X-ray crystallography5 have revealed
that the 248 residue polypeptide chain of this protein folds into seven transmembrane
helices that are connected by six solvent-exposed loops, similar to the G protein-coupled
receptors of higher organisms.31-33

The seven BR helices surround a central retinal

chromophore that is bound to Lys216 via a protonated Schiff-base, giving the protein its
characteristic purple color. In its native environment BR is packed in clusters of three that
form a two-dimensional hexagonal lattice referred to as purple membrane.30 Trans/cis
isomerization of the retinal allows the protein to act as a light-driven proton pump.

While the structure of native BR is well known, there continue to be uncertainties regarding
the properties of this protein in environments other than the purple membrane. In particular,
the structure of the SDS-denatured state continues to be a matter of debate,34 although this
form frequently serves as starting point for BR folding experiments.35 Using a combination
of optical spectroscopy and HDX/MS, this work explores the properties of five different
types of samples: BR in its native purple membrane, as well as solubilized in two different
detergents (SDS and DM), refolded BR in bicelles, and after cleavage of the Schiff-base
linkage. Owing to the experimental difficulties outlined above, we focus on the HDX
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behavior of the intact protein, but it is hoped that the experiments described here provide
the groundwork for future spatially-resolved studies.27, 28

5.2 Experimental
5.2.1 Proteins and Reagents
Purple membranes from H. salinarum were harvested and purified as described in
Chapter-2, resulting in aqueous stock suspensions with a BR concentration of ~170 µM.
Samples were stored at -80 °C prior to analysis. Deuterium oxide was obtained from
Cambridge Isotope Laboratories (Andover, MA). SDS, DM, sodium phosphate, formic
acid, hydroxylamine, and all-trans-retinal were from Sigma (St. Louis, MO). DMPC was
procured from Avanti (Alabaster, AL) and CHAPS from Calbiochem (San Diego, CA).

To ensure consistency with previous work

36

all protein solutions were adjusted to pH 6

using 50 mM sodium phosphate buffer (referred to simply as "buffer", unless noted
otherwise). Five types of different protein samples were examined. (i) For studies on native
BR, purple membrane stock suspensions were prepared in buffer at a protein concentration
of 100 µM. (ii) DM-solubilized protein was obtained by exposing native BR stock
suspensions to 0.1 % DM in buffer. These solutions were vortex-mixed for 30 seconds,
followed by sonication in a water bath (Fisher Scientific, FS60, Ottawa, Ontario, Canada)
for 15 minutes, and equilibration at room temperature for six hours. (iii) Bleached
membranes 21, 37, 38 were prepared by exposing 10 µM native BR suspensions in buffer to
0.5 M hydroxylamine at pH 7.7. Subsequently the samples were irradiated for 30 h by 546
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nm light from a Xe/Hg lamp, using the fiber optics-coupled output of a Biologic SFM 4S/Q
(Molecular Kinetics, Indianapolis, IN) spectrometer. The resulting suspension was dialyzed
twice against 3 L buffer (5 mM, pH 6) to remove hydroxylamine. The final bleached sample
was lyophilized and resuspended in water to a protein concentration of 100 µM in buffer.
(iv) SDS-denatured protein was produced by exposing native BR stock suspension to
1.25% (w/v) SDS, followed by vortex mixing, sonication and equilibration as for the DM
samples. The CMC of SDS under the conditions here is around 0.1 % (≈ 3 mM).39 A higher
concentration was used here to ensure the detergent concentration remained well above the
CMC even after dilution during HDX. (v) Refolded BR was prepared from SDS-denatured
bacterioopsin (BO) following established procedures.40 Briefly, native BR purple
membranes were exposed to chloroform/methanol/triethylamine (100:100:1 v/v/v).
Addition of 0.1 M buffer in a 1:1 volume ratio followed by 10 seconds of vortex mixing
resulted in phase separation. Delipidated BO was recovered as a precipitate at the interface.
Phase separation and recovery of the protein interphase were repeated twice. The final
pellet of delipidated BO was dissolved in an aqueous solution of 5% w/v SDS. The
SDS-solubilized BO was diluted to 0.2% SDS and dialyzed against 10 mM buffer
containing 0.2% SDS to remove residual organic solvent. To initiate refolding, the resulting
delipidated BO solution in 0.2 % SDS / 10 mM buffer was vortex mixed with an equal
volume of buffer containing 2% DMPC / 2% CHAPS bicelles at pH 6. All-trans-retinal
(1:1 retinal:protein molar ratio) was added simultaneously from ethanol stock. The final
refolding buffer contained 1 % DMPC/1 % CHAPS/0.1 % SDS, and 0.1 % ethanol. The
solution was equilibrated for one day at room temperature in the dark.
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5.2.2 Optical Spectroscopy
UV-Vis absorption measurements were carried out on a Cary 100 spectrophotometer
(Varian, Mississauga, Ontario, Canada). Trp fluorescence emission spectra were acquired
on a Fluorolog-3 instrument (Horiba Jobin Yvon, Edison, NJ) with an excitation
wavelength of 280 nm. All optical measurements were performed at a protein concentration
of 7 µM at room temperature, using protein-free solutions as blanks.

5.2.3 Hydrogen/Deuterium Exchange
Isotope exchange was initiated by mixing 100 µM protein solutions, prepared as described
above, and D2O-based buffer (with a pH meter reading of 6) at room temperature in a 1:4
volume ratio. After initiation of labeling, 35 µL aliquots were removed at various time
points ranging from one to 120 minutes. These aliquots were quenched by mixing with
6 µL of 500 mM buffer (pH 2) for a final pH of 2.5, followed by flash freezing in liquid
nitrogen. Zero time point controls (m0) for the correction of artifactual in-exchange were
performed by exposing protein solutions to a mixture of labeling and quenching buffer.
Maximally deuterated samples (m100) for the correction of back-exchange were prepared by
incubating 20 µM BR in 0.4% SDS containing 80% D2O at pHread 11.8 and 40 °C for 30 h.
Relative HDX levels were determined as 9
deuteration level = (m - m0) / (m100 - m0)

(5-1)

In this expression m is the mass of the protein, and m0 and m100 are the values of the
corresponding control measurements. The procedure used for determining m100 induces
retinal loss, and hence the measured mass had to be corrected by adding 284.4 Da (mass of
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free retinal) and subtracting 18 Da (loss of water after Schiff base formation) for those
sample that contained the chromophore. The kinetic data were fitted to the biexponential
expression:
deuteration level = A1(1−exp[−k1t]) + A2(1−exp[−k2t])

(5-2)

where A1 and A2 are the hydrogen fractions that undergo labeling with apparent kex rate
constants of k1 and k2, respectively.

5.2.4 Liquid Chromatography/Mass Spectrometry
LC/MS measurements were conducted by using a Waters Acquity UPLC (Milford, MA)
with a Waters SEC column (BioSuite, 4 µm UHR SEC, 4.6 mm × 300 mm), employing
isocratic chloroform/methanol/water/formic acid (400/400/90/25/ v/v/v/v) flow at 0.25 mL
min-1 under quenching conditions (pH 2.5, 0 ºC). The column and extensively coiled
solvent delivery lines were embedded in an ice bath. For each injection 20 µL of sample
were loaded onto the column. The protein eluted after about 10 minutes. The SEC column
was coupled to the Z-spray ESI source of a Q-TOF Ultima API mass spectrometer (Waters).
Spectra were acquired in positive ion mode at a sprayer voltage of 3 kV and desolvation
temperature of 250 °C. Experimental data were converted to mass distributions using the
MaxEnt 1 routine provided by the instrument manufacturer for determination of m, m0, and
m100 in Eq. 5-1. Using maximally deuterated control samples, amide back exchange was
determined to be around 10 %.
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5.3 Results and Discussion
5.3.1 Optical Spectroscopy
Prior to exploring structural aspects of BR by HDX/MS, it is instructive to study the five
different types of samples highlighted in this work by traditional spectroscopic tools. The
retinal absorption spectrum is sensitive to the protein conformation. Native light-adapted
BR in its purple membrane environment has its absorption maximum at 568 nm, indicative
of the covalently linked chromophore in a structurally intact environment.41 For the
SDS-solubilized protein a maximum at 392 nm is observed (Figure 5-1A). This dramatic
blue shift is caused by hydrolytic cleavage of the Schiff-base linkage. SDS denaturation
also affects the emission properties of the eight Trp residues.42 Native BR exhibits a
relatively low fluorescence intensity, mainly because of FRET-based retinal quenching
(Figure 5-1B).43 SDS induces a five-fold increase in Trp fluorescence intensity (Figure
5-1B). These spectroscopic changes reflect the transition to a partially unfolded structure,
concomitant with Schiff-base hydrolysis and release of the detergent-solubilized retinal
into the solvent.44 The lack of a major red shift in the emission reveals that
SDS-denaturation does not cause significant water-exposure of Trp residues. The optical
spectra obtained here for native BR and the SDS-denatured form are consistent with earlier
observations in Chapter-3. The reason for including these data in Figure 5-1 is to facilitate
a comparison with results obtained under the other experimental conditions.

The structural changes that occur upon solubilization of the protein are highly dependent on
the detergent used. DM-solubilized BR exhibits an absorption maximum at the same
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Figure 5-1. (A) UV-Vis absorption spectra and (B) fluorescence emission spectra of BR.
The five line styles represent different experimental conditions as noted in panel A.
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wavelength as the native protein (Figure 5-1A), and the fluorescence intensity increases
only moderately, by a factor of less than two (Figure 5-1B). This behavior is consistent with
previous NMR work45 and indicates that the DM-solubilized protein retains a structure
similar to the native state, despite the breakdown of membrane-bound BR trimers into
monomeric units.46 Our data reiterate the generally accepted view of DM as a "mild"
detergent that tends to preserve membrane protein structure and (to some extent) function,
47-49

whereas SDS typically induces extensive structural perturbations.44

Purple membrane bleaching by hydroxylamine entails cleavage of the retinal-protein
linkage and retinaloxime formation,37 a step that is accompanied by a major change in λmax
to 358 nm (Figure 5-1A). AFM studies have shown that this process leaves the trimeric BR
structure inside the membrane largely intact, but induces loss of crystallinity.38
Interestingly, the fluorescence emission properties of the bleached protein in Figure 5-1B
are almost indistinguishable from those of native BR, implying that FRET-based Trp
quenching by the chromophore still takes place. It can be concluded that the detached
retinaloxime remains trapped inside the chromophore binding pocket, thereby putting a
qualifier on earlier suggestions of chromophore "removal"

21

under the conditions used

here. Extraction of the retinaloxime from the membrane can be achieved by bovine serum
albumin.50

Exposure of SDS-denatured BO to bicelles and free retinal triggers refolding to a
monomeric state.51, 52 The 557 nm absorption maximum of the refolded samples is close to
that of native BR, indicating that the Schiff-base linkage between retinal and K216 has been
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regenerated for the majority of the protein molecules (Figure 5-1A). Compared to the
SDS-denatured state, the Trp fluorescence intensity of refolded BR is greatly reduced.
However, the emission remains ca. two-fold higher than for the native protein (Figure
5-1B). The origin of this behavior is further investigated below.

5.3.2 Size Exclusion Chromatography/ESI-MS
With few exceptions,53, 54 MS analyses of membrane proteins require the analyte to be
separated from surfactants and salts. One approach is to precipitate the protein, followed by
dissolution in organic solvent/acid mixtures. Alternatively, SEC or reverse-phase
chromatography can be used.55 MS studies on intact proteins are an important tool for the
detection of covalently linked co-factors and post-translational modifications.56-58
Unfortunately, the harsh solvent environment typically employed for membrane protein
analyses can induce the loss of some covalently coupled moieties. For example, the MS
detection of intact BR with its chromophore attached is problematic owing to the labile
nature of the Schiff-base linkage. Hence, although retention of the chromophore has been
demonstrated in a few instances,59, 60 most previous MS studies on BR involved complete
or partial BO formation in the course of the analysis.61-65

During the work leading up to the HDX measurements discussed below, we initially carried
out SEC/ESI-MS analyses on BR at room temperature. Those conditions resulted in partial
degradation of the protein-retinal complex consistent with ref. (data not shown). It was then
noticed that the stability of the complex is dramatically enhanced by lowering the elution
temperature to 0 ºC. Analysis of native BR under these conditions results in a major signal
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for the intact complex, whereas retinal-free BO is almost undetectable (Figure 5-2A).
Virtually the same spectrum was obtained for BR after solubilization in DM (data not
shown). In contrast, SDS-denatured protein, as well as bleached membrane samples were
found to be largely devoid of the covalently linked chromophore (illustrated for an SDS
sample in Figure 5-2B). These SEC/ESI-MS findings are in agreement with the optical
results of Figure 5-1, which indicated that the retinal-Lys216 bond remains intact in native
and DM-solubilized BR, whereas both membrane bleaching and SDS-denaturation induce
cleavage of the Schiff-base linkage.

From the data of Figure 5-2A, B it can be concluded that the low temperature SEC/ESI-MS
procedure used here provides an accurate reflection of the retinal binding state in bulk
solution. This technique can therefore be used to determine the regeneration yield of
samples that had undergone SDS denaturation and subsequent refolding. Typical
SEC/ESI-MS data for refolded BR are depicted in Figure 5-2C, revealing the presence of
a dominant peak for the retinal-bound protein and a less intense signal for BO. On the basis
of the 8:1 peak intensity ratio the regeneration yield is 8/9 = 89 %, which is in close
agreement with the A568 ratio of the two samples in Figure 5-1A, as well as with previously
reported values.40 The presence of 11% BO after refolding contributes to the elevated
fluorescence intensity in Figure 5-1B (dash-dotted line).

5.3.3 Hydrogen/Deuterium Exchange SEC/ESI-MS
HDX/ESI-MS protocols typically employ reverse-phase chromatography.66 For the
membrane protein experiments of this work we pursued the SEC-based strategy outlined
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Figure 5-2. Deconvoluted mass distributions obtained by SEC/ESI-MS of unlabeled
protein samples at 0 ºC. (A) native BR, (B) SDS-denatured state, (C) refolded BR. Satellite
peaks are due to sodium adducts. Dashed vertical lines indicate the masses expected for BO
(mBO = 26784 Da) 56 and BR (mBR = 27050 Da).65
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above, as it allows the covalently linked chromophore to be preserved during analysis, such
that co-existing BO and BR species in solution can be monitored separately. High quality
intact protein HDX data were obtained for all five experimental conditions. Native BR
undergoes only a relatively small mass change during the 120 min time window examined
here (Figure 5-3, A-D). In contrast, much more extensive HDX is observed for the
SDS-denatured state (Figure 5-3, E-H). All the samples studied in this work underwent
gradual mass shifts without peak splitting, indicative of HDX in the EX2 regime.18
Satellite peaks in Figure 5-3 are due to sodium adducts, not to EX1 dynamics.18

Amide deuteration levels were determined according to Eq. 5-1 (Figure 5-4). The HDX
kinetics were analyzed on the basis of a biphasic expression (Eq. 5-2), resulting in fits that
are shown as solid lines in Figure 5-4 (parameters are summarized in Table 5-1). The
apparent rate constants determined by this approach are on the order of k1 ≈ 1 min-1 and k2
≈ 0.1 min-1. The kinetic amplitudes associated with these two phases represent the
percentage of amide hydrogens that are weakly (A1) and moderately protected (A2). Anon-ex
= 100 - A1 - A2 represents the percentage of amide hydrogens that is non-exchangeable on
the time scale of our experiments.

In the case of native BR, A1 = 12 % of the amide hydrogens are weakly protected, A2 = 11.7
% are moderately protected, and Anon-ex = 76.3 % do not undergo exchange (Table 5-1). It is
interesting to compare these data with the H-bonding pattern in the 1.55 Å X-ray structure
of the protein. Stable H-bonds were identified by analyzing pdb file 1C3W 5 using Swiss
PDB Viewer default values,67 i.e., a donor-acceptor distance between 2.195 and 3.3 Å, and
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Figure 5-3. Deconvoluted ESI mass distributions of native BR (A-D) and SDS-denatured
protein (E-H), obtained after HDX for exchange times of t = 0 min, 2 min, 10 min, and 120
min. Dotted lines represent mass values for the m0 and m100 controls. The mass range for the
SDS samples (panels on the right hand side) is shifted to account for the loss of retinal.
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a minimum angle of 90º. According to this analysis, almost all of the amide N-H groups in
the transmembrane helices are H-bonded, with the exception of a small number of residues
close to the helix termini. Most of the non-bonded N-H groups are located in the
extramembrane loops (Table 5-2). BR has a total of 248 residues, corresponding to 247
backbone amide bonds. Taking into account the presence of 11 prolines, the number of
backbone N-H groups is 236. Table 2 shows 181 stable H-bonds, which means that an
amide fraction of 181/236 = 76.7 % is expected to be strongly protected. This value is in
very close agreement with the measured value of Anon-ex = 76.3 %. A high resilience against
HDX in the seven transmembrane helices has previously been inferred from tritium
exchange 68, 69 and infrared spectroscopic HDX studies,20, 22 which found the total amide
protection to be in the range of 71 - 80 %. Our HDX kinetics show that the remaining N-H
groups in native BR can be grouped in two categories. A2 = 11.7 % are likely involved in
weak hydrogen bonds that do not appear in the X-ray structure when applying the criteria
listed above. The remaining A1 = 12 % experience an even lower degree of protection,
although their apparent rate constant (k1 = 1.5 min-1) is below the value of kch ≈ 60 min-1 that
would be expected for completely exposed amides in a random coil environment.17

Solubilization of BR in SDS results in dramatically more extensive HDX. Almost half of
all amide hydrogens become rapidly exchangeable (A1 = 46.7 %), whereas A2 = 28.5 %
undergo isotope exchange with an apparent rate constant of k2 = 0.028 min-1. Only one
quarter (Anon-ex = 24.8 %) of all amide hydrogens are non-exchangeable in SDS. These HDX
kinetics suggest partial helix unraveling in the SDS state but with retention of a protein core
that remains inaccessible to solvent water. It is consistent with our oxidative labeling
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Figure 5-4. (A) HDX kinetics of BR under five different solvent conditions, normalized
according to Eq. (5-1). Each data point represents an average of two or three independent
measurements. The experimental error was found to be less than 2%. Solid lines are
biexponential fits, using the expression of eq. (5-2). Fitting parameters are summarized in
Table 5-1. (B) Refolded BR data (open squares) are identical to those in panel A.
Star-shaped symbols represent the HDX behavior of the 11% BO sub-population in the
refolded BR sample (see Figure 5-2C).
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Table 5-1. Parameters obtained from fitting the HDX kinetics of Figure 5-4A according to
the bi-exponential expression of Eq. 5-2. The percentage of "non-exchangeable" hydrogens
(last column) has been calculated as Anon-ex = 100 - A1 - A2.

A1 (%)

k1 (min-1)

A2 (%)

k2 (min-1)

Anon-ex (%)

Native BR

12.0

1.5

11.7

0.074

76.3

BR in DM

16.6

1.5

9.7

0.074

73.7

Refolded BR

26.9

0.97

10.7

0.027

62.4

bleached
membrane

21.5

2.1

11.9

0.050

66.6

0.69

28.5

0.028

24.8

SDS-denatured 46.7
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Table 5-2. Amino acid sequence of BR.70 Residues that act as amide N-H hydrogen bond
donor (to an amide carbonyl, or to a side chain acceptor) are underlined and bold. Hydrogen
bonds were determined from the X-ray structure of native BR

5

using the procedure

outlined in the text. Non-hydrogen bonded residues include eleven prolines, as well as three
short disordered segments (italicized, not seen in the X-ray structure5). X represents
pyroglutamate.

Segment
N-term.
Helix A
A-B loop
Helix B
B-C loop
Helix C
C-D loop
Helix D
D-E loop
Helix E
E-F loop
Helix F
F-G loop
Helix G
C-term.

Sequence
1
9

H-bon
ds

XAQITGRP8

1

EWIWLALGTALMGLGTLYFLVKG

31

21

32

M G V S35

3

36

D P D A K K F Y A I T T L V P A I A F T M Y L S M L L G 63

24

64

Y G L T M V P F G G E Q N P I Y W 80

9

A R Y A D W L F T T P L L L L D L A L L V 101

19

81

102

D A 103

2

104

D Q G T I L A L V G A D G I M I G T G L V G A L 127

21

128

T K V Y S 132

1

133
156
164
193
200
226

YRFVWWAISTAAMLYILYVLFFG
FTSKAESM

155

23

163

0

RPEVASTFKVLRNVTVVLWSAYPVVWLIG

SEGAGIV

199

25
6

PLNIETLLFMVLDVSAKVGFGLILLR

S R AIFGEAEAPEPSAGDGAAAT S

192

248

225

23
3
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studies in Chapter-3, as well as other earlier work.34, 36 Our date indicate that this residual
core encompasses a total of 0.248 × 236 ≈ 59 protected backbone amides.

In contrast to the behavior observed after SDS exposure, solubilization of BR in DM results
in HDX kinetics that is almost indistinguishable from those of the native state (Figure 5-4,
Table 5-1). Hence, the transition from the native trimeric structure in the purple membrane
to a monomeric DM-solubilized state

46

induces virtually no changes to the BR structure

and dynamics, as previously suggested on the basis of NMR data.45 Bleached membranes
exhibit a roughly two-fold increase in the amplitude of rapidly exchanging hydrogens (A1)
relative to native BR, whereas the value of A2 remains more or less unchanged. Comparison
with the HDX behavior of the SDS-denatured state shows that the structural perturbations
induced by cleavage of the Schiff-base are relatively moderate. The percentage of
non-exchangeable amide hydrogens in the bleached membranes is 66.6 %. Our findings are
consistent with previous

13

C-NMR,37,

71

AFM,38 FRET,72 and infrared studies,21 all of

which indicate that the protein structure in the bleached membrane remains similar to that
of native BR, despite the loss of membrane crystallinity and the occurrence of greater
disorder in some local regions. Thus, major aspects of the native BR structure are not
dependent on the presence of an intact covalent linkage between protein and chromophore.

As noted in the Introduction, one intriguing feature of BR is the possibility to refold the
protein in a bicelle environment after SDS denaturation.35, 73 In contrast to the crystalline
trimeric assembly within the purple membrane, refolded BR is monomeric .51, 52 It remains
somewhat unclear in how far individual refolded protein chains differ from the native timer
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in terms of their structure and dynamics. Optical assays of the type discussed above (Figure
5-1) are not necessarily suitable for exploring this interesting question, because the spectra
represent ensemble averages. In particular, it is difficult to decide whether the presence of
11 % BO in the refolded samples (Figure 5-2C) can account for the elevated fluorescence
intensity seen in Figure 5-1B, and whether the 89 % BR population is affected by structural
perturbations. The SEC/ESI-MS protocol employed here allows the HDX behavior of BO
and BR in the refolded samples to be monitored separately. We find that the HDX kinetics
of these two co-existing sub-population are very similar to each other (Figure 5-4B),
resembling the behavior seen for bleached membranes (Figure 5-4A). Thus, it can be
concluded that in vitro refolding of the protein leads to a native-like conformation, but that
structural perturbations persist for both the retinal-bound (89 %) and the retinal-free (11 %)
forms. NMR data suggest that some of this disorder is attributable to loop elements that do
not fully recover during BR folding in vitro.71,

74

Our findings suggest that the

chromophore plays a relatively minor role as far as the formation of secondary structure is
concerned.75 This assertion is in agreement with the oxidative labeling experiments, which
revealed that the retinal-free protein can fold into a conformation resembling the native
state, where only one of the seven helices (D) remains partially disordered in Chapter-4

5.4 Conclusions
This work employed a combination of optical spectroscopy and ESI-MS-based methods for
exploring the structure and dynamics of BR under various experimental conditions.
UV-Vis absorption measurements report on the intactness of the Schiff-base linkage
between protein and retinal, whereas the fluorescence intensity is sensitive to changes in
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retinal-tryptophan distance. Low temperature SEC/ESI-MS was found to be an even more
direct tool for probing the intactness of the sensitive Schiff-base linkage. This procedure
will likely be applicable to other retinal-containing membrane proteins as well.
SDS-denaturation and purple membrane bleaching induce loss of the chromophore,
whereas solubilization in DM leaves the linkage intact. Bicelle-mediated refolding
predominantly results in the formation of BR, whereas a smaller fraction of the protein
remains in the BO state. HDX measurements by SEC/ESI-MS were shown to represent a
straightforward alternative to traditional infrared spectroscopy experiments

20-22

for

monitoring global changes in BR structure and dynamics. To the best of our knowledge,
this study conducts the first side-by-side comparison of the HDX characteristics for this
important model system under different biochemical conditions. Backbone amide
hydrogens within the seven transmembrane helices of native BR are highly protected. The
number of non-exchangeable hydrogens decreases in the order:

native BR ≈

DM-solubilized BR > bleached membranes ≈ refolded BO ≈ refolded BR >>
SDS-denatured state. However, even the SDS-denatured protein retains a sizeable number
of protected backbone amides.

On the basis of CD measurements it has previously been suggested that SDS denaturation
reduces the helical content of the protein from the native state value of 74 % down to 42
%

36

. That interpretation has been challenged by noting that CD studies on BR are

associated with unique experimental difficulties.34 It is interesting to compare those
previous CD data to the findings of the current work. When judging the secondary structure
content of the SDS state on the basis of amide protection, our data suggest that Anon-ex = 24.8
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% of all amide hydrogens are involved in stable helical elements (Table 5-2). In addition,
the A2 = 28.5 % moderately protected hydrogens in SDS are likely located in regions that
retain some helix propensity as well. A residual helicity of 42 % in SDS as suggested in ref.
36

is therefore not in disagreement with our findings. It is noted, however, that caution

should be exercised when estimating the secondary structure content of a membrane protein
solely on the basis of HDX data, because amide protection might involve significant
contributions from surrounding surfactant molecules.

It is remarkable that ·OH labeling reveals significantly enhanced solvent accessibility for
only two of the helices after SDS exposure in Chapter-3, whereas changes in amide HDX
protection are much more dramatic in this work. This behavior illustrates the
complementarity between the two methods. Covalent labeling strategies probe the solvent
accessibility of reactive sites, whereas HDX monitors structural dynamics and the
intactness of the H-bonding network.76 From an analytical point of view, the stable nature
of protein covalent labels greatly facilitates the proteolytic mapping procedure. HDX
experiments are considerably more challenging in this regard, because back-exchange
requires the digestion and LC separation steps to be completed in as little as about fifteen
minutes.10 The situation is particularly challenging for membrane proteins where digestion
efficiencies under quenching conditions tend to be low,27 and where detergents often
interfere with the analysis. It is therefore not surprising that membrane protein covalent
labeling has become a fairly routine approach, whereas only a handful of HDX studies in
this area have appeared over the past few years.25-28
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Although this work provides interesting information on the global structure and dynamics
of BR, the lack of a robust protocol for spatially-resolved membrane protein studies
represents a severe impediment for studies in this area. In a recent study, Joh et al. applied
the standard HDX/MS approach to SDS-denatured BR,27 and identified less than 50% of
the protein sequence. Spatially-resolved data for native BR could not be obtained.
Unfortunately, we were not successful in extending the approach of that work further,
neither by using pepsinolysis in bulk solution, nor by employing a pepsin column. We
attribute these difficulties to the well known tendency of BR to precipitate under the acidic
conditions required for HDX quenching.77 Rietschel et al.29 recently reported the successful
pepsinolysis of BR, but only under conditions that are incompatible with the HDX
workflow, i.e., up to 16 hours of digestion at room temperature. Nonetheless, results
obtained for a number of other systems

25, 26, 28

suggest that spatially-resolved HDX/MS

studies on membrane proteins will soon cease to be considered a fringe area.
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Chapter-6 Hydrogen Exchange Mass Spectrometry Reveals
Light-Induced Changes in the Structural Dynamics of a
Biomolecular Machine
6.1 Introduction
Native proteins adopt unique structures that are linked to specific biological functions.
However, these structures are not static. Numerous investigations have highlighted a close
association between protein function and dynamics,1-7 although the exact nature of this
relationship remains a matter of debate.8-11 Also, the term "conformational dynamics" can
carry different connotations.12 We propose the following classification:
(i) A switching motion (SM) represents an externally triggered conformational
change. SMs are singular events that may be caused by ligand binding, covalent
modifications, or an alteration in solvent environment. As a result of one of these factors,
the conformational equilibrium of the protein shifts from one region of the energy
landscape to another.13
(ii) Many proteins act as molecular machines that undergo externally driven cyclic
motions (CMs). In contrast to thermal fluctuations (see below), CMs require a non-thermal
energy source that drives structural changes along a well-defined cyclic trajectory. For
example, a number of transporters in the cell membrane exploit energy stored in an ion
concentration gradient to translocate substrate molecules across lipid bilayers. This
pumping action involves protein motions that expose a substrate binding site alternatively
to the cytoplasmic and the extracellular surface.14-16 In a related fashion, the CMs of
stator-rotor assemblies are energized by a proton-motive force or by nucleotide-
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triphosphate hydrolysis.17, 18 The salient feature that distinguishes SMs from CMs is the
inherently repetitive nature of the latter.
(iii) All proteins undergo incessant thermal fluctuations (TFs) that are coupled to
random motions of the surrounding solvent.19 TFs are stochastic events that span a
multitude of time and length scales, from picosecond movements of individual side chains
to infrequent unfolding/refolding transitions of the entire protein.12, 20 At equilibrium, all
states on the energy landscape are populated according to their Boltzmann weights.21 TFs
lead to an ongoing interconversion between these states, with rates that are governed by free
energy barriers.12, 20, 22 SMs and CMs will generally be superimposed by TFs.

In many cases the character of TFs is profoundly different before and after a SM has
occurred. This relationship allows changes in protein switching state to be monitored by
techniques that probe TFs.23, 24 In contrast, much less is known about the relationship
between TFs and CMs.25, 26 One possibility is that TFs are more pronounced when a protein
undergoes CMs. On the other hand, CMs often manifest themselves as rigid-body
movements,27, 28 and it seems conceivable that these motions might have only minor effects
on TFs. The current work explores this issue by monitoring the dynamics of a molecular
machine under "engine-on" and "engine-off" conditions.

TFs can be probed by a variety of techniques. These include computer simulations,29
crystallographic temperature factors,12 single molecule fluorescence assays,30 quasielastic
neutron scattering,26 Mössbauer spectroscopy,20 and NMR spin relaxation measurements.31
In addition, amide hydrogen/deuterium exchange (HDX) methods are being widely used.
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The readout of HDX experiments may be performed by NMR,32 infrared spectroscopy,6
and mass spectrometry.33-36 The latter approach is particularly attractive due to its
conceptual simplicity, high sensitivity, the possibility to distinguish co-existing protein
conformers, and the capability to study proteins that are beyond the NMR size range.

In typical continuous-labeling HDX experiments the protein is placed in a D2O-containing
environment, and deuterium incorporation is monitored as a function of time.32 Backbone
amide hydrogens can reside either in a closed or in an open state.37 Closed sites are
protected from exchange, either by N-H····O=C hydrogen bonding or by solvent exclusion
(or a combination of both). Open sites are not involved in hydrogen bonding and they are
accessible to the solvent.38 HDX at these unprotected sites proceeds with a chemical rate
constant kch.39 Most amide groups in natively folded proteins predominantly reside in a
closed state. Slow HDX at these sites nonetheless takes place due to short-lived excursions
to open conformations. As a result of these TFs, each amide group undergoes exchange
with a characteristic rate constant kHDX. Opening and closing rate constants are designated
as kop and kcl, respectively, and the overall HDX mechanism can be described as 32, 40

kop
Hclose

Hopen
kcl

kch

D

D2 O

(6-1)

The EX1 regime (kch >> kcl) is characterized by kHDX = kop. Under EX2 conditions (kcl >>
kch) isotope exchange occurs with kHDX = Kop × kch where Kop = (kop / kcl). The free energy
difference associated with opening of an amide group in the EX2 regime is

∆GEX2 = - RT ln Kop

(6-2)
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Most HDX investigations in the literature have focused on the effects of SMs.23, 34, 41-47
Comparing "before" and "after" scenarios (such as free vs. ligand-bound), those studies
exploit the fact that the stability of a protein depends on its switching state, leading to
differences in the TFs that modulate the EX2 kinetics according to equation 6-2.48 In
contrast to the numerous HDX studies devoted to SMs, there appear to be no prior attempts
to explore whether the HDX behavior of molecular machines is sensitive to the occurrence
of CMs.

Bacteriorhodopsin (BR) is a molecular machine that acts as light-driven proton pump. In its
natural purple membrane environment BR is packed as trimers that form a two-dimensional
lattice. However, monomers represent the functional unit of the protein.49, 50 Each monomer
consists of seven transmembrane helices that are connected by short loops. In addition, the
protein contains a central retinal chromophore that is bound to K216 via a Schiff base. H+
translocation is mediated by a photocycle that starts with the light-adapted all-trans/15-anti
ground state and proceeds through a number of sequential intermediates.51-54
Photoisomerization of the retinal to the 13-cis/15-anti configuration represents the primary
event. The resulting strained chromophore configuration drives all subsequent steps of the
cycle.54 Vectorial H+ translocation involves proton transfer from the Schiff base to D85,
and subsequent Schiff base reprotonation by D96. Reisomerization ultimately regenerates
the BR ground state. The photocycle is coupled to various protein conformational changes
55, 56

that involve partial rotation, tilting, and bending motions of helices.57-60 In the dark,

the retinal equilibrates between the all-trans/15-anti and 13-cis/15-syn forms.61 Protein
structural differences between the light-adapted ground state and dark-adapted BR are
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small when compared to the substantial motions that occur during the photocycle.62

BR represents a suitable test system for exploring a possible relationship between CMs and
TFs. Under continuous illumination the protein performs an ongoing cycle of structural
transitions,57, 58 whereas many of these motions are absent in the dark.62 We probe the
extent of TFs in comparative HDX measurements with and without illumination. Under
properly controlled conditions our investigations reveal dramatically different isotope
exchange kinetics that reflect a light-induced destabilization of the protein. It appears that
this destabilization is caused by retinal-mediated mechanical agitation, which acts in a
manner comparable to an internal heat source. Our findings highlight the utility of HDX
techniques for studying the behavior of molecular machines.

6.2 Experimental
6.2.1 Reagents and Sample Preparation
Purple membranes from Halobacterium salinarum were harvested and purified by sucrose
gradient centrifugation as described in Chapter-2. SDS, sodium phosphate and formic acid
were from Sigma (St. Louis, MO). L-α-1,2-dimyristoylphosphatidylcholine (DMPC) was
obtained from Avanti (Alabaster, AL) and 3-[(3-cholamidopropyl) dimethylammonio]-1
-propanesulfonate (CHAPS) was from Calbiochem (San Diego, CA). All chemicals were
used as received.

Most experiments were conducted on monomeric BR50, 63 that was generated by refolding
of SDS-denatured bacterioopsin (BO, the retinal-free form of the protein). SDS-denatured
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BO was prepared by delipidation as described in Chapter-4, and the absence of retinal was
confirmed by UV-Vis spectroscopy. Monomeric BR50,

63

was prepared by mixing

SDS-denatured BO with all-trans retinal from an ethanol stock solution in equimolar
retinal:protein ratio. Subsequently, 10 mM phosphate refolding buffer (pH 6) containing
2% DMPC/CHAPS bicelles was added to the mixture. The regeneration yield of this
procedure is on the order of 90%,64 as confirmed on the basis of BR:BO peak intensity
ratios in the mass spectra shown in Chapter-5. Monomeric BO was generated following the
same procedure, but without addition of retinal. All samples were equilibrated overnight at
room temperature in the dark. The resulting solutions contained 10 µM protein, 1% DMPC,
1% CHAPS, 0.1% SDS, and less than 0.2 % (v/v) ethanol. The protein was concentrated
tenfold by lyophylization and subsequent resuspension in phosphate buffer. In addition to
studies on monomeric BR, we also conducted HDX measurements on intact purple
membranes. For these measurements purple membrane stock suspension was diluted with
phosphate buffer to a protein concentration of 100 µM. The final buffer concentration was
100 mM. All other steps were performed as described below for the monomeric samples.

6.2.2 Hydrogen/Deuterium Exchange Under Light/Dark Conditions
All HDX experiments of this work were conducted in continuous-labeling mode. In order
to promote extensive isotope exchange, HDX was conducted in mildly basic solution (pH
meter reading 8.5). Chemical exchange rate constants kch under these conditions are in the
range of 1000 s-1, roughly three orders of magnitude higher than in neutral solution.39, 65
This difference in pH is the reason for the greater exchange levels observed in the current
work, as compared to previous experiments that were conducted at a pH meter reading of
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6 in Chapter-5. BR consists of 248 residues, 11 of which are prolines, such that the number
of backbone N-H groups is 236. Isotope labeling was initiated by mixing the protein
solutions with D2O-based buffer (100 mM sodium phosphate) in a 1:4 volume ratio. The
resulting solution was transferred into two identical microcentrifuge tubes (Eppendorf,
Hamburg, Germany) that had their lids fitted with transparent windows made from glass
cover slips and fastened with epoxy glue. Each tube contained 350 µL protein solution. One
tube was wrapped in aluminum foil and kept in the dark. The other one was continuously
illuminated at 530 nm using a Thorlabs light-emitting diode (model M530L1, Newton, NJ)
that was operated using a 275 mW power supply. The light source was fitted with a
collimator, and the protein samples were irradiated from above through the transparent lid
with a distance of 3 cm between the collimator output and the surface of the solution. Both
tubes were thermostated at 26 °C in a circulating water bath; a digital resistance
thermometer was used to confirm that light and dark samples were at the same temperature.
35 µL aliquots were removed at various time points ranging from 4 minutes to 48 hours.
These aliquots were quenched by mixing with 3 µL of 2 M hydrochloric acid for a final pH
of 2.4, followed by flash freezing in liquid nitrogen.

6.2.3 Liquid Chromatography/Mass Spectrometry
LC/MS measurements were conducted using the same protocol as described in Chapter-5.
The low-temperature SEC/MS analysis can preserve retinal binding to BR, such that the
HDX properties of BR and BO sub-populations in bulk solution could be tracked
independently. Experimental spectra were converted to mass distributions using
deconvolution software provided by the instrument manufacturer. Relative HDX levels of
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the intact protein were determined from the deconvoluted mass distributions using the
relationship36

deuteration percentage =

m − m0
× 100%
m100 − m0

(6-3)

In this expression m is the measured mass (peak maximum) of the protein, and m0 and m100
are the values of zero time point controls and maximally deuterated samples. Zero time
point control data were obtained by exposing the protein first to the 0 ºC quenching solution
and then to the labeling buffer. Maximally deuterated protein samples were obtained by
exposing refolded BO to labeling buffer for 24 h using the same conditions as for the
light/dark samples. The uncorrected labeling level of these samples was 97% (229 out of
236 amide hydrogens), indicating the occurrence of 3% back exchange during analysis.
Normalized HDX kinetics (equation 6-3) was analyzed by single- or double-exponential
fitting using Sigmaplot. All data shown are based on triplicate independent experiments.
Error bars correspond to standard deviations. Both proteolytic digestion34 and top-down
strategies66, 67 were pursued in an effort to obtain spatially-resolved HDX information.
Unfortunately, the sequence coverage of those experiments was not adequate, such that the
considerations of this work must be restricted to HDX data at the intact protein level.

6.2.3 Flash Absorption Spectroscopy
Photocycle kinetics were measured by time-resolved difference spectroscopy, using a
custom-built flash photolysis apparatus.68 0.5 mL of BR solution (prepared as above for
HDX experiments) with an optical density of ~0.6 were placed in a cuvette which allowed
the 532 nm second harmonic of a Nd:YAG Minilite II laser to excite the sample at a 90°
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angle to the probe light beam from a Oriel QTH source. The photocycle was triggered with
a 7 ns laser flash at room temperature. The resulting absorbance changes were recorded
using a photomultiplier, amplifier, and Gage Compuscope AD converter. Up to 600
single-shot traces were averaged to produce an adequate signal-to-noise ratio.

6.3 Results and Discussion
6.3.1 HDX Measurements on Purple Membranes
For comparing BR structural dynamics under illumination and in the dark by HDX mass
spectrometry, investigations were initially conducted on intact purple membranes.
Somewhat disappointingly, the isotope exchange behavior observed under light/dark
conditions for these samples is virtually indistinguishable (Figure 6-1). Consistent with
earlier reports,69, 70 purple membranes exhibit a high degree of protection. Even after an
extended labeling period of 24 h the BR deuteration level is only 43%. Although
spatially-resolved HDX studies on BR are difficult,71 labeling under the conditions of
Figure 6-1 is known to occur predominantly in peripheral regions, i.e., loops and helix
termini.55, 69, 72 Possible effects of light-induced CMs are expected to be most prevalent for
transmembrane segments in the vicinity of the retinal.55, 57, 58 Previous work69 already
implied that opening/closing events (equation 6-1) at these internal segments are
exceedingly rare and/or short-lived, such that the lack of light-induced differences in Figure
6-1 is not completely surprising. Minor light-induced differences in exchange kinetics were
reported in an older tritium exchange study.73 However, those earlier purple membrane
radiolabeling data73 exhibited considerable scatter, and no error bars were reported. Under
the conditions of our work we cannot confirm the effects reported in ref.73 We do not
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dispute that purple membranes undergo a certain "softening" upon illumination, as
suggested by neutron scattering26 and hydroxylaminolysis investigations.63, 74 Nonetheless,
light-induced changes in structure and dynamics do not manifest themselves in altered
HDX kinetics under the conditions of Figure 6-1.

% HDX (EX2)

45
40
35

dark
light

30
0

5

10

15

20

Time (h)

Figure 6-1. HDX kinetics of native BR in purple membranes monitored by ESI-MS. Red
triangles and black circles represent data recorded under green light illumination (530 nm)
and in the dark, respectively. The blue lines represent a bi-exponential fit, D%(t) = y0 +
a1(1−exp[−k1t]) + a2(1−exp[−k2t]), with y0 = 28.7, a1 = 8.1, k1 = 2.56 h-1, a2 = 6.4, k2 = 0.18
h-1. Isotope exchange under the conditions of this experiment proceeds in the EX2 regime;
no EX1-related peak splitting was observed in the BR mass distributions (not shown).
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6.3.2 HDX Measurements on Monomeric BR
Packing effects inside the purple membrane can restrict the extent of protein motions.75, 76
For the remainder of this study we therefore shift our attention from purple membranes to
monomeric BR.50, 63 The monomeric form is known to undergo more extensive HDX as
described in Chapter-5, reflecting greater overall dynamics with enhanced solvent access to
formerly protected amide sites.50 Flash photolysis was used to verify that monomeric BR
undergoes a photocycle (Figure 6-2, black solid lines).28, 77-79 The protein remains active
even after extensive continuous illumination (Figure 6-2, green and blue lines), mimicking
the conditions used for subsequent HDX experiments. For comparison, Figure 6-2 also
shows data for intact purple membranes (black broken line) which reveal photocycle
kinetics that are somewhat faster than for the monomeric protein. The data of Figure 6-2 are
consistent with earlier work on solubilized BR,80, 81 where it was shown that reprotonation
of the Schiff base is slower in the absence of the purple membrane lattice. These altered
kinetics extend the lifetime of the M state, and thus lead to a greater accumulation of this
photocycle intermediate (as seen from the slower decay of the 420 nm signals in Figure 6-2).
Overall, the data of Figure 6-2 confirm that monomeric BR is a functional molecular
machine that continuously undergoes CMs upon illumination, albeit at a lower rate than
purple membrane samples.

Monomeric BR exhibits HDX kinetics that are profoundly different in the dark (Figure 6-3,
a-d) and under illumination (Figure 6-3, e-h). In both cases the protein exhibits a
combination of EX2 and EX1 exchange. The former manifests itself as a gradual shift of
the BR main peak to higher mass (highlighted in green, Figure 6-3). Superimposed on this
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Figure 6-2. BR photocycle kinetics monitored by time-resolved absorption difference
spectroscopy following a 532 nm excitation pulse at pH 8.5. The transients were recorded
at 560 nm (BR ground state), 420 nm (M intermediate), and 640 nm (O intermediate). Data
are shown for monomeric BR without prior continuous illumination (black solid line), after
4 h of continuous illumination (green), and after 24 hour of continuous illumination (blue).
Also included are the kinetics of native purple membranes (black broken line). The data
shown for each sample were normalized to the absorbance of the 568 nm retinal peak.
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Figure 6-3. Mass distributions of monomeric BR at selected HDX time points. Panels (a)
-(d) represent the behavior of samples kept in the dark. Data in panels (e)-(f) were recorded
after continuous illumination of the protein. Black broken lines represent experimental
spectra. Dotted horizontal lines at 27100 Da separate contributions attributable to BO and
BR, as highlighted in panels (b) and (f). Gaussian curve fitting was employed to determine
the locations of peak areas and maxima of BR. Green: EX2 component, blue: EX1
component, black solid line: sum of EX1 and EX2 components.
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EX2 process is the appearance of a highly deuterated EX1 component that increases in
magnitude over time (Figure 6-3, blue). Combined EX1/EX2 processes have previously
been observed for other proteins.40, 82, 83 Figure 6-3 also reveals the occurrence of BR  BO
conversion, leading to ca. 50% retinal loss after 31 h of illumination (Figure 6-3h). This
hydrolysis reaction can also be traced by UV-Vis spectroscopy (data not shown).84 Retinal
loss is less extensive in the dark (Figure 6-3d). The occurrence of retinal loss under
illumination has previously been reported for intact purple membranes, where the
hydrolysis rate was shown to increase with pH. Hence, the observation of this process under
the conditions of the current work (monomeric BR at pH 8.5) is not unexpected. In Figure
6-2 this degradation is not apparent because the photocycle signals were normalized to the
absorption maximum of the active protein. We emphasize that the MS approach used here
allows the HDX kinetics of co-existing BR and BO to be monitored separately. As a result,
the BR behavior can be probed without interference from BO signals (Figure 3). In other
words, the BR data discussed below exclusively reflect the properties of the intact protein,
prior to retinal loss.

Least-square analyses of the measured kinetics reiterate the considerable differences in
HDX behavior for the light/dark samples. Illumination enhances the EX2 rate constant by
a factor of two (Figure 6-4a, see caption for fitting parameters). A similar acceleration
factor is seen for the EX1 process (Figure 6-4b). BO formation under illumination proceeds
with an apparent rate constant of 0.12 h-1. In the dark this Schiff base hydrolysis is much
slower, and the reaction rate cannot be readily determined (Figure 6-4c). The maximum of
the EX1 component (blue peak envelopes in Figure 6-3) corresponds to an HDX level of
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Figure 6-4. Kinetic behavior of monomeric BR under illumination (red) or in dark (black).
(a) EX2 HDX kinetics, determined from the maxima of the "green" component in Figure
6-3. (b) EX1 HDX kinetics, reflecting the rise of the "blue" component relative to the
"green" one in Figure 6-3. (c) Percentage of BO in the protein samples as a function of time.
Blue lines are exponential fits with y(t) = y0 + a(1−exp[−kt]), fitting parameters are shown
in the fugure. Panel (d) shows the results of control experiments, displaying a light/dark
comparison of the EX2 HDX kinetics for pure refolded BO samples.
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89% for all conditions studied. BO peak maxima in Figure 6-3 reveal somewhat higher
HDX levels, between 95% and 100%.

As noted in the Methods section, care was taken to ensure that comparative light/dark
experiments were conducted in an artifact-free fashion. As an additional control, HDX
studies were carried out on pure BO samples, i.e., monomeric protein that had been
refolded in the absence of retinal. Figure 6-4d confirms that the HDX kinetics of these
chromophore-free samples are indistinguishable under illumination and in the dark. This
result reinforces the conclusion that the HDX differences seen for monomeric BR (Figures
6-3, 4) are the result of light-induced protein structural dynamics.

Some readers might be tempted to ascribe the kinetic phenomena (Figure 6-3, e-h) directly
to CMs that occur during the photocycle, possibly interpreting the EX1 "blue" peak as an
accumulating photocycle intermediate. Unfortunately, such an interpretation is incorrect.
The link between illumination and HDX behavior is more subtle, as can be seen from
several arguments. First, the EX1 amide opening rate of 4 × 10-5 s-1 (Figure 6-4b) is many
orders of magnitude slower than the ~ 1 s-1 photocycle turnover rate (Figure 6-2). Thus, the
EX1 peak cannot represent a photocycle intermediate. Also, X-ray crystallographic studies
did not reveal any photocycle intermediates with a large number of open amide hydrogens54
that would be required HDX via equation 6-1. Most importantly, the general nature of the
phenomena seen in Figure 6-3 (i.e., a combination of EX2 and EX1 with slow retinal loss)
is the same in the dark and under illumination. Light exposure enhances the rates of these
processes, while their overall character remains unchanged. It must be concluded that the
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protein motions that mediate HDX largely correspond to intrinsic TFs, rather than
photocycle-associated CMs. The extent of these TFs is dramatically enhanced in the
presence of light-induced CMs. Thus, TFs that mediate HDX are closely coupled to
photon-driven CMs, but the two types of dynamics remain distinct from each other.

6.3.3 Casting the HDX Kinetics in a Thermodynamic/Kinetic Model
The data presented here allow the development of a minimalist model that can account for
the HDX behavior of monomeric BR under light/dark conditions. Our considerations are
based on equation 6-1, according to which HDX is mediated by TFs that result in amide
hydrogen opening/closing transitions.32 For reasons of simplicity, we assume that these
fluctuations encompass distinct groups of amide hydrogens in a cooperative fashion. The
interpretation of protein structural dynamics in terms of such cooperative units (foldons) is
well established.85, 86

For any protein, the occurrence of parallel EX1 and EX2 kinetics implies the involvement
of at least four different conformational species.40,

83, 87

EX2 exchange reflects rapid

fluctuations between the natively folded state F, and a native-like (but partially unfolded)
excited species F*. EX1 exchange can be attributed to the occurrence infrequent transitions
between F and a significantly unfolded conformer U. Slow interconversion between F and
U requires crossing of a major free energy barrier that is associated with a transition state
TS.40, 83, 87 For clarity, we emphasize again that none of the four conformers F, F*, TS, or
U corresponds to a BR photocycle intermediate. Instead, the entire photocycle proceeds
largely within the confines of the native conformational ensemble F. Thermally activated

177

excursions to F* or U are not directly linked to vectorial proton transport.

Figure 6-5 displays the number of open hydrogens for F, F*, TS, and U, together with the
corresponding free energy values. Light and dark scenarios are distinguished by subscripts.
The free energy of U is arbitrarily normalized to zero. The number of open hydrogens in U
is 89%, in accordance with the EX1 signals of Figure 6-3 (blue Gaussian curves). Based on
its HDX level, U is extensively unfolded while retaining some residual protection. We
make the simplifying assumption that the same transition state is encountered under
illumination and in the dark. The positioning of all the species in the two-dimensional
diagram of Figure 6-5 is consistent with the measured HDX parameters (Table 6-1). Only
the location of TS is somewhat arbitrary, since its properties cannot be ascertained with
certainty from the data of this work.

6.3.4 Mechanistic Origin of Differences in Light/Dark HDX Behavior
The findings of this work reveal that illumination of monomeric BR causes sub-global as
well as global destabilization of the protein. EX2 processes report on the former, whereas
EX1 events are related to the latter. At the sub-global level, TFs involve a considerably
larger number of EX2 sites under illumination (15%) than in the dark (9%, Table 6-1). This
implies that transitions between F and F* entail more extensive structural changes when
the protein is exposed to light.26 In other words, F*light represents a more unfolded
conformation than F*dark (Figure 6-5). The occurrence of light-induced destabilization
becomes most obvious when relating the ∆GEX2 values to the number of hydrogens
involved. Accordingly, the average free energy required for the opening of a single EX2 site
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Figure 6-5. Schematic diagram, depicting the properties of monomeric BR conformers
under illumination (red) and in the dark (black). Species highlighted in blue are common to
both scenarios. The x-axis displays the percentage of amide hydrogens that adopt an open
(unprotected) state. The y-axis represents free energy. The positioning of all species is
consistent with the data displayed in Table 1. EX2 processes are mediated by fluctuations
between F and F*, whereas EX1 exchange arises due to interconversion between F and U.
Note that the scaling of the free energy axis in this diagram is not linear, to emphasize
differences between Fdark and Flight. Additional information is provided in the text.
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Table 6-1. Structural and thermodynamic parameters associated with the HDX kinetics of
monomeric BR.

% open N-H
sites in F a

∆GEX2
(kJ/mol) b

% additional open

Free energy difference

N-H sites in F *c

Between U and F
(kJ/mol)

Light

49

40.5

15

3.4 d

Dark

47

42.4

9

5.5 e

Notes:
a

EX2 burst phase amplitude (fitting parameter y0) in Figure 6-4a.

b

Determined from equation 6- 2, with kch ≈ 1000 s-1.39, 65

c

EX2 amplitude (fitting parameter a) in Figure 6-4a.

d

Determined from the EX1 burst phase amplitude, which implies a [U]/[F] equilibrium

ratio of 0.25 under illumination.
e

The ratio of the EX1 rates reflects an activation energy difference according to22

rate1/rate2 = exp(∆∆G#/RT), where |∆∆G#| = 2.1 kJ mol-1. In combination with (d), this
implies an overall free energy difference of (3.4 + 2.1) kJ mol-1 = 5.5 kJ mol-1.
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is 4.8 kJ mol-1 in the dark, but only 2.7 kJ mol-1 during illumination. The EX1 behavior of
monomeric BR suggests that illumination reduces the thermodynamic stability (i.e., the
free energy difference between F and U) from 5.5 to 3.4 kJ mol-1 (Figure 6-5, Table 6-1).
This destabilization causes U to be more highly populated in the light (~ 20%) than in the
dark (< 10%). In our view Schiff base hydrolysis likely occurs from U. The Schiff base is
sensitive to attack by water and other nucleophiles.63, 88 U represents a highly unfolded
conformer that will not significantly protect the Schiff base from solvent access. A
light-induced equilibrium shift from F to U will therefore lead to accelerated retinal loss,
consistent with the behavior seen in Figure 6-4c.

6.4 Conclusions
HDX is mediated by opening/closing events of exchangeable hydrogens that occur as the
result of TFs. In this work we examined the behavior of a molecular machine, with the goal
of determining whether the extent of these TFs depends on the occurrence of CMs. BR is
a molecular machine that is fuelled by light. It is a simple matter to perform comparative
measurements for this system under CM-on and CM-off conditions. Irrespective of the
illumination state, monomeric BR undergoes two types of TFs. Small-scale EX2
fluctuations between the natively folded F and a native-like excited species F* only affect
a handful of N-H sites. In addition, F also undergoes rare EX1 transitions to a much more
unfolded state U.

Amide hydrogen opening/closing events that are probed by HDX do not directly
correspond to structural transitions between individual photocycle intermediates.54,57-59
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Yet, our experiments reveal dramatically enhanced HDX kinetics when the monomeric
protein undergoes CMs in the presence of light. We attribute this phenomenon to a
destabilizing effect of the light-driven trans/cis retinal switching cycle on the overall
protein structure. The retinal is intimately coupled to the surrounding polypeptide
elements.89 Mechanical agitation of the chromophore is transferred to the protein scaffold,
before the energy dissipates into the bulk solvent. The conversion of photon energy to
mechanical motions is therefore comparable to the presence of a heat source in the protein
interior. In other words, the enhanced TFs seen in our HDX experiments can be ascribed to
local heating that occurs as the result of the protein's CMs. The heat involved in this
phenomenon likely represents only a small fraction of the initially absorbed energy (226 kJ
mol-1 for a 530 nm photon). Our interpretation of retinal movements as a source of thermal
energy is consistent with earlier proposals.84 We reiterate that the light/dark comparisons of
this work were conducted at the same bulk temperature. On its way from the retinal "hot
spot" to the thermostated solvent, however, the thermal energy must pass through the
protein where it enhances TFs (opening/closing events) that promote HDX. Investigations
on various different systems have suggested that thermally activated conformational
dynamics can "lubricate" certain aspects of protein function.11,26,53 In this sense, it is to be
expected that the light-enhanced TFs seen here for monomeric BR facilitate certain
structural events that are associated with proton translocation. In any case, the current study
reveals that HDX-based TF measurements offer a window into the inner workings of
molecular machines. In future work, it will be interesting to see if our findings can be
corroborated for other proteins that have their function coupled to an external energy source.
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Chapter-7 Summary and Future Work
7.1 Summary
The fact that membrane proteins are water insoluble and prone to aggregate makes them a
formidable challenge for most analytical techniques. Biochemists require new ways to look
at membrane proteins. This work resulted in the first application of laser-induced oxidative
labeling coupled with MS for exploring the structure and folding of a membrane protein,
bacteriorhodopsin (BR).

In the first step (Chaper-2), native BR in its native lipid environment was exposed to
laser-induced oxidative labeling. It was found that the resulting oxidative labeling occurred
exclusively at methionine (Met) residues. In contrast to previous studies on water-soluble
proteins, the resulting Met oxidative labeling pattern is in excellent agreement with the
known structure of native BR. The finding demonstrates that Met oxidative labeling can
provide structural information on membrane proteins.

In subsequent studies (Chapter-3), the newly developed labeling strategy was applied to
probe the conformational changes of non-native BR samples induced by heat, acid or SDS.
It was found that each of the tested denaturing conditions results in unique structural
features that give rise to characteristic labeling patterns. The labeling data confirmed the
structural resilience of BR against acidic pH. In contrast, both SDS exposure and thermal
denaturation induce marked conformational changes. These results demonstrate the
capability of laser-induced oxidative labeling as a novel tool for characterizing structural

187

changes of membrane proteins in response to the alteration of physiochemical environment.
Oxidative labeling experiments on BR variants that carry additional Met residues provided
even more detailed structural insights that would have been unavailable with the wild-type
protein. Combining oxidative labeling with site-directed mutagenesis and fluorescence
measurements, this work yielded a detailed structural model of SDS-denatured BR, which
has been unobtainable based on previously existing experimental techniques.

In Chapter-4, the oxidative labeling approach was extended further to study the kintetic
folding mechanism of BR. A continuous-flow rapid mixing device was coupled with laser
labeling for this purpose. After the unfolded BR was mixed quickly with a solution
containing lipid/detergent micelles which mimic the native lipid bilayer, short-lived folding
intermediates were labeled. In this way, structural properties of membrane folding
intermediates were uncovered on the basis of their Met labeling patterns. The combination
of pulsed oxidative labeling and stopped-flow spectroscopy revealed unprecedented
insights into the pathways by which the protein inserts and folds into lipid bilayers. The
work conducted thus far highlights the usefulness of laser-induced oxidative labeling in
conjunction with rapid mixing and MS as a new approach for probing temporal structural
changes of membrane proteins under various physiochemical conditions.

In addition to covalent labeling, hydrogen/deuterium exchange (HDX) coupled with MS is
a potentially powerful approach for investigating the structure and dynamics of membrane
proteins. In Chapter-5, in an attempt to enhance the general applicability of HDX/MS to
membrane proteins, low-temperature size exclusion chromatography (SEC) was developed
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to purify various lipid/detergent-bound BR samples prior to ESI-MS analysis. High quality
HDX profiles of BR under various conditions were obtained. Unlike other MS-based
approaches, the newly developed low-temperature SEC/ESI-MS allows the labile
Schiff-base linkage between the protein and retinal chromophore to be completely
preserved, such that HDX properties of co-existing protein sub-populations can be
monitored individually. The distinct structural features of native BR, detergent-solubilized
BR, and regenerated BR were revealed by their HDX kinetics.

In Chapter-6, comparative HDX experiments of BR were carried out in the dark (resting
state) and under steady illumination which induces continuous retinal isomerization that is
associated with the vectorial proton transport (functioning state). The HDX kinetics of BR
are dramatically accelerated in the presence of light. In contrast, control experiments on
retinal-free proteins produced no discernible differences. It was concluded that the extent
of thermal fluctuations in BR strongly depends on photon-driven retinal isomerization. The
result highlights the potential of HDX/MS for probing the structural dynamics of molecular
machines under "engine on" and "engine off" conditions.

7.2 Future Work
7.2.1 Application of Laser-induced Oxidative Labeling
Membrane proteins are key players in many important cellular processes. Due to the
difficulties associated with the expression, purification and crytallization of membrane
proteins, resolving high-resolution structure of these species remains highly challenging.
Topological mapping is thus widely used to provide useful information of the structure and
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function of membrane proteins. Using BR as model system, this work has proven that
laser-induced Met oxidative labeling is a straightforward method for mapping the surface
of membrane proteins. It is especially useful when considering that many of these species
are methionine rich.1,

2

The introduction of additional Met residues as conformational

probes, as well as in vivo structural investigations, represents exciting future extensions of
this methodology.

Currently, we are applying the laser-induced radical labeling coupled with MS to
characterize the structure of WaaL (from E .coli.). WaaL is a transmembrane enzyme
implicated in the biosynthesis of lipopolysaccharides in Gram-nagative bacteria.3 The
structure of WaaL is unknown. The resulting Met labeling pattern was found to be
consistent with the putative topology generated by computational modeling, such that it
provides a preliminary experimental validation to the structural model. Oxidative labeling
experiments on WaaL variants that are engineered with extra methionines are ongoing. The
resulting labeling data will provide more detailed structural information. Also these data
can serve as constrains for further refining the structural model. It is expected that this
technique can serve as a valuable tool for guiding topology prediction and computational
modeling of membrane proteins.4, 5

In addition to providing structural information on native membrane proteins, the
laser-induced oxidative labeling has succeeded in investigating the structure of
semi-denatured BR and even short-lived BR folding intermediates. The approaches
developed in this work should be applicable to other membrane proteins as well.
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7.2.2 Application of HDX/MS for Membrane Proteins
HDX/MS is a powerful tool for studying the structure and dynamics of proteins, but thus far
this technique has been applied mostly to soluble species. In this work, HDX/MS coupled
with low-temperature SEC was developed and validated to be a straightforward strategy to
probe the global conformational changes of BR. Unfortunately, the lack of a robust protocol
for spatially-resolved membrane protein studies represents a severe impediment for studies
in this area. Nonetheless, the ongoing improvements of the HDX and digestion workflow
6-9

suggest that membrane proteins will soon become amenable to spatially-resolved

HDX/MS studies on a routine basis. The utilization of more efficient Ultra Performance
Liquid Chromatography (UPLC) and prior detergent/lipid removal can generally improve
the separation.10, 11 An alternative future development is the combination of solution-phase
HDX with electron-based dissociation techniques for top-down HDX/MS.12-14
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